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Background: Chinese populations have been reported to have a higher stroke 
incidence as well as different stroke epidemiology compared with white populations. 
However, reliable comparisons have been precluded by a lack of methodologically 
robust studies. I aimed to systematically evaluate the incidence of stroke, the 
distribution of its main types/subtypes, and risk factor distributions among stroke 
types/subtypes in Chinese, and to compare these with data from white populations. 
Methods: I performed a series of systematic reviews and meta-analyses of studies 
conducted since 1990 which had data on (1) incidence of stroke, (2) pathological 
types of stroke or ischaemic stroke subtypes, and (3) frequency of risk factors among 
pathological types of stroke or ischaemic stroke (IS) subtypes in Chinese populations, 
and in white populations for comparison. I calculated age-standardized stroke 
incidence and the proportions of each pathological type and ischaemic subtype. For 
each risk factor, I calculated study-specific and pooled odds ratios (ORs) using a 
random effects model for intracerebral haemorrhage (ICH) versus IS, for each IS 
subtype versus other subtypes, and for overall IS patients, comparing findings for 
Chinese versus Whites.  
In addition, I conducted individual patient analyses of data from the National Taiwan 
University Hospital (NTUH) Stroke Registry, which consecutively recruited 6675 
acute stroke patients from 2006-2011, comparing risk factor profiles among stroke 





Results: From my systematic reviews, I found a younger onset of stroke, a slightly 
higher overall stroke incidence and higher proportion of ICH in Chinese versus white 
populations. Although the overall proportion of lacunar infarct appeared higher in 
Chinese from hospital-based studies than white populations, confirming the different 
distributions of ischaemic subtypes will need further comparable population-based 
studies.  
In my meta-analyses comparing risk factors for ICH versus IS, in Chinese - but not 
Whites – hypertension (HTN) and alcohol intake were significantly more frequent, 
while mean age was lower in ICH than IS. In IS, the overall prevalence of 
hypertension, diabetes, smoking, and alcohol intake were similar between Chinese 
and white IS patients, whereas hypercholesterolaemia, ischaemic heart disease (IHD) 
and atrial fibrillation (AF) were less common in Chinese IS patients. As for IS 
subtypes, the relative frequencies of risk factors were mostly qualitatively similar 
(although different in size) in Chinese and white populations. Compared with other 
ischaemic subtypes: large artery atherosclerosis (LAA) strokes were associated with 
diabetes; cardioembolic (CE) strokes were associated with AF and IHD; small vessel 
disease (SVD) strokes or lacunar strokes were associated with hypertension and 
diabetes.  
Analyses of NTUH individual patient data showed that HTN and alcohol intake were 
independent risk factors for ICH versus IS in a Chinese population in Taiwan, 
regardless of age, sex, or other risk factors. The results were consistent with my 
previous risk factor meta-analyses for ICH versus IS. In IS analyses, the prevalence 




Taiwan were higher than the pooled results in my risk factor meta-analysis for IS for 
all Chinese populations including mainland China. In terms of risk factor 
associations with IS subtypes, the findings after controlling for potential confounders 
were mostly close to my previous meta-analysis results with the exception of 
stronger associations of hypertension and diabetes with SVD (lacunar) strokes.  
Conclusion: I have shown a younger onset of stroke, a higher overall stroke 
incidence, an around twofold higher proportion of ICH and different distribution of 
IS subtypes, as well as some differences in risk factor distributions among 
pathological types of stroke and IS subtypes in Chinese compared with white 
populations.  My results help to inform us of different stroke mechanisms in different 
populations, to guide further well-designed research in this area, and to direct better 






AF   Atrial fibrillation 
ARIC  Atherosclerosis Risk in Communities 
CI   Confidence interval 
CE  Cardioembolism 
CS   Carotid stenosis 
CT   Computed Tomography 
DM  Diabetes mellitus 
MRI   Magnetic resonance imaging 
ECG   Electrocardiography 
HC  Hypercholesterolaemia 
HTN  Hypertension 
ICH   Intracerebral haemorrhage 




IS  Ischaemic stroke 
LAA  Large artery atherosclerosis 
LACI   Lacunar infarct 
MI   Myocardial infarction 
MR  Magnetic resonance 
NINDS National Institute of Neurological Disorders and Stroke 
NLAC  Non-lacunar infarct 
NTUH  National Taiwan University Hospital 
OCSP   Oxfordshire Community Stroke Project 




PACI   Partial anterior circulation infarct 
POCI   Posterior circulation infarct 
SAH  Subarachnoid haemorrhage 
SD  Standard deviation 
SVD  Small vessel disease 
TACI   Total anterior circulation infarct 
TIA   Transient ischaemic attack 
TOAST  Trial of Org 10172 in Acute Stroke Treatment 
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Chapter 1.Global stroke epidemiology and classification of stroke types/subtypes 26 
 Global stroke epidemiology and the Chapter 1:
classification of stroke types/subtypes  
1.1 Global epidemiology of stroke 
Stroke is a major global disease and public health challenge. It is the second 
commonest cause of death worldwide after ischaemic heart disease (when cancers 
are counted in different types), and an important global cause of disability (Lopez et 
al. 2006). According to the World Health Organisation (WHO), it is defined as 
“rapidly developed clinical signs of focal (or global) disturbance of cerebral function, 
lasting more than 24 hours or leading to death, with no apparent cause other than of 
vascular origin” (Hatano et al. 1976; Aho et al. 1980).  
 
 Mortality and disability 1.1.1
Stroke caused an estimated 5.7 million deaths worldwide in 2005, and 87% of these 
deaths happened in developing countries (Strong et al. 2007). The impact of stroke 
has not decreased in the following years. From a recent report of the Global Burden 
of Disease Study, stroke was still the second leading cause of death in 2010, 
accounting  for 11% of all causes of death (nearly 5.9 million deaths in worldwide), 
an increase of 26% since 1990 (Lozano et al. 2012). On top of that, stroke also 
results in long term disability and is the fourth leading cause of disease burden 
worldwide (measured in disability-adjusted life years) (Lopez et al 2006).  
 
Chapter 1.Global stroke epidemiology and classification of stroke types/subtypes 27 
The mortality and disability of stroke varies substantially between countries (Warlow 
et al. 2003). There is a ten-fold difference in stroke mortality and disability-adjusted 
life years [DALY] loss, with the highest rates in affecting most in low income 
countries in eastern Europe, north Asia, central Africa, and the south Pacific regions 
(Johnston et al. 2009). Stroke mortality depends on both the incidence of stroke and 
case fatality. Although it has been declining over recent decades in most countries, it 
is increasing in eastern Europe (Sarti et al. 2003). However, some areas do not have 
complete medical records or reliable death certificates, meaning that accurate 
mortality rates are not available for all countries. 
 
 Incidence 1.1.2
Stroke is a non-communicable disease mainly occurring in older people, and the 
incidence of stroke increases with each decade of life. In a systematic review of 
worldwide stroke incidence study, more than half of all strokes occur in patients aged 
75 years or older (Feigin et al. 2003). The average age affected by stroke was 70 
years in men, and 75 years in women. In people aged 55 years or beyond, the overall 
age-standardised incidence of stroke ranged from 420 to 1180 per 100,000 person-
years in population-based studies (Feigin et al. 2003).  
Comparing stroke incidence in different countries, regions or populations as well as 
measuring the trend in incidence needs to use the same definition of stroke, the same 
methods of case ascertainment and data presentation (Sudlow et al. 1996; Okamoto 
et al. 2003; Feigin et al. 2003). However, limited numbers of population-based 
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studies of incidence of stroke have been conducted well enough, using rigorous 
methods to be comparable. In the 1980s, the WHO MONICA (World Health 
Organization Monitoring Trends and Determinants in Cardiovascular Disease) 
project was launched to record the incidence of stroke and myocardial infarction 
aged 35-64 years and to monitor the trends using uniform methods across many 
countries, including 16 European and 2 Asian populations. It revealed large 
geographical variations of all strokes in both incidence and mortality (Thorvaldsen et 
al. 1995). A later systematic review (without upper age limit for the populations 
studied) showed that geographical variations in incidence of all strokes combined 
were modest, smaller than that in the MONICA project, except Ukraine, Russia and 
Japan (Feigin et al. 2003). Methodological variances including case ascertainment 
and age limit may partly explain the difference. However, all these data are mostly 
based on white populations of European origin in developed countries. Few reliable 
and comparable data are available from other populations around the world or from 
developing countries, where the stroke burden is high and where there have been 
rapid changes recently in both economies and lifestyles.  
 
 Stroke in the developing world 1.1.3
While stroke incidence has decreased by around 40% in high income countries over 
the past four decades, it has increased more than 100% in low to middle income 
countries (Feigin et al. 2009). Nowadays, the overall stroke incidence rates, the 
incidences and the proportions of intracerebral haemorrhage and subarachnoid 
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haemorrhage in low to middle income countries are higher than those in high income 
countries (Feigin et al. 2009). Although the 1 month case fatality of stroke is 
decreasing in both high and low to middle income countries, the overall 1 month 
stroke case fatality in low to middle income countries is still 25% higher than that in 
high income countries (Feigin et al. 2009).  
As life expectancy and populations increase, developing countries, especially those 
with rapid economic and epidemiological transition such as China, will possibly have 
a major increase of overall burden of stroke (Truelsen et al. 2001; Yusuf et al. 2001; 
Feigin et al. 2011). Its increasing global impact in the decades ahead is predicted to 
be greatest in middle income countries, and stroke is expected to be the leading cause 
of death in 2030, accounting for around 14% of total deaths (Mathers et al. 2006). 
For intervention and prevention of stroke to be effective with limited resources, it is 
important to establish reliable and accurate data on stroke epidemiology. Thus, 
further research using the best possible sources and rigorous methods to study the 
incidence of stroke and its subtypes, risk factors, and outcome is urgently needed in 
the developing world including Chinese populations (Sudlow et al. 1996; Truelsen et 
al. 2001; Okamoto et al. 2003; Feigin et al. 2003; Feigin et al. 2004; Feigin et al. 
2011). 
 
1.2 Classification of pathological types of stroke 
Stroke is a heterogeneous clinical syndrome. The World Health Organization (WHO) 
has divided stroke into four pathological types – cerebral infarction (or ischaemic 
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stroke), intracerebral haemorrhage (blood vessel rupture with bleeding within brain 
tissue), subarachnoid haemorrhage (blood vessel rupture with bleeding within the 
subarachnoid space), and type unknown (Aho et al. 1980). For large epidemiological 
comparisons, all types of stroke have to fulfil the stroke definition of WHO based on 
clinical manifestations, and appropriately timed brain computed tomography (CT) or 
magnetic resonance imaging (MRI) is important for differential diagnosis of stroke 
types (within 30 days of stroke has been suggested though it may be different in 
clinical practice) (Bamford et al. 1990; Sudlow et al. 1997). Cerebral infarction (or 
ischaemic stroke) has been suggested to have brain CT (or MRI) scan within 30 days 
of stroke, which shows infarct or no relevant lesion, or autopsy proof of infarction. 
Intracerebral haemorrhage (ICH) must have evidence of haemorrhage from brain CT 
(or MRI) scan within 30 days of stroke or autopsy. Subarachnoid haemorrhage (SAH) 
must have appropriate clinical history, and subarachnoid blood on brain CT scan or 
lumbar puncture or source of subarachnoid bleeding from cerebral angiography 
(Sudlow et al. 1997). Patients who have WHO-defined stroke but do not fulfil the 
aforementioned criteria for cerebral infarction, ICH or SAH are assigned to unknown 
type. Among these pathological types of stroke, ischaemic stroke (i.e. cerebral 
infarction) accounts for the largest proportion of stroke, ranging from 67% to 81% of 
total stroke cases, while ICH is responsible for 7% to 20%, SAH for 1% to 7%, and 
unclassified type (i.e. unknown type) for 2% to 15% (Feigin et al. 2003).   
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1.3  Classification of ischaemic subtypes of stroke 
 Trial of Org 10172 in Acute Stroke Treatment (TOAST) 1.3.1
classification  
Ischaemic stroke (IS) can be further classified into several ischaemic subtypes based 
on presumed aetiology or brain anatomy. The Trial of Org 10172 in Acute Stroke 
Treatment (TOAST) classification is the most common used classification system 
clinically (Adams et al. 1993). Ischaemic strokes are classified into five aetiological 
subtypes: 
1. Large-artery atherosclerosis (LAA)  
Clinical findings include cortical, brain stem or cerebellar dysfunction, and 
the corresponding infarct lesions are greater than 1.5 cm in diameter on CT or 
MRI. There is supportive evidence of greater than 50% stenosis of an 
intracranial or extracranial artery by duplex imaging or arteriography, and 
potential sources of cardiogenic embolism are excluded.  
2. Cardioembolism (CE)  
At least one cardiac source for an embolus, such as atrial fibrillation, should 
be identified for cardioembolic stroke. Clinical and brain imaging findings 
are similar to those in large-artery atherosclerosis. The possibility of potential 
large-artery atherosclerotic thrombosis or embolism should be excluded. 
3. Small-vessel occlusion (lacunar, small vessel disease [SVD] strokes) 
Clinical findings of one of the lacunar syndromes should be present, without 
evidence of cortical dysfunction. The patients should also have a normal or 
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relevant infarct lesion with a diameter of less than 1.5 cm on brain CT or 
MRI examination. Potential cardiac sources for embolism and extracranial 
large artery stenosis more than 50% should be absent. A history of 
hypertension or diabetes supports the diagnosis. 
4. Stroke of other determined aetiology  
Patients with clinical and brain CT or MRI findings of an acute IS are found 
to have unusual causes of stroke after investigations, such as non-
atherosclerotic vasculopathies, hypercoagulation states or haematological 
disorders. Cardiac embolism and large-artery atherosclerosis should be 
excluded. 
5. Stroke of  undetermined aetiology 
Acute IS patients have two or more causes identified, or no identifiable 
causes of stroke following complete or incomplete evaluation.  
 
Although the TOAST classification is logical, simple and widely used, it has only 
moderate inter-rater reliability since the interpretation and application of the TOAST 
classification is likely to vary among stroke physicians (Gordon et al. 1993; Meschia 
et al. 2006). In addition, TOAST classification is dependent on a range of 
investigations for possible aetiologies, such as echocardiography, carotid Doppler, 
transcranial ultrasound, and cerebral angiography. These investigations are not 
widely available in all hospitals. Thus, differences in diagnostic work-up may lead to 
substantial variations in the proportion of undetermined IS subtype, which then affect 
the proportions of other ischaemic subtypes and preclude reliable comparisons across 
different studies. Moreover, the definition of TOAST classification is somewhat risk-
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factor dependent. For instance, patients with atrial fibrillation are more likely to be 
assigned to cardioembolic subtype directly, irrespective other risk factor 
investigation results. This could cause a potential classification bias when assessing 
the associations between risk factors and ischaemic subtypes (Jackson et al. 2005). 
 
 Oxfordshire Community Stroke Project (OCSP) 1.3.2
classification 
In the OCSP classification system, patients with cerebral infarction are classified into 
four subtypes according to the clinical presentations of stroke patients, corresponding 
to the arterial territory involved (Bamford et al. 1991): 
1. Lacunar infarct (LACI)  
Patients present with a pure motor stroke, pure sensory stroke, sensori-motor 
stroke, or ataxic hemiparesis. 
2. Total anterior circulation infarct (TACI) 
Patients present with combination of new higher cerebral dysfunction (e.g. 
dysphasia, dyscalculia, visuospatial disorder); homonymous visual field defect, 
and ipsilateral motor and/or sensory deficits.  
3. Partial anterior circulation infarct (PACI) 
Patients present with only two of the three components of the TACI syndrome, 
with higher cerebral dysfunction alone, or with a motor/sensory deficit more 
restricted than those in LACI. 
4. Posterior circulation infarct (POCI)  
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Patients present with any of the following symptoms/signs: ipsilateral cranial 
nerve palsy (III-XII) with contralateral motor and/or sensory deficit; bilateral 
motor and/or sensory deficit; conjugated eye movement deficit; cerebral 
dysfunction; or isolated homonymous visual field defect. 
 
It is simple, quick, and practical, and clinically competent stroke physicians can use 
this method for all ischaemic stroke patients in hospital or in the community. Also, 
the OCSP classification can predict size and site on brain imaging, functional 
outcome, mortality and recurrent stroke clinically (Mead et al. 2000; Bamford et al. 
1991). In contrast to TOAST classification, the OCSP classification scheme does not 
rely on clinical investigations beyond a CT or MR brain scan to distinguish 
ischaemic from haemorrhagic stroke. Thus, differences in diagnostic work-up do not 
lead to variations in ischaemic subtypes. In addition, it is a risk factor-free 
classification method, and is recommended for use in comparing the risk factor 
profiles between lacunar and non-lacunar infarctions (Jackson et al. 2005). The inter-
observer reliability of the OCSP classification is moderate to good (Lindley et al. 
1993; Dewey et al. 2001). However, the OCSP classification is unlikely to give 
information of stroke aetiology. Furthermore, it may not have accurate differentiation 
between small cortical and subcortical infarcts (Asdaghi et al. 2011). Total reliance 
on clinical stroke syndrome classification may lead to misclassification in some 
patients, especially in those with less severe clinical presentations and when no 
lesion is found on brain CT (Asdaghi et al. 2011). 
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 Conclusion 1.3.3
 
In this chapter, I have reviewed the global epidemiology of stroke. I have also 
outlined the pathological types and ischaemic subtypes of stroke, and approaches to 
their classifications in large epidemiological studies. In the following chapters, I 
systematically aim to assess the incidence of stroke, and distributions of pathological 
types and ischaemic subtypes of stroke using the TOAST or OCSP classification, and 
risk factor profiles among pathological and ischaemic subtypes of stroke in Chinese 
populations, which contribute to the largest number of people in the developing 
world, and compare these findings with data from white populations. I hope to 
establish more reliable and accurate analyses of stroke data in Chinese populations, 
to have better understanding of the characteristics of stroke epidemiology, to provide 
helpful information to make effective strategies of stroke prevention, and to reduce 
stroke burden in the years ahead.
 
  36 
Section B: Epidemiology of Stroke in Chinese 
versus White Populations – Systematic Review 
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 Incidence of stroke  Chapter 2:
2.1 Introduction 
Compared with white populations, Chinese have been reported to have a higher 
incidence of overall stroke (Thorvaldsen et al. 1995; Chau et al. 2011; Fuh et al. 
2000; Liu et al. 2007; Jeng et al. 2007). However, reliable comparisons have been 
precluded by a lack of methodologically robust studies of stroke incidence among 
Chinese populations, and age-standardization of incidence rates in different studies to 
different standard populations (Feigin et al. 2009; Feigin et al. 2003). Moreover, no 
previous review of the stroke epidemiology in Chinese populations has taken an 
explicitly systematic approach. 
To clarify what is known and what remains uncertain about the epidemiology of 
stroke in Chinese populations and differences from white populations, I aimed 
systematically to evaluate the incidence of stroke in Chinese populations, and to 
compare this with data from white populations, standardized to the same world 
population.   
 
2.2 Methods 
 Search strategy  2.2.1
I comprehensively sought articles published in any language on incidence in 
populations of Chinese origin. I used electronic searches in Medline and EMBASE 
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from 1990 (since prior to this, brain imaging with CT or MR was not used widely) to 
January 2012 (Appendix 1), carried out forward citation searches of relevant reviews 
(Liu et al. 2007; Feigin et al. 2009) and perused the reference lists of included 
primary articles and relevant reviews.  
 
 Selection criteria for studies of stroke incidence  2.2.2
I adapted inclusion criteria from those proposed for an “ideal” study of stroke 
incidence (Sudlow et al. 1996; Feigin et al. 2004): standard World Health 
Organization (WHO, Hatano et al. 1976), National Institute of Neurological 
Disorders and Stroke (NINDS Ad Hoc Committee. 1990) or Atherosclerosis Risk in 
Communities (ARIC, Rosamod et al. 1999) definition of stroke; first-ever strokes 
from a large well-defined population; comprehensive, community-based case 
ascertainment - including fatal and non-fatal cases not admitted to hospital - using 
multiple overlapping sources (primary and secondary care clinics, health centres, 
hospital admissions, death certificates etc.); prospective study design, ideally with 
“hot pursuit” of cases; lower age limit 45 years or younger; no upper age limit; 
data collection from 1990 onwards; numbers of first-ever stroke cases per year and of 
people in the population (or age-specific annual incidence) available in 10 year mid-
decade age bands.  
I excluded studies with hospital-based design, upper age limit, not first-ever strokes, 
populations overlapped with another included study, or serious data inconsistencies. I 
 
Chapter 2. Incidence of stroke  39 
sought essential information that was unavailable in publication(s) directly from the 
primary study authors. 
 
 Data extraction 2.2.3
From included studies of overall stroke incidence, I extracted information on: 
geographical area of the study; sources of case ascertainment; study period; size and 
age range of the population; stroke definition; number of first-ever strokes; mean age 
and sex distribution of stroke cases; the proportion of CT or MR brain imaging, and 
admission to hospital; and 1 month case fatality. I extracted or calculated age-
specific incidence rate for each 10 year mid-decade age group.  
 
 Comparisons with studies in white populations 2.2.4
For comparison, I selected studies performed from 1990 onwards in predominantly 
white populations from a recent worldwide systematic review of community-based 
stroke incidence studies (Feigin et al. 2009). I sought relevant additional studies 
published up to January 2012 through forward citation searches of this review, and 
perused the reference lists of relevant publications identified. I used the same 
inclusion criteria as outlined above. 
 
 Statistical analysis 2.2.5
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For each included study, I calculated age-standardized (to the WHO standard 
population) incidence of first-ever-in-a-lifetime stroke per 100,000 person years and 
95% confidence intervals (CI) (Ahmad et al. 2000; Fay et al. 1997). I standardized 
for sex to a standard population with equal proportions of males and females in each 
age stratum. To compare studies, I focused on standardized incidence data for ages 




 Included studies  2.3.1
Of 3,063 papers describing studies in Chinese populations, 45 were potentially 
relevant but only six (described in four papers, all published in English) fulfilled the 
inclusion criteria (Figure 2.1). They included 404,254 people, 2,044,941 person-
years and 3,935 first-ever stroke patients (Hu et al. 1992; Chang et al. 1995; Chen et 
al. 1995; Jiang et al. 2006). 
 
 Stroke incidence in Chinese populations 2.3.2
Characteristics of these included studies in Chinese populations are shown in Table 
2.1. Four were based in China and two in Taiwan. Mean age of stroke onset was 66-
70 years. The proportion of stroke cases with brain imaging varied widely (30-91%, 
mean [weighted by study size] 76%). Age-standardized stroke incidence rates across 
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all ages varied widely (92-328 per 100,000 person-years), but are not fully 
comparable because of the substantial variation in the distribution of ages within the 
open-ended upper age band and exclusion of people under 35 years from one study. 
Age-standardized stroke incidence also varied up to fourfold among the seven 
Chinese cities included in one study, being higher in the north (Harbin) than in the 
south (Shanghai) of China (Data standardized to the world population were not 
available separately for the seven cities included in this study, Chen et al. 1995). As 
expected, age-specific annual incidence increased with age (Figure 2.2).  In terms of 
1 month case fatality, only one small study reported this around 17% (Hu et al. 1992). 
 
 Comparisons with white populations 2.3.3
I compared these results from Chinese populations with those from 10 community-
based studies among predominantly white populations, which included 1,333,447 
people, 2,162,088 person years, and 4,568 first-ever stroke cases (Giuseppe et al. 
1995; Vemmos et al. 1999; Hanne et al. 1997; Kolominsky-Rabas et al. 1998; 
Steward et al. 1999; Wolfe et al. 2000; Carlo et al. 2003; Thrift et al. 2001; Correia et 
al. 2004; Appelros et al. 2002). Characteristics of these included studies in 
predominantly white populations are shown in Table 2.2. Mean age of stroke onset 
was younger in Chinese populations (range 66-70 versus 72-76 years). Age-
standardized annual first-ever stroke incidence was more variable and somewhat 
higher in Chinese than Whites for ages 45-74 years (range 205-584 versus 170-335 
per 100,000) (Figure 2.3). There were similar although less marked Chinese-Whites 
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differences for ages 45-75+ years. These data included many more incident strokes 
since all ages over 75 years are included, but were less comparable because of age 
variation in the open-ended upper age band (Figure 2.4). Additional standardization 
for sex made no material difference to the results. 
 
2.4 Discussion  
To my knowledge, this is the first systematic review of the epidemiology of stroke 
comparing data from Chinese populations with data from predominantly white 
populations. 
I have shown that, compared with Whites, Chinese populations have a higher age-
adjusted incidence of stroke, and a lower mean age of stroke onset. These differences 
are based on comparisons of methodologically robust, community-based studies, 
with appropriate age-standardization, avoiding inclusion of an open-ended upper age 
band. Therefore they are unlikely to be an artefact of variable hospital admission 
rates or of incomplete adjustment for age. In addition, there is striking variation 
among Chinese populations in overall stroke incidence.  
Earlier studies suggested higher stroke incidence in Chinese versus white populations, 
and variable stroke incidence rates within China (higher rates in the north with a 
north-south gradient), but did not include people aged older than 64 years and some 
comparisons included recurrent as well as first-ever strokes (Thorvaldsen et al. 1995; 
Wu et al. 2001). My results show reliably that such differences exist after 1990 and 
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extend previous findings to those aged 65 years or beyond, among whom most 
strokes occur.  
Proposed explanations for Chinese-Whites differences in stroke incidence and the 
variations among Chinese populations in overall stroke include differences in risk 
factors, dietary habits (e.g., variable intake of salt and preserved food), smoking, 
weather, socioeconomic status, and genetic factors (Wu et al. 2001; Yang et al. 2004; 
Asch et al. 2010). These vary substantially within Chinese populations as well as 
between Chinese and white populations. In parallel with the north-south gradient in 
stroke incidence, geographic variations of blood pressure, salt intake, and intracranial 
atherosclerosis have been also reported - higher rates in the northern and lower in the 
southern Chinese (Zhao et al. 2004; Pu et al. 2013).   
 
 Strengths and limitations  2.4.1
The major strengths of my study are: rigorous, systematic methods, including a 
comprehensive search strategy for relevant studies published in any language 
(including Chinese), reducing the selection bias of including only reports published 
in English; inclusion of Hong Kong and Taiwan as well as mainland China, covering 
more than 95% of Chinese populations worldwide and including those with highly 
developed economies; age-standardization of data from Chinese and predominantly 
white populations to the same world population; and inclusion of data from older 
people, who were omitted from many previous stroke incidence studies in Chinese 
populations (Feigin et al. 2004). 
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An important limitation is that, despite comprehensive searching, I found few 
community-based studies of incidence of stroke in Chinese populations published up 
to January 2012, and only one study reported 1 month case fatality. Chinese literature 
databases were not available to me because I did not have access to the full-text 
databases. Also, despite including only studies which appeared to fulfil accepted 
methodological criteria, we could not exclude the possibility of inaccurate or 
incomplete case ascertainment in some included studies. However, rapid 
developments and improvements in comprehensive primary health care and 
centralized health insurance should facilitate future, well-designed epidemiological 
studies (Liu et al. 2011; Heeley et al. 2009; Wang et al. 2005). 
 
 Conclusion 2.4.2
Here, I report a slightly higher overall stroke incidence in Chinese compared with 
predominantly white populations since 1990, with substantial regional variation 
among Chinese populations. A better understanding of the reasons for the observed 
differences in epidemiology of stroke should help us better to predict the potential 
effects of the rapidly growing economy and changing lifestyles, and contribute to 
efforts to reduce the stroke burden in Chinese populations. 
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Tables 





































Hu HH Taiwan  
(4 counties) 
door to door, local 
clinic, hospital, 
death certificate  
1986- 
1990 
8562 366389 >35 NR 59% NINDS 104 65% 17% 328  
(268-397) 
Chang SF Taiwan 
(Ilan) 
door to door, 
hospital, death 
certificate 
1991 184073 184073 All 66 51% WHO 185 99% NR 117  
(101-135) 
Chen XM China  
(7 cities) 







57914 289570 All NR 58% WHO 631 30-
60% 
NR 201  
(185-217) 
Jiang B China 
(Beijing) 





50906 509060 All 70 50% ARIC 1062 91% NR 150  
(141-159) 
Jiang B China- 
(Shanghai) 





51972 519720 All 70 49% ARIC 785 80% NR 92 
(86-99) 
Jiang B China- 
(Changsha) 





50827 508270 All 70 56% ARIC 1168 74% NR 175  
(165-185) 
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WHO=World Health Organisation; NINDS=National Institute of Neurological Disorders; ARIC=Atherosclerosis Risk in Communities; CT=computed 
tomography; MR=magnetic resonance imaging; CI=confidence interval; NR=not reported; Y=years. 
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Giuseppe L Italy 
(Belluno) 
Home visit, clinic 
recruitment and 
hospital admission  
1992-
1993 













80774 161548 >=18 75 56% WHO 555 90% 27% 133 
(120-146) 
Hanne E Norway 
(Innherred) 



















101450 202900 All 73 41% WHO 354 95% 19% 85 
(76-95) 









167834 335668 All 74 47% WHO 489 84% 27% 73 
(66-81) 
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143088 286176 All NR 48% WHO 591 89% 15% 67 
(48-85) 






nursing home, GP, 
and death 
certificate 
1996 179186 179186 All 73  51% WHO 321 96% 31% 87 
(78-97) 
 









133816 133816 All NR 54% WHO 276 91% 20% 100 
(95-105) 
Correia M Portugal 
(Porto, 
rural) 
GP, home visit, 
emergency , 
health centre, 





37089 74178 All 74 48% WHO 226 96% 15% 261 
 (249-273) 
Correia M Portugal 
(Porto, 
urban) 
GP, home visit, 
emergency 




death certificate  
1998-
2000 
86023 172046 All 72 38% WHO 462 97% 17% 118 
(112-124) 
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GP, nursing home, 
radiology, 




123503 123503 All 76 45% WHO 388 84% 23% 126 
(111-140) 
WHO=World Health Organisation; GP=general practitioner; CT=computed tomography; MR=magnetic resonance imaging; CI=confidence interval; 
NR=not reported; Y=years. 
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Figures 
Figure 2.1 Selection of Chinese stroke incidence studies.   
 
a 
Two studies had age limits of 35 to 64 years, and 25 to 74 years (Thorvaldsen et al. 1995, 
Zhao et al. 2008), one study included patients aged 35 to 64 years (Wang et al. 2006), and 
the other included only patients aged 50 years or beyond (Fuh et al. 2000).
 
  
All abstracts screened 
3018 irrelevant studies excluded  
45 full-text articles of relevant studies 
reviewed 
39 articles excluded:  
-hospital-based studies (6)   
-not pure first-ever stroke (6)  
-retrospective design (4) 
-age limit (4) 
a 
-study period before 1990(3) 
-mixed with other Asians (2) 
-overlap population (5) 
-no age-specific data (9) 
 
  
6 Chinese stroke incidence studies 
included 
3063 studies retrieved through 
database searching 
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Figure 2.2 Age-specific incidence in included studies (per 100,000 person-years).a 
 
a
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Figure 2.3 Age standardized incidence (per 100,000 person-years) for ages 45-74 years in 




 Confidence interval could not be calculated in one study because the number of strokes in 
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Figure 2.4 Age standardized incidence (per 100,000 person-years) for ages 45-75+ years in 




 Confidence interval could not be calculated in one study because the number of strokes in 
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 Pathological types of stroke Chapter 3:
3.1 Introduction 
Stroke is a clinical syndrome with three main pathological types (ischaemic stroke 
[IS], intracerebral haemorrhage [ICH], and subarachnoid haemorrhage [SAH]). Each 
has several subtypes with different underlying vascular pathologies. Apart from a 
higher stroke incidence mentioned in Chapter 2, Chinese have been reported to have 
a higher proportion of ICH in comparison with other populations (Chau et al. 2011; 
Liu et al. 2007; Jeng et al. 2007). However, few studies provide reliable comparisons 
due to a lack of robust methods, accurate and consistent classification of stroke types, 
and systematic approach (Feigin et al. 2009; Feigin et al.2003).  
To assess the differences in epidemiology of pathological types of stroke between 
Chinese and white populations, I aimed to systematically evaluate the distribution of 
main pathological types of stroke in Chinese populations, and to compare these 
results with data from white populations.  
 
3.2 Methods  
 Search strategy  3.2.1
I comprehensively searched for articles published in any language on pathological 
types of stroke in populations of Chinese origin. I performed electronic searches in 
Medline and EMBASE from 1990 (since prior to this, brain imaging with CT or MR 
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was not used widely) to January 2012 (Appendix 2), forward citation searches of 
relevant reviews (Liu et al. 2007; Feigin et al. 2009), and perusal of the reference 
lists of included primary articles and relevant reviews.  
 
 Selection criteria for studies of pathological types of 3.2.2
stroke 
The inclusion criteria were: standard World Health Organization (WHO, Hatano et al. 
1976) or National Institute of Neurological Disorders and Stroke (NINDS Ad Hoc 
Committee. 1990) or similar definition of stroke; prospective study design with “hot 
pursuit” of cases; lower age limit 45 years or younger; no upper age limit; data 
collection from 1990 onwards. For studies of pathological types of stroke ( as 
compared with those of stroke incidence – see chapter 2), I relaxed the criteria to 
include both community-based and hospital-based studies of recurrent as well as 
first-ever strokes, since I expected to find few “ideal” studies. However, for reliable 
diagnosis and classification of pathological types, I required CT/MR brain imaging 
(or autopsy) in more than 70% of cases. Strokes had to be classified as IS, ICH, SAH 
or unknown pathological type (Sudlow et al. 1997). 
I excluded studies with retrospective design, highly selected patients, low CT/MR 
rate, patients overlapped with another included study, unclear classification methods 
or serious data inconsistencies. I contacted the primary study authors directly to find 
the essential information that was unavailable in publication(s). 
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 Data extraction 3.2.3
From included studies of pathological types of stroke, I extracted information on: 
geographical area of the study; sources of case ascertainment; study period; size and 
age range of the population; stroke definition; number of first-ever and recurrent 
strokes; mean age and sex distribution of stroke cases; the proportion of CT or MR 
brain imaging, and admission to hospital; and 1 month case fatality if available. I 
also extracted data from each study on: whether it was community-based or hospital-
based; whether it included recurrent as well as first-ever strokes; stroke type 
classification method; and case numbers of each pathological type.  
 
 Comparison studies in white populations 3.2.4
For comparison, I selected studies conducted from 1990 onwards in predominantly 
white populations from a recent worldwide systematic review of community-based 
stroke incidence studies (Feigin et al. 2009). I sought relevant additional studies 
published up to January 2012 through forward citation searches of this review, and 
perused the reference lists of relevant publications identified. I used the same 
inclusion criteria as outlined above, except that no hospital-based studies were 
included in predominantly white populations. 
 
 Statistical analysis 3.2.5
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I calculated the proportions of all strokes of each main pathological type. Where 
possible, I used age-standardized incidence data to obtain the age-adjusted proportion 
of each pathological type. I compared community-based versus hospital-based 
Chinese studies, different geographical areas among the Chinese populations, and 
Chinese versus predominantly white populations, by visual inspection of graphical 
data. Using StatsDirect software (http://www.statsdirect.com), I computed and 
compared distributions of pooled proportions of pathological types between Chinese 
and predominantly white populations. I used random effects meta-analysis because 
of the substantial heterogeneity of individual study estimates in Chinese and in 
predominantly white populations (Borenstein et al. 2009). 
 
3.3 Results  
 Included studies 3.3.1
For stroke pathological types, from 5,160 papers, 43 studies were potentially relevant, 
and 11 pathological, described in nine papers, met our inclusion criteria (Figure 3.1). 
Eight were published in English and one was published in Chinese (Chang et al. 
1999; Zhang et al. 2003; Wang et al. 2007; Jeng et al. 1998; Yip et al. 2000; Lin et al. 
2002; Hsieh et al. 2010; Hao et al. 2011; Wang et al. 2011). 
 
 Pathological types of stroke in Chinese populations 3.3.2
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Of the 11 pathological type studies, five were community-based and six were 
hospital-based. Characteristics of these studies are shown in Table 3.1. There were 
64,392 first-ever or recurrent stroke cases. Mean age of stroke onset (reported in 
eight studies) ranged from 63 to 73 years. 74-100% of stroke cases had brain imaging. 
Only three studies reported 1 month case fatality.  
Among included studies, 41-79% of strokes were classified as IS, 17-52% ICH, 1-
8% SAH, and 0-10% as unclassified type. I was only able to calculate age-
standardized proportions for one study, and found the age-standardized and crude 
proportions of pathological types to be very similar (Chang et al. 1995). In Chinese 
populations, there was a greater, more variable proportion of ICH in community-
based than hospital-based studies (27-51% versus 17-30%), and in China than 
Taiwan (range 25-51% versus 17-28%), and (Figure 3.2).  
 
 Comparisons with white populations  3.3.3
For comparison, I identified 13 community-based studies in predominantly white 
populations, including 6,065 first-ever stroke cases (Giuseppe et al. 1995; Vemmos 
et al. 1999; Hanne et al. 1997; Kolominsky-Rabas et al. 1998; Steward et al. 1999; 
Wolfe et al. 2000; Carlo et al. 2003; Thrift et al. 2001; Correia et al. 2004; Appelros 
et al. 2002; Islam et al. 2008; Feigin et al. 2006; Rothwell et al. 2004). 
Characteristics of these included studies in whites are shown in Table 3.2. 
Compared with predominantly white populations, Chinese generally had a higher 
proportion of ICH (17-51% versus 6-20%). The random effects pooled proportion of 
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ICH was higher in Chinese than in Whites (28.0% [95% CI 23.6-32.6%] versus 
12.4% [95% CI 10.2-14.7%]) while the proportion of unclassified pathological type 
was lower in Chinese (1.7% [95% CI 0.5-3.6%] versus 7.3% [95% CI 5.2-9.7%]). 
Considering community-based studies of pathological types only, the pooled 
proportion of ICH was still, and even higher in Chinese compared with Whites 
(33.5% [95% CI 24.4-43.1% versus 12.4% [95% CI 10.2-14.7%]), while proportions 
of unclassified stroke type were similar (5.4% [95% CI 3.2-8.0%] versus 7.3% [95% 
CI 5.2-9.7%]) (Table 3.3). Heterogeneity between individual studies’ proportions 
was substantial in all comparisons of pooled proportions of pathological types.  
 
3.4 Discussion  
The study is the first systematic review of pathological types of stroke comparing 
data from Chinese populations with that from predominantly predominantly white 
populations. 
I have shown that, compared with white populations, Chinese have a higher 
proportion of strokes attributable to ICH. The proportion of ICH was generally lower 
in hospital-based than in community-based studies in Chinese. In addition, there was 
striking variation among Chinese populations in the proportion of strokes due to ICH.  
Although previous studies have reported a higher proportion of ICH in Chinese as 
compared with white populations, as well as regional variation within mainland 
China, these have been mostly hospital-based (Wei et al. 2010; Yang et al. 2004). 
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Immigration studies provide additional relevant data but there are few large studies 
of stroke types among Chinese and white people living in the same region (Fang et al. 
2004; Feigin et al. 2006; Khan et al. 2004). A recent systematic review of 
population-based studies of ICH found two-fold higher ICH incidence in Asian 
versus white people, whether living in the same geographical area or in different 
countries, but included only one study in Chinese and did not consider Chinese 
populations separately (Asch et al. 2010).
   
Proposed explanations for Chinese-Whites differences and variations in the 
proportion of ICH in Chinese populations include differences in hypertension, 
hyperlipidaemia, diabetes, obesity, dietary habits especially variable salt intake, 
smoking, alcohol, extreme weather, socio-economic status, and genetic factors (Wei 
et al. 2010; Yang et al. 2004; Asch et al. 2010; Zhou et al. 2003, He et al. 1999). 
These vary substantially within Chinese populations as well as between Chinese and 
white populations (Wei et al. 2010; Wu et al. 2003). 
The Sino MONICA community-based stroke study (1987-1993) found a higher 
proportion of haemorrhagic stroke (ICH and SAH) in Chinese people aged 35-64 
years, ranging from 25% to 64% (Wu et al. 2003). The subsequent Sino-MONICA-
Beijing community-based stroke study between 1984 and 2004 further showed a 4% 
increase in total stroke, including 5% increase in IS and 1% decrease in 
haemorrhagic stroke (ICH and SAH) in Chinese among people aged 25-74 years, 
with a large reduction in the proportion of incident strokes attributed to haemorrhage 
(43% in 1984 versus 14% in 2004) (Zhao et al. 2008). Some – but certainly not all - 
of this change may be explained by overdiagnosis of haemorrhagic stroke in the 
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1980s when CT brain scan rates were low. These changes occurred during a time of 
rapid economic development and increasing adoption of Western lifestyles, increased 
dietary fat and cholesterol intake, increased prevalence of obesity and diabetes, and 
possibly better hypertension control. My study shows that the higher proportion of 
haemorrhagic stroke is due to ICH, not SAH, and has persisted in the most recent 
studies of incident stroke in Chinese populations, even those with highly developed 
economies, such as Taiwan. However, there are few comparable, community-based 
data including ages more than 75 years yet available after 2000, since when further 
economic and lifestyle changes in Chinese populations may have further impact on 
stroke rates. 
 
 Strengths and limitations  3.4.1
The major strengths of my study are: rigorous, systematic methods, including a 
comprehensive search strategy for relevant studies published in any language 
(including Chinese), reducing the selection bias of including only reports published 
in English; inclusion of Hong Kong and Taiwan as well as mainland China, covering 
more than 95% of Chinese populations worldwide and including those with highly 
developed economies; and inclusion of data from older people, who were omitted 
from many previous Chinese stroke studies. Also, for reliable diagnosis and 
classification of types, I required CT/MR brain imaging (or autopsy) in more than 
70% of cases (Sudlow et al. 1997). Actually, most included studies had high brain 
imaging rates up to 90-100%.  
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An important limitation is that, despite comprehensive searching, I found few 
community-based studies of pathological types of stroke in Chinese populations 
published up to January 2012. Chinese literature databases were not available to me 
because I did not have access to the full-text databases. Additionally, despite 
including only studies which appeared to fulfil accepted methodological criteria, I 
could not exclude the possibility of inaccurate report or incomplete case 
ascertainment in the included primary studies.  
 
 Conclusion 3.4.2
Here I report a higher proportion of ICH in Chinese compared with predominantly 
white populations since 1990, with substantial regional variation among Chinese 
populations, which is even more marked in comparisons restricted to community-
based studies only. These findings help us realize the different distributions of 
pathological types of stroke between Chinese and white populations, and shed light 
on the possibly different stroke mechanisms in different populations.  
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Tables 
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Table 3.2 Characteristics of included pathological types of stroke studies in white populations. 
Study 
(first author) 

































NR NR 90% 33% 474 2.5% 19.6% 67.3% 10.6% 






















73 41% 96% 19% 354 3.4% 13.6% 78.5% 4.5% 







73.6 49% 88% 27% 489 6.1% 11.0% 70.4% 12.5% 






NR 48% 97% 15% 591 2.0% 6.3% 88.0% 3.7% 
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Carlo AD Italy 
(Vibo 
Valentia) 
1996 First- ever 
stroke 
73 51% 96% 24% 321 3.7% 19.3% 72.9% 4.1% 






NR 46% 91% 20% 276 4.4% 14.5% 72.5% 8.7% 






72.7 59% 96% 17% 688 3.3% 15.7% 76.2% 4.8% 






76.3 45% 84% 19% 388 2.8% 11.4% 70.6% 15.9% 






NR 48% 89% 20% 183 6.6% 10.4% 75.4% 7.7% 








74.6 47% 91% 21% 1052 5.9% 10.6% 73.2% 10.4% 






73.6 48% 98% 17% 262 6.1% 6.5% 85.1% 2.3% 
SAH=subarachnoid haemorrhage; ICH=intracranial haemorrhage; IS=ischaemic stroke; UC=unclassified; NR=not reported; Y=years. 
  
 
Chapter 3. Pathological types of stroke                        67 
Table 3.3 Comparison of pathological type distributions between Chinese and white populations. 
 
 











Random effects pooled 








Random effects pooled 
proportion (95% CI) 





SAH % (95% CI) 
1951  2.9% (2.2-3.6%) 94% 241 3.9% (3.1-4.8%) 67% 
 
ICH % (95% CI) 
14547 28.0% (23.6-32.6%) 99% 755 12.4% (10.2-14.7%) 86% 
 
IS % (95% CI) 
46738 66.0% (60.2-71.6%) 99% 4593 76.0% (72.4-79.3%) 90% 
 
UC % (95% CI) 











Random effects pooled 








Random effects pooled 
proportion (95% CI) 





SAH % (95% CI) 
198 1.8% (1.1-2.8%) 85% 241 3.9% (3.1-4.8%) 67% 
 
ICH % (95% CI) 
3482 33.5% (24.4-43.1%) 99% 755 12.4% (10.2-14.7%) 87% 
 
IS % (95% CI) 
6920 58.2% (49.1-67.1%) 98% 4593 76.0% (72.4-79.3%) 90% 
 
UC % (95% CI) 
868 5.4% (3.2-8.0%) 95% 476 7.3% (5.2-9.7%) 91% 
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Figures 
Figure 3.1 Selection of pathological types of stroke studies in Chinese populations. 
 
a One study excluded all patients with suspected cardioembolic stroke (Tan et al. 2005); a second excluded stroke patients with major medical 
illnesses (Zhang et al. 2009).  
All abstracts screened 
5117 irrelevant studies excluded 
43 full-text articles of relevant studies 
reviewed 
5160 studies identified through database 
searching 
34 articles excluded: 
-incomplete data of stroke types (13) 
-retrospective design (6) 
-study period before 1990(3) 
-selected patients (2) 
a 
-low CT/MRI rate (1) 
-overlap patients (1)  
-only ischaemic stroke data (8) 
11 pathological type studies from 9 papers 
included 
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Figure 3.2 Distributions of pathological types of stroke in Chinese and in white populations. 
 
C= community-based; H=hospital-based; UC=unclassified; SAH=subarachnoid haemorrhage; IS=ischaemic stroke; ICH=intracerebral haemorrhage; 
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 Ischaemic stroke subtypes Chapter 4:
4.1 Introduction 
Among pathological types of stroke, ischaemic stroke (IS) is the most common type, 
accounting for the majority of total strokes (Liu et al. 2007). By contrast with 
western populations, stroke mortality in Chinese exceeds that of ischaemic heart 
disease, and some studies claimed a different distribution of IS subtypes in Chinese 
populations (Wu et al. 2001; Liu et al. 2007; Jeng et al. 2007; Fang et al. 2012). 
Nonetheless, there are few reliable comparisons using rigorous methods and 
conducted in a systematic way (Feigin et al. 2009; Feigin et al. 2003).  
Herein, I aimed to systematically evaluate the distribution of ischaemic subtypes in 
Chinese populations, and to compare these results with data from white populations.   
 
4.2 Methods  
 Search strategy  4.2.1
I comprehensively sought articles published in any language on IS subtypes in 
populations of Chinese origin. I carried out electronic searches in Medline and 
EMBASE from 1990 (since prior to this, brain imaging with CT or MR was not used 
widely) to January 2012 (Appendix 2), forward citation searches of relevant reviews 
(Liu et al. 2007; Feigin et al. 2009), and perusal of the reference lists of included 
primary articles and relevant reviews.  
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 Selection criteria for studies of ischaemic stroke 4.2.2
subtypes  
The selection criteria were: standard World Health Organization (WHO, Hatano et al. 
1976) or National Institute of Neurological Disorders and Stroke (NINDS, NINDS 
Ad Hoc Committee. 1990)  or similar definition of stroke; prospective study design, 
ideally with “hot pursuit” of cases; lower age limit 45 years or younger; no upper age 
limit; data collection from 1990 onwards. However, for reliable diagnosis and 
classification of types, I required CT/MR brain imaging (or autopsy) in >70% of 
cases. Similar to studies of pathological types, for studies of IS subtypes, I relaxed 
the criteria used to select studies of the stroke incidence in Chapter 2 to include both 
community-based and hospital-based studies of recurrent as well as first-ever strokes, 
since I expected to find few “ideal” studies. Ischaemic strokes had to be classified 
into five aetiological subtypes - large artery atherosclerosis (LAA), cardioembolism 
(CE), intracranial small vessel occlusion (SVD), other determined aetiology, 
undetermined aetiology, according to the Trial of Org 10172 in Acute Ischaemic 
Stroke (TOAST) or NINDS classification schemes, or into the four anatomical 
subtypes of the Oxfordshire Community Stroke Project (OCSP) classification 
scheme - lacunar infarct (LACI), total anterior circulation infarct (TACI), partial 
anterior circulation infarct (PACI), posterior circulation infarct (POCI) (Adams et al, 
1993; Bamford et al.1991; NINDS Ad Hoc Committee, 1990). I excluded studies 
with retrospective design, highly selected patients, low CT/MR rates, patients 
overlapped with another included study, unclear classification methods or serious 
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data inconsistencies. I contacted the primary study authors to acquire essential 
information that was unavailable in publication(s). 
 
 Data extraction 4.2.3
From included studies of IS subtypes, I extracted information on: geographical area 
of the study; sources of case ascertainment; study period; size and age range of the 
population; stroke diagnosis and definition; number of first-ever and recurrent 
strokes; mean age and sex distribution of stroke cases; the proportion of CT or MR 
brain imaging, and admission to hospital; and 1 month case fatality. I also extracted 
data on: whether it was community-based or hospital-based; whether it included 
recurrent as well as first-ever strokes; IS subtype classification method; and numbers 
of each ischaemic subtype.  
 
 Comparison studies in white populations 4.2.4
For comparison, I selected studies performed from 1990 onwards in predominantly 
white populations from a recent worldwide systematic review of community-based 
stroke incidence studies (Feigin et al. 2009). Furthermore, I searched for relevant 
additional studies published up to January 2012 through forward citation searches of 
this review, and perused reference lists of relevant publications identified. I used the 
same inclusion criteria as outlined above, except that no hospital-based studies were 
included in predominantly white populations. 
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 Statistical analysis 4.2.5
For included ischaemic stroke subtype studies, I calculated the proportions of all 
ischaemic strokes for each ischaemic subtype. I compared the studies in Chinese with 
those in predominantly white populations, by visual inspection of graphical data. 
Using StatsDirect software (http://www.statsdirect.com), I calculated the pooled 
proportions of ischaemic subtypes based on random effects model because of 
substantial heterogeneity among individual study estimates, and compared the 
distributions of ischaemic subtypes between Chinese and predominantly white 
populations (Borenstein et al. 2009). 
 
4.3 Results  
 Included studies  4.3.1
For IS subtypes, from 5,160 papers, 43 articles were potentially relevant, and 14 
studies were included (Figure 4.1). 11 were published in English, and three were 
published in Chinese (Yip et al. 2000; Lin et al. 2002; Hsieh et al. 2010; Yip et al. 
1997; Tan et al. 2001; Wu et al. 2010; Zhou et al. 2004; Liu et al. 2006; Wu et al. 
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 Ischaemic subtypes in Chinese populations  4.3.2
All 14 ischaemic subtype studies in Chinese populations were hospital-based, ten 
using the TOAST (or similar) aetiological classification and four using the OCSP 
anatomical classification. Characteristics of these studies are shown in Table 4.1. In 
total, they included 33,923 first-ever or recurrent stroke cases. Mean age of stroke 
onset (reported in ten studies) was 61-69 years. 74-100% of stroke cases had brain 
imaging. Only three relatively small studies reported 1 month case fatality. 
Among studies using the TOAST classification, the proportion of strokes due to 
LAA ranged from 12-54%; SVD 20-42%; CE 10-26%; and the combination of other 
specific determined and undetermined etiology subtypes (presented together since 
not all studies presented data separately for these two subtypes) 4-34%. Among 
studies using the OCSP classification in Chinese populations, the proportions of 
different ischaemic subtypes were more consistent than among the TOAST studies: 
LACI 38-46%; TACI and PACI 40-48%; POCI 10-18%. I could not calculate age-
standardized proportions because of no available relevant information from these 
studies. 
 
 Comparison with white populations 4.3.3
For comparison, I identified six community-based studies using the TOAST 
classification in Whites, including a total of 4,163 ischaemic strokes (Schneider et al. 
2004; Kolominsky-Rabas et al, 2001; Hajat et al. 2011; Feigin at al.2006; Schulz et 
al. 2003; Bejot et al. 2008) (Figure 4.2). Characteristics of these included studies in 
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predominantly white populations are shown in Table 4.2. In these studies, the 
proportion of LAA strokes ranged from 6-36%; SVD 11-27%; CE 19-31%; and the 
combination of other specific determined and undetermined aetiology subtypes 13-
54%. I also identified one community-based IS subtype study using OCSP 
classification in white populations with LACI 32%, TACI and PACI 51%, and POCI 
17% (Wolfe et al. 2002). 
I compared random effects pooled proportions of ischaemic subtypes from these 
Chinese studies with those from white studies. In TOAST classification, hospital-
based studies in Chinese populations had a higher proportion of SVD stroke (33.1% 
[95% CI 29.7-36.7%] versus 19.3% [95% CI 14.7-24.3%]) and of LAA stroke 
(25.4% [95% CI 19.1-32.3%] versus 14.7% [95% CI 9.0-21.4%]), and a lower 
proportion of CE stroke (15.8% [95% CI 12.8-19.0%] versus 25.7% [95% CI 22.1-
29.6%]) and of other/unknown ischaemic stroke (23.2% [95% CI 18.5-29.2%] versus 
38.8% [95% CI 28.0-50.1%]) (Figure 4.2, Table 4.3). However, there was substantial 
variation in the distribution of ischaemic subtypes. Heterogeneity between individual 
studies’ proportions was substantial in all comparisons of pooled proportions of IS 
subtypes. Furthermore, few studies in Chinese or Whites reported the proportion of 
patients undergoing various investigations, such as echocardiography and imaging of 
the extra- or intra-cranial arteries. Where reported, investigation rates were low. 
In terms of IS subtype studies using the OCSP classification, comparison of pooled 
proportions in hospital-based Chinese studies with one available community-based 
white study showed a relatively higher proportion of LACI (42.1% [95% CI 38.6-
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45 .7%] versus 32.2% [95% CI 28.7-35.8%]), and lower proportions of TACI/PACI 
and POCI in Chinese versus Whites (Wolfe et al. 2002) (Figure 4.3; Table 4.2).  
 
4.4 Discussion   
The current study is also the first systematic review of IS subtypes comparing data 
from Chinese with that from predominantly white populations. My study has shown 
an apparently different distribution of ischaemic stroke subtypes among Chinese 
compared with Whites, with a higher proportion of SVD stroke (lacunar infarction), 
a lower proportion of CE stroke and of other/unknown ischaemic subtype in Chinese.  
However, since only hospital-based studies using the TOAST or OCSP classification 
were available from Chinese populations, different hospital admission rates could 
contribute to the variations among Chinese studies as well as between the Chinese 
studies and the community-based studies in Whites (Sudlow et al. 1996; Feigin et al. 
2004). In addition, the proportion of strokes in the ‘other or undetermined’ subtype 
using the TOAST classification scheme varied widely among the Chinese studies, 
and was generally lower than among studies in predominantly white populations. 
This could partly be due to differences in the interpretation and application of 
aetiological classification systems for ischaemic stroke subtypes (Gordon et al. 1993), 
or in the proportion of stroke cases with complete investigation, since the higher this 
proportion, the lower will be the proportion assigned an undetermined subtype 
(Jackson et al. 2005). The problem of variable investigation rates does not influence 
the anatomical OCSP classification system, which is based on symptoms and signs, 
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requiring no investigation results except for a brain scan to exclude haemorrhage. 
This may explain the more consistent findings among the Chinese studies using the 
OCSP system, and makes comparisons between studies based on this system more 
reliable. However, although the OCSP-based Chinese-Whites comparisons still 
suggest a higher proportion of lacunar strokes in Chinese populations, only 
comparisons based on community-based studies in both Chinese and white 
populations will be able to confirm this finding. 
 
 Strengths and limitations  4.4.1
The major strengths of our study are: rigorous, systematic methods, including a 
comprehensive search strategy for relevant studies published in any language 
(including Chinese), reducing the potential bias of including only reports published 
in English; inclusion of Hong Kong and Taiwan as well as mainland China, covering  
more than 95% of Chinese populations worldwide and including those with highly 
developed economies; and inclusion of data from older people, who were omitted 
from many previous Chinese stroke studies. Also, for reliable diagnosis and 
classification of types, I required CT/MR brain imaging (or autopsy) in more than 
70% of cases (Sudlow et al. 1997). In fact, most included studies had high 
performance rates of brain imaging over 80%.  
An important limitation is that, despite comprehensive searching, I found no 
community-based studies of IS subtypes in Chinese populations published up to 
January 2012. Chinese literature databases were not available to me because I did not 
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have access to the full-text databases. In addition, despite including only studies 
which appeared to fulfill accepted methodological criteria, I could not exclude the 
possibility of inaccurate information or incomplete case ascertainment in some 
included studies.  
 
 Conclusion 4.4.2
Here I report a different distribution of IS subtypes, with an overall higher proportion 
of lacunar stroke in Chinese compared with predominantly white populations since 
1990, with substantial regional variation among Chinese populations. Confirming 
variation in the distribution of ischaemic subtypes will require comparable 
population-based studies with consistent definitions and interpretations of the 
classification method in Chinese populations. 
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Tables  
Table 4.1 Characteristics of included ischaemic stroke subtype studies using the TOAST and OCSP classifications in Chinese populations. 
Study 
(first author) 



























O and U 
(%) 
Yip PK Taiwan 
(Taipei) 
1995 First- ever 
and recurrent  
NR 57% 100% 6% 676 28.8% 16.7% 19.7% 34.8% 




NR NR 100% NR 446 33.6% 11.9% 21.5% 33.0% 
Tan TY Taiwan 
(Kaohsiung) 
1998-1999 First-ever  64 56% 100% NR 219 29.2% 21.9% 17.4% 31.5% 
Lin YT * Taiwan 
(Kaohsiung) 
1999 First- ever 
and recurrent  
67 67% 100% 12% 408 37.5% 44.9% 14.0% 3.7% 
Hsieh FI Taiwan 
(39 hospitals) 
2006-2008 First-ever 
and recurrent  
NR NR 100% NR 22642 37.7% 27.7% 10.9% 23.7% 




66 63% 100% NR 1161 39.4% 14.6% 12.0% 34.1% 
Zhou H China 
(Beijing) 
2002-2003 First-ever  62 64% >80% NR 300 31.3% 40.0% 12.3% 16.3% 
Liu X China 
(Nanjing) 
2002-2003 First-ever  67 66% 98% 14% 610 20.2% 19.7% 26.2% 33.9% 
Wu B China 
(Chengdu) 
2002-2007 First-ever  65 59% 74% NR 3905 42.3% 14.0% 16.2% 27.6% 
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Ma Y China 
(Beijing) 
2007-2008 First-ever 
and recurrent  











Lai SL Taiwan 
(Chiayi) 
2003-2005 First-ever  NR 53% 100% NR 424 41.5% 40.1% 18.4% 
Cheung RTF Hong Kong 1996-1999 First-ever 
and recurrent  
69  56% NR** NR 672 45.7% 42.0% 12.4% 
Li W China 
(Chengdu) 
2002-2005 First-ever 
and recurrent  
64  57% 98% NR 1314 38.2% 47.6% 14.2% 
Zhang XY China 
(Xinjiang) 
2005-2009 First-ever 67  59% 100% NR 769 43.4% 46.0% 10.5% 
IS= ischaemic stroke; TOAST=Trial of Org 10172 in Acute Ischaemic Stroke; LAA=large artery atherosclerosis; SVD=small vessel disease; 
CE=cardioembolism; O=other determined aetiology; U=undetermined etiology; NR=not reported; OCSP= Oxfordshire Community Stroke Project; 
LACI= lacunar infarct; TACI=total anterior circulation infarct; PACI=partial anterior circulation infarct; POCI= posterior circulation infarct; Y=years; 
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Table 4.2 Characteristics of included ischaemic stroke subtype studies using the TOAST and OCSP classifications in white populations. 
Study 
(first author) 



























































































696 32.2% 51.0% 16.8% 
 
IS= ischaemic stroke; TOAST=Trial of Org 10172 in Acute Ischaemic Stroke; LAA=large artery atherosclerosis; SVD=small vessel disease; 
CE=cardioembolism; O=other determined aetiology; U=undetermined etiology; NR=not reported; OCSP= Oxfordshire Community Stroke Project; 
LACI= lacunar infarct; TACI=total anterior circulation infarct; PACI=partial anterior circulation infarct; POCI= posterior circulation infarct; Y= years.  
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Table 4.3 Comparison of ischaemic subtype distributions between Chinese and white populations. 
 
 
Ischaemic stroke patients in Chinese populations  Ischaemic stroke patients in European populations  
Ischaemic subtypes 
(TOAST) 
Hospital-based studies Community-based studies 
 IS patients 
(N=30744) 
Random effects pooled 







Random effects pooled 
proportion (95% CI) 




LAA% (95% CI) 7827 25.4% (19.1-32.3%) 99% 531 14.7% (9.0-21.4%) 97% 
SVD% (95% CI) 11539 33.1% (29.7-36.7%) 95% 745 19.3% (14.7-24.3%) 93% 
CE% (95% CI) 3795 15.8% (12.8-19.0%) 96% 1068 25.7% (22.1-29.6%) 85% 
O and U% (95% CI) 7583 23.2% (18.5-28.2%) 98% 1819 38.8% (28.0-50.1%) 98% 
Ischaemic subtypes  
(OCSP) 
Hospital-based studies Community-based studies 
 IS patients  
(N=3179) 
Random effects pooled 







Random effects pooled 




LACI% (95% CI) 1319 42.1% (38.6-45.7%) 75% 224 32.2% (28.7-35.8%) NA 
TACI or PACI% (95% 
CI) 
1432 44.3% (40.1-47.6%) 72% 355 51.0% (47.2-54.8%) NA 
POCI% (95% CI) 428 13.7% (11.0-16.6%) 80% 117 16.8% (14.1-19.8%) NA 
IS=ischaemic stroke; N=total number; TOAST=Trial of Org 10172 in Acute Ischaemic Stroke; LAA=large artery atherosclerosis; SVD=small vessel 
disease; CE=cardioembolism; O=other determined etiology; U=undetermined etiology; OCSP= Oxfordshire Community Stroke Project; LACI= 
lacunar infarct; TACI=total anterior circulation infarct; PACI=partial anterior circulation infarct, POCI= posterior circulation infarction; I
2
=inconsistency; 
NA=not applicable because of only one study.  
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Figures 
Figure 4.1 Selection of ischaemic stroke subtype studies. 
 
a
 One study excluded all patients with suspected cardioembolic stroke (Tan et al. 2005); a second excluded stroke patients with major medical 
illnesses (Zhang et al. 2009).   
All abstracts screened 
5117 irrelevant studies excluded 
43 full-text articles of relevant studies reviewed 
5160 studies identified through database searching 
29 articles excluded: 
-incomplete IS subtype data (13) 
-retrospective design (6) 
-study period before 1990 (3) 
-selected patients (2) 
a 
-low CT/MRI rate (1) 
-overlap patients (1)  
-only pathological type data (3) 
14 ischaemic stroke subtype studies included 
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Figure 4.2 Distributions of ischaemic stroke subtypes by the TOAST classification in Chinese and in white populations. 
 
TOAST=Trial of Org 10172 in Acute Ischaemic Stroke; C= community-based; H=hospital-based; IS=ischaemic stroke; O=other determined aetiology; 
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Figure 4.3 Distributions of ischaemic stroke subtypes by the OCSP classification in Chinese and in white populations. 
 
OCSP= Oxfordshire Community Stroke Project; LACI=lacunar infarct; TACI=total anterior circulation infarct; PACI=partial anterior circulation infarct; 
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Section C: Risk Factors for Stroke in Chinese 
versus White Populations – Systematic Review 
and Meta-Analysis
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 Risk factor meta-analyses in Chapter 5:
pathological types of stroke – intracerebral 
haemorrhage versus ischaemic stroke 
5.1 Introduction 
The distribution of pathological types of stroke may vary in different populations. 
Asians (including Chinese) were reported to have a higher incidence of intracerebral 
haemorrhage (ICH) versus white populations (Asch et al. 2010). My systematic 
reviews in Chapter 2 and 3 also found a relatively higher stroke incidence, younger 
age of onset, an approximately twofold higher proportion of ICH and a lower 
proportion of ischaemic stroke (IS) in Chinese versus predominantly white 
populations of European origin (Tsai et al. 2013). The reasons for the difference in 
relative frequency of the main pathological types of stroke between Chinese and 
white populations are not fully understood. They may relate to differences in the 
prevalence of risk factors (both genetic and environmental) in the different 
populations, as well as to differences in the associations between stroke risk factors 
and different pathological types of stroke (O’Donnell et al. 2010; Woodward et al. 
Asia Pacific Cohort Studies Collaboration 2005; Tzourio et al. 2008; Wu et al. 2009).  
To further explore the possible causes for a higher proportion of ICH and a lower 
proportion of IS in Chinese populations, and to test the hypothesis that the 
associations of risk factors with ICH versus IS vary in different populations, I 
systematically assessed the evidence for differences in the vascular risk factor 
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profiles between ICH and ischaemic stroke (IS) in Chinese and compared these 
results with data from predominantly white populations.  
 
5.2 Methods  
 Search strategy  5.2.1
I searched Medline and EMBASE for studies published in any language that 
compared the frequency of risk factors among different pathological types of stroke 
in Chinese populations (Appendix 2). For comparison, I sought similar studies in 
predominantly white populations with Medline and EMBASE searches that aimed to 
identify existing systematic reviews and meta-analyses of risk factors for 
pathological types of stroke (Appendix 3). I also conducted citation searches of key 
relevant reviews and perused the reference lists of included primary articles and 
relevant reviews (Feigin et al. 2009; Liu et al. 2007; Ariesen et al. 2003).  
 
 Selection criteria for risk factor studies of pathological 5.2.2
types of stroke 
I included community-based or hospital-based studies published by August 2012, 
with prospective collection of stroke cases, standard World Health Organization 
(WHO, Hatano et al. 1976) or National Institute of Neurological Disorders and 
Stroke (NINDS Ad Hoc Committee. 1990) or similar definition of stroke definition 
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of stroke, and data collection from 1990 onwards since brain imaging with computer 
tomography (CT) or magnetic resonance (MR) were not used widely before this. 
Strokes had to be classified as ischaemic stroke (IS), intracerebral haemorrhage 
(ICH), subarachnoid haemorrhage (SAH])or unknown pathological type, with CT or 
MR brain imaging in >70% of cases (Sudlow et al. 1997). I excluded studies with 
retrospective case ascertainment, unclear definitions of stroke or its pathological 
types, highly selected patients, traumatic ICH, only one unusual risk factor studied, 
low CT/MR rate, stroke cases overlapping with those in another included study, or 
serious data inconsistencies. I contacted original study authors directly for essential 
information not available in publication(s).  
 
 Data extraction  5.2.3
I extracted information from included studies on: the geographical area and time 
period of the study; sources of case ascertainment; whether or not recurrent as well 
as first-ever strokes were included; definitions of stroke and its pathological types; 
the proportion of cases with CT or MR brain imaging; mean age and sex distribution 
of stroke cases; risk factor definitions; and numbers of cases with each risk factor for 
each pathological type.  
 
 Statistical analysis 5.2.4
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For each risk factor, I calculated study-specific odds ratios (ORs) with 95% 
confidence intervals (CIs) for ICH versus IS. Where data were available from more 
than one study, I performed meta-analyses, calculating pooled ORs for each risk 
factor for Chinese and predominantly white populations, and for Chinese populations 
in Taiwan and mainland China separately.  
I assessed heterogeneity among studies with I
2
 and Cochrane Q chi-square statistics, 
and adapted a random-effects model since there was evidence of statistically 
significant heterogeneity, obtaining within-group heterogeneity (Higgins et al. 2003; 
Ryan R, Cochrane Consumers and Communication Review Group. 2013). To assess 
whether pooled ORs for each risk factor comparison differed between Chinese and 
white groups, and also between populations in Taiwan versus mainland China, I 
treated ethnic groups or geographical subgroups within Chinese populations as if 
they were studies and performed a test for heterogeneity, using the within-group 
pooled estimates, standard errors and chi-square statistics to test for statistical 
significance (Borenstein et al. 2009; Ryan R, Cochrane Consumers and 
Communication Review Group. 2013; Sedgwick P. 2013). A probability value of 
less than 0.10 was regarded significant because heterogeneity tests were typically 
used in a conservative manner for meta-analysis (Petitti et al. 2001). I performed 
analyses with StatsDirect (http://www.statsdirect.com). 
 
5.3 Results 
 Characteristics of included studies  5.3.1
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My search for studies in Chinese populations retrieved 5810 publications. From these, 
I identified 48 potentially relevant publications for full text review, eventually 
including six eligible studies with a total of 36190 patients, of whom 35294 had an 
IS or ICH (Hsu et al. 1997; Hsu et al. 1996; Jeng et al. 1998; Liu et al. 2006; Hsieh et 
al. 2010; Hao et al. 2011) (Figure 5.1). From 3051 articles retrieved through my 
search for studies in white populations, I reviewed 15 potentially relevant full text 
publications and eventually included five eligible studies (Figure 5.2) with 47885 
patients, of whom 47671 had IS or ICH (Marti-Vilalta. 1999; Vemmos et al. 2000; 
Silvestrelli et al. 2006; Feigin et al. 2006; Andersen et al. 2009). 
Characteristics of these included studies are shown in Table 5.1. All Chinese studies 
were hospital-based - two in China, four in Taiwan – with around 80% of the cases 
from one large multicentre study in Taiwan (Hsieh et al. 2010). Of the five white 
studies, one was a community-based study from New Zealand, while the others were 
hospital-based studies from European countries. Around 80% of the cases were from 
a large, multicentre, Danish, hospital-based study (Andersen et al. 2009). Stroke 
diagnoses in both Chinese and predominantly white populations were based on WHO, 
NINDS or similar criteria in all studies and all had CT or MR brain imaging in >90% 
of cases. White stroke patients were older and less often male than Chinese (overall 
mean age 72 versus 68 years, males 52% versus 61%). Chinese ICH patients were 
younger and more often male than IS patients (mean age 62 versus 69 years, males 
65% versus 60%, male/female OR, 1.22 [95% CI 1.09-1.37], p<0.001), while mean 
age and gender distribution in the white ICH and IS groups was the same (mean age 
72 versus 72 years, males 51% versus 52%, male/female OR, 1.03 [95% CI 0.87-
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1.22], p=0.099). All studies had risk factor data for ICH and IS, but only two 
reported such data for SAH. Therefore I restricted my meta-analyses of risk factors 
to ICH versus IS. Risk factors analysed were those with data available from more 
than one study in both Chinese and white stroke patients: hypertension, diabetes, 
atrial fibrillation (AF), ischaemic heart disease (IHD), hypercholesterolaemia, 
alcohol intake and smoking. Study risk factor definitions are summarised in Table 
5.2.  
 
 Risk factor comparisons for ICH versus IS 5.3.2
For hypertension, all Chinese and white studies (Chinese: 6470 ICH and 28824 IS 
patients; Whites: 5001 ICH and 40255 IS) had relevant data. All gave definitions of 
hypertension, mainly based on a history of raised blood pressure with anti-
hypertensive treatment before stroke, and on elevated blood pressure recorded after 
stroke (Table 5.2). Although there was substantial heterogeneity within Chinese and 




=93%; Figure 5.3), ICH patients had 
consistently higher frequency of hypertension than IS in Chinese populations, 
yielding a pooled OR for ICH versus IS of 1.38 (95% CI [1.18 to 1.62]; Figure 5.3). 
By contrast, there was no significant difference in frequency of hypertension 
between ICH and IS in white stroke studies (OR 1.15, 95% CI 0.84 to 1.57). 
However, the results did not differ significantly between Chinese and Whites 
(heterogeneity between Chinese and whites studies: p=0.308; Figure 5.10). 
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All Chinese and white studies also had data on diabetes, with definitions based on 
history of diabetes before stroke or fasting plasma glucose levels (> 7.0 mmol/L after 
stroke in Chinese; >6.0 mmol/L before or after stroke in Whites, Table 5.2). With the 
exception of one relatively small study (Liu et al. 2006), all Chinese and white 
studies reported a lower prevalence of diabetes in ICH than in IS patients, with 
similar pooled ORs for ICH versus IS among Chinese and whites studies but 
substantial heterogeneity among individual studies (Chinese pooled OR 0.55, 95% 
CI 0.39 to 0.75, I
2
=87%; Whites pooled OR 0.67, 95% CI 0.54 to 0.83, I
2
=69%; no 
significant heterogeneity between ORs for Chinese versus Whites: p=0.336; Figures 
5.4 and 5.10).  
Four Chinese studies (6165 ICH, 28051 IS) and three white studies (4239 ICH, 
35843 ICH) provided data on AF, although only four (two Chinese, two white 
studies) gave clear definitions (history of AF before stroke or electrocardiographic 
documentation after stroke; Table 5.2). AF prevalence was consistently lower in ICH 
than in IS patients, with substantial heterogeneity among both Chinese and white 
studies. (Chinese pooled OR 0.26, 95% CI 0.18 to 0.40, I
2
=66%; Whites pooled OR 
0.35, 95% CI 0.16 to 0.77, I
2
=96%; heterogeneity between Chinese and white 
subgroups p=0.515; Figures 5.5 and 5.10).  
Four Chinese studies (6165 ICH, 28051 IS) and two white studies (3586 ICH, 33701 
ICH) provided data on IHD, although only three (two Chinese, one white) provided a 
definition (usually history of angina or myocardial infarction; Table 5.2). IHD 
prevalence was lower in ICH than IS, much more so among Chinese than white 
studies, with substantial heterogeneity among Chinese and white studies (Chinese 
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pooled OR 0.46, 95% CI 0.42 to 0.51, I
2
=91%; Whites pooled OR 0.70, 95% CI 0.62 
to 0.80, I
2
=86%; Chinese-Whites heterogeneity: p<0.001; Figures 5.6 and 5.10). 
For hypercholesterolaemia, four Chinese studies (1322 ICH, 3526 IS) and three 
white studies (936 ICH, 3674 IS) provided relevant data. Definitions were based on 
medical history or raised cholesterol after stroke, with threshold cholesterol levels 
varying between studies (Table 5.2). Pooled results showed a lower prevalence of 
hypercholesterolaemia in ICH versus IS, but this was statistically significant only in 
white studies (Chinese pooled OR 0.76, 95% CI 0.38 to 1.52; Whites pooled OR 0.52, 
95% CI 0.38 to 0.72; Chinese-Whites heterogeneity: p=0.428; Figures 5.7 and 5.10). 
There was also substantial heterogeneity among Chinese studies (I
2
=85%) and 
moderate heterogeneity among white studies (I
2
=49%). 
For smoking, all six Chinese and five white studies presented relevant information, 
generally defining smoking as current or former smoking (Table 5.2). Overall, 
prevalence of smoking was similar among Chinese ICH and IS patients, but less 
prevalent among white ICH versus IS patients, and heterogeneity among individual 
Chinese and white studies was moderate to substantial (Chinese pooled OR 0.94, 
95% CI 0.82 to 1.08, I
2
=45%; Whites pooled OR 0.71, 95% CI 0.52 to 0.97, I
2
=92%; 
heterogeneity between Chinese and white subgroups p=0.103; Figures 5.8 and 5.10). 
Five Chinese studies (1557 ICH, 4129 IS) and two white studies (3415 ICH, 31417 
IS) presented data on alcohol intake, but only three Chinese and one white study 
provided clear (yet different) definitions (Table 5.2). Meta-analysis showed a 
significant excess of regular alcohol intake in ICH versus IS patients in Chinese but 
not in predominantly white populations, and substantial heterogeneity among 
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individual Chinese and white studies (Chinese pooled OR 1.46, 95% CI 1.12 to 1.91, 
I
2
=62%; Whites pooled OR 0.82, 95% CI 0.37 to 1.85, I
2
=94%; Chinese-Whites 
heterogeneity p=0.182; Figures 5.9 and 5.10). 
 
 Subgroup analysis in Chinese populations 5.3.3
When studies from Taiwan and mainland China were considered separately, 
heterogeneity remained substantial within both Chinese population subgroups for all 
risk factors except hypertension (Figures 5.11 to 5.17). The OR of hypertension for 
ICH versus IS appeared more marked in Taiwan (Taiwan pooled OR 1.49, 95% CI 
1.38 to 1.61; mainland China pooled OR 1.12, 95% CI 0.97 to 1.30; heterogeneity 
between Taiwan and mainland China: p<0.001), and heterogeneity among studies 





=0%; Figure 5.18). 
 
5.4 Discussion 
My results in this study showed that the relative frequencies of risk factors in ICH 
versus IS were generally of similar direction in stroke patients from both Chinese and 
predominantly white populations, but varied in size and significance. Diabetes, AF 
and IHD were significantly less common in ICH in both ethnic groups. Both 
hypertension and alcohol intake were significantly more frequent in ICH versus IS in 
Chinese but not in white stroke patients, while both hypercholesterolaemia and 
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smoking were significantly less frequent in ICH versus IS in white but not Chinese 
stroke patients. However, the risk factor associations with ICH versus IS did not 
differ significantly between Chinese and Whites except for IHD, which had a 
stronger association with IS versus ICH in Chinese than predominantly white 
populations. These results should be interpreted with caution since individual studies 
varied substantially beyond the differences in ethnicity (including variation in risk 
factor definitions). Furthermore, other confounding factors, for which we could not 
adjust, may partly explain the observed differences, in particular the finding that 
Chinese ICH were younger and more often male than IS patients, while mean age 
and gender distribution were similar in white ICH and IS patients.   
My systematic search revealed few studies and no previous systematic reviews 
comparing risk factors in ICH versus IS, in either Chinese or white populations. 
Recently, a large international case-control study (the INTERSTROKE study) in 22 
countries (including low, middle and high income countries) reported on risk factors 
for all stroke, IS and ICH among 3000 cases of stroke and 3000 controls (O’Donnell 
et al. 2010). Around a third of the cases were from Southeast Asia (including China) 
and India, with less than a sixth from high income (predominantly Whites) countries. 
22% of cases had ICH. Hypertension was more strongly associated with ICH than IS. 
Cardiac causes (including atrial fibrillation, ischaemic heart disease and valvular 
heart disease) were associated with IS but not ICH. For smoking, associations 
appeared stronger with IS than ICH. Risk of ICH increased with increasing alcohol 
intake, while for IS, modest alcohol intake (up to around one drink per day) was 
protective, but heavier alcohol intake increased risk. However, risk factor 
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associations for IS and ICH were not provided separately for the different ethnic 
groups. 
Immigration studies have demonstrated different risk factor distributions between 
Chinese and white stroke patients living within the same area but there are no 
published comparisons of risk factor distributions for ICH versus IS in these different 
ethnic groups (Fang et al. 2004; Shen et al. 2011). 
The contrasts in the strength and significance of several risk factor associations with 
ICH versus IS in our study could be due – at least in part - to differences in 
distributions of ICH and IS subtypes in Chinese compared with white stroke patients, 
as well as to differences in the prevalence of these risk factors in Chinese and white 
populations. For example, a higher proportion of strokes in Chinese compared with 
Whites may be due to deep ICH (predominantly associated with hypertension) and 
lacunar ischaemic stroke among ICH and IS respectively, with a lower proportion 
due to lobar ICH (predominantly associated with amyloid angiopathy) and non-
lacunar subtypes, reflecting a different combination of genetic and non-genetic 
exposures.
 
(Wang et al. 2012; Woo et al. 2002; Chen et al. 2010).  
Meta-analyses of data from prospective studies among predominantly eastern Asian 
(Chinese and Japanese) populations and among predominantly white populations of 
European origin suggest a stronger association of blood pressure with stroke among 
eastern Asian than predominantly white populations (44% versus 27% increase in 
stroke risk per 5mm Hg higher diastolic blood pressure) (Eastern Stroke and 
Coronary Heart Disease Collaborative Research Group.1998; Prospective Studies 
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Collaboration. 1995). Furthermore, among the predominantly eastern Asian 
populations, associations of BP with haemorrhagic stroke appeared stronger than 
with IS (Eastern Stroke and Coronary Heart Disease Collaborative Research 
Group.1998), while such differences have not been demonstrated for predominantly 
white populations (Prospective Studies Collaboration. 1995).These findings are 
consistent with my results and suggest that the effect of BP reduction may be 
particularly greater in eastern Asian populations including Chinese.  
Similar meta-analyses of data from prospective studies among eastern Asian and 
predominantly white populations have shown that the associations of cholesterol 
with stroke and its pathological types are complex. There seems to be a positive 
association of increasing cholesterol with IS and a negative association with 
haemorrhagic stroke (Zhang et al. Asia Pacific Cohort Studies Collaboration 2003). 
However, the strength of these associations is probably influenced by age, blood 
pressure and cholesterol level (Asia Pacific Cohort Studies Collaboration 2005; 
Suzuki et al. 2011). Since Chinese stroke patients are younger on average than white 
ones, and average cholesterol levels are lower in Chinese than in predominantly 
white populations, these can affect the strength of associations with stroke and its 
pathological types between populations. 
Previous studies have suggested that alcohol has a dose-dependent relationship with 
haemorrhagic stroke, but a curvilinear relationship with ischaemic stroke - a 
protective effect for low to moderate intake and increased risk for high consumption 
(O’Donnell et al. 2010; Patra et al. 2010). Different definitions of alcohol intake in 
the Chinese and white studies included in our review, combined with different shapes 
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of the relationship of alcohol with ICH and IS, could partly explain why we observed 
a higher prevalence of alcohol consumption in ICH versus IS in Chinese but not 
white stroke studies. 
 
 Strengths and limitations 5.4.1
My study has several major strengths. First, I used a comprehensive search strategy 
to identify all relevant studies published in any language (including Chinese), 
reducing the potential bias of including only English language publications. Second, 
I included only studies using a standard definition of stroke and reliable classification 
of its pathological types. Third, I documented carefully the characteristics, 
methodology and risk factor definitions used in each included study, and carried out 
rigorous meta-analyses between Chinese and predominantly white populations and 
subgroup analyses within Chinese studies to explore potential explanations for some 
of the substantial statistical heterogeneity encountered.  
There were some limitations. First, despite a comprehensive literature search, I found 
only a limited number of studies in either Chinese or predominantly white 
populations which fulfilled our inclusion criteria (Chinese literature databases were 
not available to me because I did not have access to the full-text databases). Most 
included studies were hospital-based rather than community-based, and so will not 
have included all stroke patients in the relevant geographical area irrespective of 
admission to hospital (Sudlow et al. 1996; Feigin et al. 2004). Prevalence of risk 
factors and stroke subtypes may have some differences between hospitalized and 
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non-hospitalized patients (Schulz et al. 2003). Second, there was substantial 
statistical heterogeneity among studies, which could arise from differences in age 
and sex distributions, methodological differences (e.g., case ascertainment methods), 
variable risk factor definitions, differences between geographical areas, as well as 
genuine differences in risk factor associations between ethnic groups. Third, because 
my study was based on published data, I did not have individual patient data to adjust 
for potential confounders, especially age. Finally, some included studies were limited 
by collection of data about risk factors prior to stroke occurrence (which may be 
subject to recall biases), while others defined risk factor status based on measures 
made after stroke, raising the possibility of apparent associations arising due to 
reverse causality.  
 
 Conclusion 5.4.2
Here I report several differences between Chinese and predominantly white 
populations in the strength and significance of associations of several risk factors 
with ICH versus IS. These differences raise interesting possibilities about varying 
mechanisms of pathological types of stroke in different ethnic groups with different 
genetic and environmental exposures. Further analyses to adjust for possible 
confounding factors in large prospective studies are needed. 
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Tables 


































First-ever 64 76% 100% 240 HTN, DM, HD, CS, HC, HTG, age, gender 










64 57% 100% 838 HTN, DM, HD,CS, HL, smoking, alcohol, obesity, previous stroke, 
HU, age, gender 









63 58% 100% 954 HTN, DM, AF, IHD, LVH, CS, HC, HTG, smoking, alcohol, 
previous stroke age, gender,  







First-ever 67. 66% 98% 752 HTN, DM, AF, IHD, HL, smoking, alcohol, age, gender 










68 60% 100% 30454 HTN, DM, AF, IHD, CS, HL, smoking, obesity, previous stroke, 
age, gender  
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73 52% 100 39484 HTN, DM, AF, smoking, alcohol, PAD, previous MI, previous 
stroke, age, gender 
CT=Computed tomography; MR=Magnetic resonance; HTN=Hypertension; DM=Diabetes mellitus; HD=Heart disease; AF=Atrial fibrillation; 
IHD=ischaemic heart disease; LVH=Left ventricular hypertrophy; CS=Carotid stenosis; HL=Hyperlipidaemia; HC=Hypercholesterolaemia; 
HTG=Hypertriglyceridaemia; HU=Hyperuricemia; PAD=peripheral artery disease; TIA=transient ischaemic attack. *This study contained 8% TIA data.  
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Table 5.2 Definitions of risk factors among included studies in Chinese and white populations 
Study (First 
author) 
HTN DM AF IHD HC Smoking Alcohol 
Hao ZL > 140/90 mmHg or use 
of antihypertensive 
medication 
Fasting serum glucose ≥ 
7.0 mmol/L or use of 
anti-diabetic medication 
NR NR Fasting serum TC ≥ 
5.7 mmol/L or use of 
lipid –lowering 
agents 
Current smoking ≥ 
1/day for at least 1 
year 
≥ 50 ml/day for more 
than one year 
Hsu LC ≥ 160/95 mmHg, or HTN 
history with anti-HTN 
drugs 
DM history with drugs -- -- NR ≥ 1/day for the 
preceding  3 months 
or more 
NR 
Hsu WC History of HTN and/or 
clinical workup 
History of DM and/or 
clinical workup 
-- -- -- NR NR 
Hsieh FI ≥ 140/90 mm/Hg 7 days 
after stroke, or HTN 
history with anti-HTN 
drugs 
Fasting plasma glucose 
> 7.0 mmol/L, or DM 
history with medication 
ECG History of 
angina or MI 
-- Current daily 
smoking for more 
than half a year or 
past daily smoking 
Daily drinking for 
more than one year 
Jeng JS History of HTN History of DM History of AF or 
ECG proof 
History of 
angina or MI 
TC ≥ 5.2 mmol/L ≥ 10/day for more 10 
years 
Habit drinking ≥  
once per week 
Liu XF > 160/95 mm/Hg or HTN 
history with anti-HTN 
drugs 
Fasting serum glucose > 
7.0 mmol/L or DM 
history with medication 
NR NR TC> 5.7 mmol/L, or 
hyperlipidaemia 
history with drugs 
NR NR 
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Andersen KK History of HTN or 
diagnosed at admission 
History of DM or 
diagnosed at admission 
History of AF or 
diagnosed at 
admission 
-- -- Current daily or 
former smoking 
>14 drinks per week 
in women and >21 
drinks per week in 
men 
Feigin V History of HTN or on 
HTN drugs 
History of DM or on  DM 
drugs 
-- -- NR Current or former 
smoker 
-- 
Marti-Vilalta JL History of > 160/95 
mm/Hg,  or evidence of 
HTN related end organ 
damage 
History of DM or glucose 
> 6.1 mmol/L at 
admission 
-- -- -- History of smoking 
within 5 years  
-- 
Silvestrelli G History of > 160/95 
mm/Hg 
History of DM drug use 
or fasting glucose > 6.0 
mmol/L before stroke 
-- -- History or 
cholesterol > 6.5 
mmol/L at admission 
Current daily 
smoking or within 
previous year  
NR 
Vemmos KN History of >160/95 
mm/Hg 
History of DM drugs use 
or fasting glucose > 6.0 
mmol/L before stroke 
By ECG History of MI, 
angina or CHF 
History or 
cholesterol > 6.5 
mmol/L at admission 
Current daily 
smoking or within 
previous year 
-- 
HTN=Hypertension; DM=Diabetes mellitus; AF=Atrial fibrillation; IHD=ischaemic heart disease; MI=myocardial infarct; CHF=congestive heart failure; 
ECG=electrocardiography; CUS=carotid ultrasound; HC=Hypercholesterolaemia; TC=Total cholesterol; HTG=Hypertriglyceridaemia; --=no data - the 
risk factor was not studied or unavailable from the publication; NR=not reported; risk factor was studied but definition not reported 
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Figures  
Figure 5.1 Selection of studies in Chinese populations.  
 
a 
Excluding patients with cardiogenic emboli (Zhao et al. 2008); excluding patients with 
cardiogenic emboli, or with arteriovenous malformation, or using anticoagulants, or mixed 
types of stroke (Tan et al. 2005); excluding patients with other major medical illness (e.g., 
cancer, anaemia, thyroid dysfunction, etc.; Zhang et al. 2009); data only in men (Zhang et al. 
2004); data only in patients aged 35-64 years (Wang et al. 2006). 
b 
Weather (Chen et al. 1995), circadian variation of stroke onset (Cheung et al. 2001), and 
dietary pattern (Li et al. 2011). 
  
All titles and abstracts screened 
5762 irrelevant studies excluded  
48 full-text articles of relevant studies 
reviewed 42 articles excluded:  
-no information of stroke types (11)  




-study period before 1990 (3) 
-only one unusual risk factor studied 
b 
(3) 
-retrospective design (3) 
-ICH and SAH data combined (2) 
-low CT/MRI rate (2) 
-overlapping population (2) 
-study not in mainly Chinese people (1) 
6 risk factors for stroke type studies in 
Chinese populations included 
5810 studies retrieved through 
database and forward citation search 
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Figure 5.2 Selection of studies in white populations.  
 
a 
Excluding patients IS due to cardiogenic emboli, or haemorrhage due to amyloid 
angiopathy (Schmal et al. 1998); data only in men (Leppala et al. 1999). 
  
All titles and abstracts screened 
3041 irrelevant studies excluded  
15 full-text articles of relevant studies 
reviewed 
10 articles excluded:  




-study period before 1990 (1) 
-unavailable original risk factor data (3) 
  
   
5 risk factors for stroke types studies in 
white populations included 
3051 systematic review/meta-
analysis/primary studies retrieved 
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Figure 5.3 Hypertension meta-analysis for intracerebral haemorrhage versus ischaemic stroke 
in Chinese and white populations. 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.5 1 2 5 
Whites                             (2602/4999, 20220/40257) 1.15 (0.84, 1.57)  I
2
=93% 
Denmark, Andersen KK   (1593/3382, 16406/33687) 0.94 (0.87, 1.01) 
NZ, Feigin                        (94/177, 580/1032) 0.88 (0.63, 1.23) 
Italy, Silvestrelli G             (344/600, 1117/1759) 0.76 (0.63, 0.93) 
Greece, Vemmos KN       (127/157, 583/885) 2.19 (1.42, 3.46) 
Spain, Marti'-Vilalta JL      (444/683, 1534/2894) 1.65 (1.38, 1.97) 
1.38 (1.18, 1.62)  I
2
=61% 
China, Hao ZL                   (447/882, 1004/2070) 1.09 (0.93, 1.28) 
China, Liu XF                     (75/142, 280/610) 1.32 (0.90, 1.94) 
Taiwan, Hsieh FI                (4171/4913, 19558/24695) 1.48 (1.36, 1.61) 
Taiwan, Jeng JS                (165/228, 434/676) 1.46 (1.04, 2.07) 
Taiwan, Hsu WC                (169/235, 364/603) 1.68 (1.20, 2.37) 
Taiwan, Hsu LC                 (48/70, 97/170) 1.64 (0.88, 3.12) 
Chinese                            (5075/6470, 21737/28824) 
 
 (ICH n/N, IS n/N)                      OR                                   OR (95% CI)   Het
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Figure 5.4 Diabetes meta-analysis for intracerebral haemorrhage versus ischaemic stroke in 
Chinese and white populations.  
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 






0.1 0.2 0.5 1 2 
Whites                             (612/5118, 6140/40054) 0.67 (0.54, 0.83)   I
2
=69% 
Denmark, Andersen KK  (382/3501, 4822/33484) 0.73 (0.65, 0.81) 
NZ, Feigin                        (18/177, 177/1032) 0.55 (0.31, 0.92) 
Italy, Silvestrelli G             (96/600, 295/1759) 0.94 (0.72, 1.22) 
Greece, Vemmos KN       (20/157, 238/885) 0.40 (0.23, 0.66) 
Spain, Marti'-Vilalta JL      (96/683, 608/2894) 0.61 (0.48, 0.78) 
Chinese                          (1993/6470, 12100/28824) 0.55 (0.39, 0.77)   I
2
=87% 
China, Hao ZL                  (58/882, 302/2070) 0.41 (0.30, 0.55) 
China, Liu XF                    (44/142, 163/610) 1.23 (0.81, 1.86) 
Taiwan, Hsieh FI               (1818/4913, 11212/24695) 0.71 (0.66, 0.75) 
Taiwan, Jeng JS               (33/228, 208/676) 0.38 (0.25, 0.58) 
Taiwan, Hsu WC               (32/235, 178/603) 0.38 (0.24, 0.57) 
Taiwan, Hsu LC                (8/70, 37/170) 0.46 (0.18, 1.09) 
 (ICH n/N, IS n/N)                             OR  OR (95% CI)      Het 
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Figure 5.5 Atrial fibrillation meta-analysis for intracerebral haemorrhage versus ischaemic 
stroke in Chinese and white populations.  
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.01 0.1 0.2 0.5 1 
Whites                              (566/4237, 6608/35845) 0.35 (0.16, 0.77)   I
2
=96%, 
Denmark, Andersen KK   (484/3480, 5810/33201) 0.76 (0.69, 0.84) 
Italy, Silvestrelli G             (71/600, 464/1759) 0.37 (0.28, 0.49) 
Greece, Vemmos KN        (11/157, 334/885) 0.12 (0.06, 0.23) 
Chinese                           (342/6165, 4433/28051) 0.26 (0.18, 0.40)   I
2
=66% 
China, Hao ZL                  (14/882, 186/2070) 0.16 (0.09, 0.28) 
China, Liu XF                   (6/142, 66/610) 0.36 (0.13, 0.86) 
Taiwan, Hsieh FI              (314/4913, 4075/24695) 0.35 (0.31, 0.39) 
Taiwan, Jeng JS              (8/228, 106/676) 0.20 (0.08, 0.41) 
                                  (ICH n/N, IS n/N)                               OR               OR (95% CI)      Het 
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Figure 5.6 Ischaemic heart disease meta-analysis for intracerebral haemorrhage versus 
ischaemic stroke in Chinese and white populations.  
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.1 0.2 0.5 1 2 5 
Whites                              (282/3586, 3587/33701) 0.70 (0.62, 0.80)   I
2
=86% 
Denmark, Andersen KK   (267/3429, 3380/32816) 0.74 (0.64, 0.84) 
Greece, Vemmos KN       (15/157, 207/885) 0.35 (0.18, 0.61) 
Chinese                           (440/6165, 3924/28051) 0.46 (0.42, 0.51)   I
2
=91% 
China, Hao ZL                 (39/882, 333/2070) 0.24 (0.17, 0.34) 
China, Liu XF                   (17/142, 58/610) 1.29 (0.68, 2.35) 
Taiwan, Hsieh FI              (339/4913, 3359/24695) 0.47 (0.42, 0.53) 
Taiwan, Jeng JS              (45/228, 174/676) 0.71 (0.48, 1.04) 
                                    (ICH n/N, IS n/N)                                 OR                              OR (95% CI)     Het
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Figure 5.7 Hypercholesterolaemia meta-analysis for intracerebral haemorrhage versus 
ischaemic stroke in Chinese and white populations. 
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.1 0.2 0.5 1 2 5 
Whites                        (108/934, 807/3676) 0.52 (0.38, 0.72)   I2=49% 
NZ, Feigin                  (28/177, 310/1032) 0.44 (0.28, 0.68) 
Italy, Silvestrelli G      (55/600, 227/1759) 0.68 (0.49, 0.93) 
Greece, Vemmos KN (25/157, 270/885) 0.43 (0.26, 0.68) 
Chinese                     (93/1322, 334/3526) 0.76 (0.38, 1.52)   I2=85% 
China, Hao ZL           (23/882, 49/2070) 1.10 (0.64, 1.86) 
China, Liu XF           (36/142, 113/610) 1.49 (0.94, 2.33) 
Taiwan, Jeng JS       (10/228, 97/676) 0.27 (0.13, 0.54) 
Taiwan, Hsu LC        (24/70, 75/170) 0.66 (0.35, 1.22) 
                             (ICH n/N, IS n/N)              OR                                    OR (95% CI)     Het 
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Figure 5.8 Smoking meta-analysis for intracerebral haemorrhage versus ischaemic stroke in 
Chinese and white populations.  
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.2 0.5 1 2 
Whites                          (1598/4496, 20881/41941) 0.71 (0.52, 0.97)    I2=92% 
Denmark, Andersen KK (1172/2879, 18676/35371) 0.61 (0.57, 0.66) 
NZ, Feigin                    (85/177, 568/1032) 0.75 (0.54, 1.05) 
Italy, Silvestrelli G         (72/600, 445/1759) 0.40 (0.30, 0.53) 
Greece, Vemmos KN (50/157, 295/885) 0.93 (0.64, 1.36) 
Spain, Marti'-Vilalta JL (219/683, 897/2894) 1.05 (0.87, 1.26) 
Chinese                     (2368/6470, 11305/28824) 0.94 (0.82, 1.06)     I2=45%     
China, Hao ZL            (258/882, 575/2070) 1.08 (0.90, 1.28) 
China, Liu XF              (64/142, 254/610) 1.15 (0.78, 1.69) 
Taiwan, Hsieh FI        (1887/4913, 9977/24695) 0.92 (0.86, 0.98) 
Taiwan, Jeng JS         (64/228, 220/676) 0.81 (0.57, 1.14) 
Taiwan, Hsu WC         (65/235, 178/603) 0.91 (0.64, 1.29) 
Taiwan, Hsu LC           (30/70, 101/170) 0.51 (0.28, 0.94) 
                               (ICH n/N, IS n/N)                            OR                       OR (95% CI)     Het 
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Figure 5.9 Alcohol meta-analysis for intracerebral haemorrhage versus ischaemic stroke in 
Chinese and white populations. 
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.2 0.5 1 2 5 
Whites                              (308/3413, 2599/31419) 0.82 (0.37, 1.85)   I
2
=94%, 
Denmark, Andersen KK   (276/2813, 2432/29660) 1.22 (1.07, 1.39) 
Italy, Silvestrelli G              (32/600, 167/1759) 0.53 (0.35, 0.79) 
Chinese                            (370/1557, 753/4129) 1.46 (1.12, 1.91)   I
2
=62% 
China, Hao ZL                  (207/882, 383/2070) 1.35 (1.11, 1.64) 
China, Liu XF                    (58/142, 130/610) 2.55 (1.69, 3.81) 
Taiwan, Jeng JS               (49/228, 79/676) 1.23 (0.83, 1.81) 
Taiwan, Hsu WC               (40/235, 79/603) 1.36 (0.87, 2.09) 
Taiwan, Hsu LC                (16/70, 38/170) 1.03 (0.49, 2.08) 
                                     (ICH n/N, IS n/N)        OR                                       OR (95% CI)     Het 
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Figure 5.10 Summary of risk factor comparisons for intracerebral haemorrhage versus 
ischaemic stroke in Chinese and white populations.  
 
SN=study number; ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of 
patients with certain risk factor; N=total number of patients; OR=odds ratio; CI=confidence 
interval; Het=Between-group heterogeneity; HTN=Hypertension; DM=Diabetes Mellitus; 
AF=Atrial fibrillation; IHD= Ischaemic heart disease; HC=Hypercholesterolaemia. Diamonds 
represent pooled ORs. Horizontal lines represent 95% CIs. 
  
0.1 0.2 0.5 1 2 
Alcohol-Whites (2)     (308/3413, 2599/31419) 0.82 (0.37, 1.85)   
Alcohol-Chinese (5)   (370/1557, 753/4129) 1.46 (1.12, 1.91)     
Smoking-Whites (5)   (1598/4496, 20881/41941) 0.71 (0.52, 0.97)     
0.94 (0.82, 1.06)     
HC-Whites (3)           (108/936, 807/3674) 0.52 (0.38, 0.72)     
HC-Chinese (4)          (93/1322, 49/2070) 0.76 (0.26, 1.52)     
IHD-Whites (2)           (282/3586, 3587/33701) 0.70 (0.62, 0.80)     
IHD-Chinese (4)         (440/6165, 3924/28051) 0.46 (0.42, 0.51)     
AF-Whites (3)            (566/4237, 6608/35845) 0.35 (0.16, 0.77)     
AF-Chinese (4)           (342/6165, 4433/28051) 0.26 (0.17, 0.40)     
DM-Whites (5)            (612/5118, 6140/40054) 0.67 (0.54, 0.83)    
DM-Chinese (6)          (1993/6470, 12100/28824) 0.55 (0.39, 0.77)     
 
HTN-Whites (5)          (2602/4999, 20220/40257) 1.15 (0.84, 1.57) 
HTN-Chinese (6)        (5075/6470, 21737/28824) 1.38 (1.18, 1.62) 
(SN)       (ICH n/N, IS n/N)                            OR                 OR (95% CI)       Het (p-value)      








                                                                  Risk factor commoner in IS         Risk factor commoner in ICH 
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Figure 5.11 Subgroup analysis of hypertension for intracerebral haemorrhage versus ischaemic 
stroke by different geographical regions in Chinese populations. 
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
 
  
0.5 1 2 5 
China subtotal       (522/1024, 1284/2680) 1.12 (0.97, 1.30)   I2=0%    
China, Hao ZL          (447/882, 1004/2070) 1.09 (0.93, 1.28) 
China, Liu XF           (75/142, 280/610) 1.32 (0.90, 1.94) 
Taiwan subtotal     (4553/5446, 20453/26144) 1.49 (1.38, 1.61)   I2=0%    
Taiwan, Hsieh FI       (4171/4913, 19558/24695) 1.48 (1.36, 1.61) 
Taiwan, Jeng JS        (165/228, 434/676) 1.46 (1.04, 2.07) 
Taiwan, Hsu WC        (169/235, 364/603) 1.68 (1.20, 2.37) 
Taiwan, Hsu LC         (48/70, 97/170) 1.64 (0.88, 3.12) 
Study                  (ICH n/N, IS n/N)        OR                     (95% CI)            Het 
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Figure 5.12 Subgroup analysis of diabetes for intracerebral haemorrhage versus ischaemic 
stroke by different geographical regions in Chinese populations. 
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 




0.1 0.2 0.5 1 2 5 
China subtotal           (102/1024, 465/2680) 0.71 (0.24, 2.07)    I2=95% 
 
China, Hao ZL             (58/882, 302/2070) 0.41 (0.30, 0.55) 
China, Liu XF               (44/142, 163/610) 1.23 (0.81, 1.86) 
Taiwan subtotal          (1891/5446, 11635/26144) 0.48 (0.31, 0.74)    I2=83% 
Taiwan, Hsieh FI           (1818/4913, 11212/24695) 0.71 (0.66, 0.75) 
Taiwan, Jeng JS           (33/228, 208/676) 0.38 (0.25, 0.58) 
Taiwan, Hsu WC          (32/235, 178/603) 0.38 (0.24, 0.57) 
Taiwan, Hsu LC             (8/70, 37/170) 0.46 (0.18, 1.09) 
Study                      (ICH n/N, IS n/N)        OR                     (95% CI)            Het 
 
Chapter 5. Risk factor meta-analyses in pathological types of stroke – ICH versus IS  118 
Figure 5.13 Subgroup analysis of atrial fibrillation for intracerebral haemorrhage versus 
ischaemic stroke by different geographical regions in Chinese populations. 
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 




0.01 0.1 0.2 0.5 1 
China subtotal        (20/1024, 252/2680) 0.23 (0.10, 0.49)   I2 =58% 
China, Hao ZL         (14/882, 186/2070) 0.16 (0.09, 0.28) 
China, Liu XF           (6/142, 66/610) 0.36 (0.13, 0.86) 
Taiwan subtotal     (322/5141, 4181/25371) 0.29 (0.18, 0.49)    I2=55% 
Taiwan, Hsieh FI     (314/4913, 4075/24695) 0.35 (0.31, 0.39) 
Taiwan, Jeng JS      (8/228, 106/676) 0.20 (0.08, 0.41) 
Study                  (ICH n/N, IS n/N)        OR                     (95% CI)            Het 
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Figure 5.14 Subgroup analysis of ischaemic heart disease for intracerebral haemorrhage versus 
ischaemic stroke by different geographical regions in Chinese populations. 
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
 
  
0.1 0.2 0.5 1 2 5 
China subtotal        (56/1024, 391/2680) 0.55 (0.10, 2.90)  I2=96% 
China, Hao ZL         (39/882, 333/2070) 0.24 (0.17, 0.34) 
China, Liu XF           (17/142, 58/610) 1.29 (0.68, 2.35) 
Taiwan subtotal     (384/5141, 3533/25371) 0.56 (0.37, 0.83)  I2=77% 
Taiwan, Hsieh FI     (339/4913, 3359/24695) 0.47 (0.42, 0.53) 
Taiwan, Jeng JS       (45/228, 174/676) 0.71 (0.48, 1.04) 
Study                 (ICH n/N, IS n/N)         OR                      (95% CI)            Het 
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Figure 5.15 Subgroup analysis of hypercholesterolaemia for intracerebral haemorrhage versus 
ischaemic stroke by different geographical regions in Chinese populations. 
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
 
  
0.1 0.2 0.5 1 2 5 
China subtotal       (59/1024, 162/2680) 1.31 (0.95, 1.82)  I2=0% 
 
China, Hao ZL       (23/882, 49/2070) 1.10 (0.64, 1.86) 
China, Liu XF         (36/142, 113/610) 1.49 (0.94, 2.33) 
Taiwan subtotal    (34/298, 172/846) 0.43 (0.18, 1.04)  I2=74% 
Taiwan, Jeng JS    (10/228, 97/676) 0.27 (0.13, 0.54) 
Taiwan, Hsu LC     (24/70, 75/170) 0.66 (0.35, 1.22) 
Study               (ICH n/N, IS n/N)         OR                      (95% CI)           Het 
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Figure 5.16 Subgroup analysis of smoking for intracerebral haemorrhage versus ischaemic 
stroke by different geographical regions in Chinese populations. 
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
 
  
0.2 0.5 1 2 
China subtotal        (322/1024, 829/2680) 1.09 (0.93, 1.27)   I2=0% 
China, Hao ZL         (258/882, 575/2070) 1.08 (0.90, 1.28) 
China, Liu XF           (64/142, 254/610) 1.15 (0.78, 1.69) 
Taiwan subtotal      (2046/5446, 10476/26144) 0.86 (0.73, 1.01) 
Taiwan, Hsieh FI     (1887/4913, 9977/24695) 0.92 (0.86, 0.98)   I2=35% 
Taiwan, Jeng JS       (64/228, 220/676) 0.81 (0.57, 1.14) 
Taiwan, Hsu WC     (65/235, 178/603) 0.91 (0.64, 1.29) 
Taiwan, Hsu LC       (30/70, 101/170) 0.51 (0.28, 0.94) 
Study                 (ICH n/N, IS n/N)                                       OR                        (95% CI)            Het 
 
Chapter 5. Risk factor meta-analyses in pathological types of stroke – ICH versus IS  122 
Figure 5.17 Subgroup analysis of alcohol intake for intracerebral haemorrhage versus ischaemic 
stroke by different geographical regions in Chinese populations. 
 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk 
factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 






0.2 0.5 1 2 5 
China subtotal       (265/1024, 513/2680) 1.52 (1.28, 1.80)   I2=88% 
 
China, Hao ZL        (207/882, 383/2070) 1.35 (1.11, 1.64) 
China, Liu XF          (58/142, 130/610) 2.55 (1.69, 3.81) 
Taiwan subtotal    (105/533, 240/1449) 1.25 (0.83, 1.81)   I2=0% 
Taiwan, Jeng JS      (49/228, 79/676) 1.23 (0.83, 1.81) 
Taiwan, Hsu WC    (40/235, 79/603) 1.36 (0.87, 2.09) 
Taiwan, Hsu LC      (16/70, 38/170) 1.03 (0.49, 2.08) 
Study                  (ICH n/N, IS n/N)                    OR                     (95% CI)            Het 
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Figure 5.18 Summary for subgroup analyses of risk factor comparisons for ICH versus IS by different geographical regions in Chinese populations. 
 
0.1 0.2 0.5 1 2 5 
Alcohol-C (2)      (265/1024, 513/2680) 1.52 (1.28, 1.80)   I
2
=88% 
Alcohol-T (3)      (105/533, 240/1449) 1.25 (0.83, 1.81)   I2=0% 
Smoking-C (2)   (322/1024, 829/2680) 1.09 (0.93, 1.27)   I2=0% 
Smoking-T (4)   (2046/5446, 10476/26144) 0.86 (0.73, 1.01)   I2=35% 
HC-C (2)           (59/1024, 162/2680) 1.31 (0.95, 1.82)   I
2
=0% 
HC-T (2)           (34/298, 172/846) 0.43 (0.18, 1.04)   I
2
=74% 
IHD-C (2)         (56/1024, 391/2680) 0.55 (0.10, 2.90)   I2=96% 
IHD-T (2)         (384/5141, 3533/25371) 0.56 (0.37, 0.83)   I2=77% 
AF-C (2)           (20/1024, 252/2680) 0.23 (0.10, 0.49)   I2=58% 
AF-T (2)           (322/5141, 4181/25371) 0.29 (0.18, 0.49)   I2=55%  
DM-C (2)          (102/1024, 465/2680) 0.71 (0.24, 2.07)   I2=95% 
DM-T (4)          (1891/5446, 11635/26144) 0.48 (0.31, 0.74)   I2=83%  
HTN-C (2)         (522/1024, 1284/2680) 1.12 (0.97, 1.30)   I2=0% 
HTN-T (4)         (4553/5446, 20453/26144) 1.49 (1.38, 1.61)   I2=0% 
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SN=study number; ICH=intracerebral haemorrhage; IS=ischaemic stroke; n=number of patients with certain risk factor; N=total number of patients; 
OR=odds ratio; CI=confidence interval; het=heterogeneity; I=inconsistency; T=Taiwan; C=mainland China; HTN=Hypertension; DM=Diabetes 
mellitus; AF=Atrial fibrillation; IHD=Ischaemic heart disease; HC=hypercholesterolaemia. Diamonds represent pooled ORs. Horizontal lines 
represent 95% CIs. 
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 Risk factor meta-analyses in Chapter 6:
ischaemic stroke subtypes – the TOAST and 
OCSP classifications 
6.1 Introduction 
My systematic review for ischaemic stroke (IS) subtypes using the Trial of Org 
10172 in Acute Ischaemic Stroke (TOAST) or the Oxfordshire Community Stroke 
Project (OCSP) classification in Chapter 4, and another recent community-based 
study using Atherosclerosis Risk in Communities (ARIC) classification scheme 
showed evidence to suggest a different distribution of ischaemic stroke (IS) subtypes, 
with a higher proportion of lacunar strokes in Chinese versus white populations (Tsai 
et al. 2013; Fang et al. 2012).  
However, the reasons for the difference in distribution of IS subtypes between 
Chinese and white populations are not clear. It may relate to differences in the 
prevalence of vascular risk factors and their associations with IS subtypes, and/or 
different genetic risk factors (Schulz et al. 2003; Jackson et al. 2005; Traylor et al. 
International Stroke Genetics Consortium. 2012). To test the hypothesis that the 
distributions of risk factors among IS subtypes vary in different populations, I 
conducted a systematic review and meta-analysis to evaluate differences in the 
prevalence of risk factors in overall IS and their associations with IS subtypes in 
Chinese compared with white patients with IS. 
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6.2 Methods 
 Search strategy  6.2.1
I used comprehensive strategies to identify articles comparing the frequency of risk 
factors among IS subtypes in Chinese populations from electronic databases Medline 
and EMBASE (Appendix 2). For comparison, I sought similar studies in 
predominantly white populations with Medline and EMBASE searches that aimed to 
identify existing systematic reviews and meta-analyses of risk factors for IS subtypes 
(Appendix 3). I also conducted citation searches of key relevant reviews and perused 
the reference lists of included primary articles and relevant reviews in both 
populations (Feigin et al. 2009; Liu et al. 2007; Schulz et al. 2003; Jackson et al. 
2005).  
 
 Selection criteria for risk factor studies of IS subtypes 6.2.2
I included studies with prospective design, standard World Health Organization 
(WHO, Hatano et al. 1976) or National Institute of Neurological Disorders and 
Stroke (NINDS Ad Hoc Committee. 1990) or similar definition of stroke definition 
of stroke, and data collection from 1990 onwards since brain imaging with computer 
tomography (CT) or magnetic resonance (MR) were not used widely before this. I 
included both community-based and hospital-based studies of recurrent as well as 
first-ever strokes. For reliable stroke diagnosis and classification, I required CT/MR 
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brain imaging (or autopsy) in >70% of cases. IS had to be classified into five 
aetiological subtypes - large artery atherosclerosis (LAA), cardioembolism (CE), 
intracranial small vessel disease (SVD), other determined aetiology, or undetermined 
aetiology according to the Trial of Org 10172 in Acute Ischaemic Stroke (TOAST) 
classification scheme or similar, or into the four anatomical subtypes of the 
Oxfordshire Community Stroke Project (OCSP) classification scheme - lacunar 
infarct (LACI), total anterior circulation infarct (TACI), partial anterior circulation 
infarct (PACI), posterior circulation infarct (POCI) (Adams et al. 1993; Bamford et 
al. 1991). I excluded studies with retrospective design, unclear stroke definition or IS 
classification, incomplete risk factor information for separate IS subtypes, IS 
classification other than TOAST or OCSP, low CT/MR rate, or highly selected 
patients (e.g. confined to a particular subgroup). I contacted study authors directly for 
essential information which was not available in their original publication(s).  
 
 Data extraction 6.2.3
From each included IS study, I extracted available information on: the geographical 
area of the study; sources of case ascertainment; whether it included only first-ever 
or first-ever and recurrent strokes; study period; stroke definition; stroke subtype 
classification method; the proportion with CT or MR brain imaging; time from 
symptom onset to brain imaging; numbers of total IS and of each IS subtype; mean 
age and sex distribution of stroke cases; risk factor definitions; number of cases with 
each risk factor for separate IS subtypes using the TOAST or OCSP classification.  
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 Statistical analysis 6.2.4
I calculated pooled proportions of each risk factor in all IS patients in Chinese and 
predominantly white populations separately.  For each risk factor, I calculated study-
specific odds ratio (OR) with 95% confidence interval (CI) for each IS subtype 
versus all others in the TOAST classification in Chinese and in predominantly white 
populations. If there was more than one study, I used a random effects model to 
compute pooled ORs with 95% CI because of the substantial heterogeneity among 
individual studies. In IS using the OCSP classification, I categorized subtypes into 
lacunar and non-lacunar groups, and used the same methods.  
I assessed heterogeneity among Chinese studies and among white studies with both 
I
2
 and Cochrane Q chi-square statistics, obtaining within-group heterogeneity 
(Higgins et al. 2003; Ryan R, Cochrane Consumers and Communication Review 
Group. 2013). To assess whether pooled ORs for each risk factor comparison 
differed significantly between Chinese and white patients, I treated ethnic groups as 
if they were studies and performed a test for heterogeneity, using the within-group 
pooled estimates, standard errors and chi-square statistics to test for statistical 
significance (Borenstein et al. 2009; Ryan R. 2013; Sedgwick P. 2013). A probability 
value of less than 0.10 was regarded significant because heterogeneity tests were 
typically used in a conservative manner for meta-analysis (Petitti et al. 2001). I 
performed analyses with StatsDirect software (http://www.statsdirect.com). 
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6.3 Results 
 Characteristics of included studies 6.3.1
I retrieved 5817 articles from my research for studies in Chinese populations. From 
these, 45 potentially relevant studies were identified for full text review, finally 
including eight studies (four using TOAST, four OCSP) with a total of 16199 
patients with a first-ever or recurrent stroke (Yip et al. 1997; Lin et al. 2002; Liu et al. 
2006; Wang et al. 2013.; Li et al. 2003; Li et al. 2008; Jia et al. 2011; Yang et al. 
2011). In white (or predominantly white) populations, I identified 11 studies (eight 
TOAST, three OCSP) in a total of 16187 white (or predominantly white) IS patients 
(Adams et al. 1993; Marti-Vilalta et al. 1999; Vemmos et al. 2000; Kolominsky-
Rabas et al. 2001; Grau et al. 2001; Silvestrelli et al. 2006; Hajat et al. 2011; Bejot et 
al. 2008; Lindgren et al. 1994; Carlo et al. 2006; Hajat et al. 2001). Study selection 
and reasons for exclusions are shown in Figures 6.1 and 6.2.  
The characteristics of these included studies are displayed in Tables 6.1 and 6.2.  
Generally, the brain imaging rates were high (range 98 to 100%). In Chinese 
populations, all were hospital-based. I could not find any community-based study 
using the TOAST or OCSP even after comprehensive search.  Two studies provided 
risk factor information in both TOAST and OCSP in the same population (Wang et 
al. 2013; Jia et al. 2011). Patients in the Chinese studies had younger onset of stroke 
compared with whites (Chinese: mean age 66, range 61 to 69; Whites: mean age 71, 
range 66 to 74). 
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 Risk factor prevalence for overall IS patients 6.3.2
Risk factors studied were hypertension, diabetes, atrial fibrillation (AF), ischaemic 
heart disease (IHD), hypercholesterolaemia, smoking and alcohol intake. The 
definitions of each risk factor reported in original studies are summarised in Tables 
6.3 and 6.4. Definitions were not always given, and where they were, there were 
some differences between studies. Compared with Whites, Chinese IS patients had 
similar pooled prevalence of hypertension (pooled proportions both 59%), diabetes 
(25% versus 21%), smoking (38% versus 30%) and alcohol intake (21% versus 15%), 
as well as lower prevalence of AF (11% versus 27%), IHD (11% versus 20%) and 
hypercholesterolaemia (9%, versus 30%) (Figure 6.3). However, heterogeneity 
within Chinese and white studies was substantial and there were some differences in 
risk factor definitions between Chinese and predominantly white populations such as 
hypertension. (e.g., Most Chinese studies used 140/90 mmHg as the cut-off point to 
define hypertension, while most white studies used 160/95 mmHg). 
 
 Risk factor associations with IS subtypes 6.3.3
Comparisons of risk factors among IS subtypes showed generally very similar 
directions of results between Chinese and white IS patients, although the size of the 
differences were sometimes different. Nevertheless, Chinese stroke patients had 
younger age onset of stroke versus white patients across major IS subtypes (mean 
age of onset: LAA 66 versus 68 years, CE 69 versus 76 years, SVD 65 versus 69 
years, lacunar 65 versus 71 years), while the proportion of male gender was higher in 
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Chinese SVD or lacunar IS subtypes as compared with Whites (LAA: 64% versus 
62%, p=0.123; CE 45% versus 47%, p=0.202; SVD 64% versus 58%, p<0.001; 
lacunar 62% versus 56%, P=0.015). 
Among studies using the TOAST classification, comparing LAA versus other IS 
subtypes, in both Chinese and Whites, diabetes was slightly but significantly more 
common in LAA stroke (ORs 1.34 and 1.42 for Chinese and whites respectively, 
Figure 6.5) and AF substantially and significantly less common (ORs 0.27 and 0.19, 
Figure 6.6). Smoking appeared slightly commoner in LAA stroke (significantly in 
Chinese, but non-significantly in whites) (Figure 6.8). Otherwise there were no 
significant risk factor differences between subtypes, with the exception of alcohol 
consumption, which appeared commoner in LAA versus other subtypes in Chinese 
but not in whites, possibly accounted for – at least in part - by different definitions of 
alcohol consumption (Figures 6.4 to 6.9; Tables 6.3 and 6.4). Overall, there was no 
significant difference in any risk factor association between Chinese and Whites 
(Figure 6.10). 
Comparing CE versus other stroke subtypes, there were consistent, significant, 
strongly positive associations with AF (ORs 71.4 and 36.8 in Chinese and Whites 
respectively) and significantly positive associations with IHD (ORs 3.62 and 1.31, 
Figures 6.13 and 6.14). Both associations were significantly more marked in Chinese 
(heterogeneity between Chinese and white studies for AF: p<0.001, for IHD: 
p=0.021; Figure 6.17). Hypertension, diabetes, smoking and alcohol were all less 
common in CE versus other subtypes in both populations (Figures 6.11, 6.12, 6.15, 
and 6.16). The negative association with diabetes was non-significant in Whites, but 
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statistically significant in Chinese, while the negative associations with smoking and 
alcohol were non-significant in Chinese but statistically significant in Whites 
(between-group heterogeneity for diabetes: p=0.079, for smoking: p=0.011, for 
alcohol: p=0.028; Figure 6.17).  
Comparing SVD versus other stroke subtypes showed, in both Chinese and Whites, 
significantly positive associations with hypertension and diabetes, and negative 
associations with AF and IHD (Figures 6.18 to 21). The negative association with 
IHD was significant in Chinese, but not in Whites (Figure 6.21). These associations 
were all similar in Chinese and Whites, without between-group heterogeneity 
(hypertension ORs 1.78 versus 1.93; diabetes ORs 1.17 versus 1.50; AF ORs 0.15 in 
versus 0.14; IHD ORs 0.55 versus 0.52; Figure 6.24). Neither smoking nor alcohol 
consumption differed significantly between SVD and other ischemic subtypes in 
either Chinese or Whites (Figures 6.22 and 23). 
Among studies using the OCSP classification scheme and comparing lacunar IS 
versus others subtypes (Figures 6.25 to 31), the direction of risk factor associations 
was very similar to that for the comparison between TOAST SVD stroke versus 
other subtypes (Figures 6.18 to 24), but the pooled estimates were less extreme and 
differences were less marked. Only AF differed significantly between lacunar stroke 
and other subtypes for both Chinese and white stroke patients, and the difference was 
similar for both groups (OR in Chinese 0.40, OR in Whites 0.49; between-group 
heterogeneity: p=0.568). No risk factors showed significant Chinese-White between-
group differences (Figure 6.31).  
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6.4 Discussion 
My results showed that, compared with Whites, Chinese IS patients had younger 
onset of stroke, a similar prevalence of hypertension, diabetes, smoking and alcohol, 
and a significantly lower prevalence of AF, IHD and hypercholesterolaemia than 
white IS patients although there was substantial heterogeneity  in either Chinese or 
white studies. In addition, I found that the risk factor associations with IS subtypes 
using the TOAST or OCSP classifications were mostly similar in direction (though 
different in size) in both Chinese and white IS patients. Compared with all other 
ischaemic subtypes, diabetes was slightly more common in LAA, AF and IHD in CE, 
and hypertension and diabetes in SVD. However, the small albeit significant 
associations with lacunar stroke became less so in the OCSP classification scheme. 
In my study, the pooled proportion of overall IS revealed a significant lower 
prevalence of AF, IHD and hypercholesterolaemia in Chinese stroke patients than 
Whites. My findings were consistent with other reports, which were probably related 
to the relatively lower prevalence of these risk factors in Chinese populations as 
compared with Whites (Zhang et al. 2004; Chien et al. 2010; Wu et al. 2001).
 
In 
addition, I found the prevalence of diabetes in overall Chinese IS patients (which 
included more than 80% of patients after 2000) was comparable to, and even a bit 
higher than that in white patients, while the prevalence of hypertension is similar 
between the groups. This result differed from the report of lower prevalence of 
diabetes in Chinese stroke patients from an earlier study (Zhang et al. 2004). The 
difference could possibly reflect around 300% increase of prevalence of pre-diabetes 
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and diabetes in the recent two decades due to the rapid growing economy and the 
westernized lifestyle of China (Yang et al. 2012). As for smoking and alcohol, my 
results showed a relatively higher prevalence (though statistically non-significant) of 
smoking and alcohol in Chinese than white IS patients. Actually, smoking and 
alcohol are increasingly common in Chinese, and China is the world’s largest 
consumer of tobacco (Yang et al. 1999). There was a strong and dose-dependent 
association between cigarette smoking and IS, while alcohol has a curvilinear 
relationship with IS - a protective effect for low to moderate intake and increased 
risk for high consumption (Kelly et al. 2008; Patra et al. 2010).  
In terms of risk factor associations with ischaemic subtypes, my study showed that 
LAA had a positive association with diabetes in both Chinese and Whites. Diabetes 
is a well-known risk factor for ischaemic stroke, especially for large vessel and small 
vessel diseases (WHO Diabetes Drafting Group, 1985). My finding was in agreement 
with previous studies (Rincon et al. 2009; Arenillas et al. 2004). Diabetes is an 
independent risk factor for intracranial large artery atherosclerosis (Arenillas et al. 
2004). Compared with extracranial atherosclerosis or non-atherosclerosis (lacunar, 
cardioembolic and cryptogenic), Diabetes was a more important determinant for 
intracranial atherosclerosis related stroke (Rincon et al. 2009). Although there were 
slight excess, but less consistent associations with smoking and with alcohol intake 
in Chinese, these findings did not appear significantly in whites. Different definitions 
in Chinese and white studies might partly explain the difference. 
In my meta-analysis, CE subtype was strongly associated with AF and IHD in both 
ethnic groups, more in Chinese.  In literature, non-valvular AF and myocardial 
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infarction are the leading causes of cardioembolism (Arboix et al. 2012, Ferro et al 
2003). However, there may be different interpretations of the TOAST classification 
system among stroke physicians, such that IS patients with AF are more likely to be 
assigned to CE stroke than other subtypes, irrespective of other risk factors and 
investigation results (Jackson et al. 2005). 
 
In terms of SVD using the TOAST classification, there was a slight excess in 
hypertension as well as diabetes when compared with other IS subtypes in both 
Chinese and whites. By contrast, it was negatively associated with AF and IHD, 
without significant differences between ethnic groups. Nevertheless, in IS subtype 
studies using the OCSP classification scheme, the slightly positive associations with 
hypertension and diabetes for lacunar versus non-lacunar infarctions became less so.  
My findings are in agreement with the earlier systematic review (Jackson et al. 2005). 
The associations with risk factors for lacunar versus non-lacunar infarcts are less 
extreme when using the OCSP classification – a risk factor-free classification. 
Although my systematic review in Chapter 4 showed a higher proportion of lacunar 
stroke from hospital-based studies in Chinese than Whites, and recently another 
community-based study using the Atherosclerosis Risk in Communities (ARIC) 
classification also reported a higher incidence rate of lacunar infarction in Chinese, 
there seemed to be no evidence of significant difference in the risk factor 
distributions in lacunar stroke between these two ethnic groups (Tsai et al. 2013; 
Fang et al. 2012). Nevertheless, the results could be possibly confounded by different 
population structures such as age and gender, along with other risk factors. Further 
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studies using individual patient data in large stroke registries to adjust for possible 
confounders and further genetic studies for IS subtypes are necessary.   
 
 Strengths and limitations 6.4.1
My study is the first systematic review and meta-analysis comparing risk factor 
distributions among IS subtypes in Chinese compared with predominantly white 
populations. It has several major strengths. First, I used a comprehensive search 
strategy including backward and forward tracking to identify all relevant studies 
published in any language (including Chinese), reducing the potential bias of 
including only English language publications. Second, I included only studies using a 
standard definition of stroke and the TOAST or OCSP classification of ischaemic 
subtypes with a high brain imaging rate. Third, I carefully documented the 
characteristics, methodology and risk factor definitions used in each included study, 
and carried out rigorous meta-analyses to assess within-group and between-group 
heterogeneity among Chinese and predominantly white populations for each IS 
subtype versus others.  
There were some limitations. First, despite a comprehensive literature search, I found 
only a limited number of studies in either Chinese or predominantly white 
populations which fulfilled our inclusion criteria (Chinese literature databases were 
not available to me because I did not have access to the full-text databases). I could 
only find hospital-based studies based on TOAST or OCSP classifications in Chinese 
and few community-based studies in predominantly white populations, whereas an 
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ideal study population should be community-based, including all stroke patients in a 
geographical area, irrespective of hospital admission rate (Sudlow et al. 1996; Feigin 
et al. 2004). Prevalence of risk factors and stroke subtypes may differ between 
hospitalized and non-hospitalized patients (Schulz et al. 2003). Second, there was 
substantial statistical heterogeneity among both Chinese and white studies. This is 
likely to have arisen from differences in age and sex distributions, methodological 
differences (e.g., case ascertainment methods), variation in classification of IS 
subtypes, variation in investigation rates affecting ability to assign a determined 
subtype with the TOAST classification, different risk factor definitions, differences 
between geographical areas, as well as genuine differences in risk factors 
associations between ethnic groups. Third, because my study was based on published 
data, I did not have individual patient data to allow adjustment for possible 
confounding factors such as age. Finally, although I included only studies which 
ascertained stroke cases prospectively, definitions of risk factors in some studies 
were limited by the need to collect information prior to stroke occurrence (which 
might have recall biases) while others were based on the measures made after stroke, 
raising the possibility of reverse causality.  
 
 Conclusion 6.4.2
My study results illustrated and compared that the overall prevalence of risk factors 
in IS and the risk factor associations with IS subtypes in a substantial number of 
Chinese and white IS patients. These findings help us understand the similarities and 
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differences in contributions of modifiable risk factors for IS and its subtypes in 
different populations, which also highlight the need for high quality community-
based studies, and provide directions for future research. Further analyses of large 
stroke registry data to adjust for possible confounding factors are mandatory. 
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65 57% 100% 676 HTN, DM, AF, IHD, CS, HC, HTG, smoking, alcohol, previous stroke, age, 
gender 























































68 58% NR **
 










































61 69% 100% 932 HTN, DM, AF, HL, smoking, alcohol, age, gender 
CT=Computed tomography; MR=Magnetic resonance; IS=ischaemic stroke; n=number; HTN=Hypertension; DM=Diabetes mellitus; HD=Heart 
disease; AF=Atrial fibrillation; IHD=Ischaemic heart disease; LVH=Left ventricular hypertrophy; CS=Carotid stenosis; DL=Dyslipidaemia; 
HL=Hyperlipidaemia; HC=Hypercholesterolaemia; HTG=Hypertriglyceridaemia; HU=Hyperuricemia; *NINDS classification= National Institute of 
Neurological Disorders and Stroke classification; **presumably high percentage. 
The order of studies was ranked according to study period in TOAST and OCSP classifications respectively. 
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66 58% 100% 5017 HTN, DM, Arrhythmia, IHD, HC, smoking, alcohol, PAD, TIA, 
age, gender  






First-ever  73 52% 100% 1759 HTN, DM, EHD, HL, HC, HTG, smoking, alcohol, obesity, TIA, 
age, gender,  
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First-ever  71 49% NR 1169 HTN, DM, smoking, TIA, age, gender 








74 45% 100% 332 HTN, DM, HC, smoking, TIA, age, gender 
OCSP classification 
 






First-ever  73 55% 100% 166 AF, CS 


















First-ever  72 48% NR 862 HTN, DM, AF, IHD, smoking, alcohol, TIA 
CT=Computed tomography; MR=Magnetic resonance; IS=ischaemic stroke; n=number; HTN=Hypertension; DM=Diabetes mellitus; HD=Heart 
disease; AF=Atrial fibrillation; IHD=Ischaemic heart disease; LVH=Left ventricular hypertrophy; CS=Carotid stenosis; EHD=Embolic heart disease; 
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HD=Heart disease; HL=Hyperlipidaemia; HC=Hypercholesterolaemia; HTG=Hypertriglyceridaemia; PAD=peripheral artery disease; TIA=transient 




OCSP classification.  
The order of studies was ranked according to study period in TOAST and OCSP classifications respectively. 
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Table 6.3 Definitions of risk factors among included studies in Chinese populations 
Study (First 
author) 
HTN DM AF IHD HC Smoking Alcohol 
Jian Q ** -- DM history or 
taking DM drugs 
-- -- -- -- -- 
Li H NR NR NR NR -- NR -- 





NR By coronary 
arteriogram 
TC>5.2 mmol/L NR NR 
Liu XF >160/95 mm/Hg 




mmol/L or DM 
history with 
medication 
NR NR TC> 5.7 mmol/L, 
or 
hyperlipidaemia 
history with drugs 
NR NR 
Li W >140/90 mm/Hg 




mmol/L or DM 
history with drugs 
NR NR TC>5.8mmol/L or 
hyperlipidaemia 
history with drugs 
NR NR 




mmol/L or taking 
DM medication 
ECG proof before 
or after stroke 




Frequent or long 
term smoking 
>=20/day 
Frequent or long 
term drinking>=50 
ml/day 
Yip PK History of HTN History of DM History of AF or 
ECG proof before 
or after stroke 
History of angina 
or MI 
>=5.2 mmol/L >=10/day for 
more 10 years 
Habit drinking >= 
once per week 
Wang Y >=140/90 mm/Hg 
during 
Fasting>=6.7 
mg/dl or use of 
History of AF or 
ECG in hospital 
History of MI, or a 





moderate or heavy 
drinking 
 





antidiabetic drugs discharge 
HTN=Hypertension; DM=Diabetes mellitus; AF=Atrial fibrillation; IHD=Ischaemic heart disease; ECG=electrocardiography; CUS=carotid ultrasound;  
HC=Hypercholesterolaemia; HTG=Hypertriglyceridaemia; --=no data - the risk factor was not studied or unavailable from the publication;  
NR=not reported; risk factor was studied but definition not reported; ** =no data in each subtype. 
The order of studies was ranked according to the alphabet initials of first author. 
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Table 6.4 Definitions of risk factors among included studies in white populations  
Study (First 
author) 
HTN DM AF IHD HC Smoking Alcohol 
Bejot Y History of HTN, or 
>=160/95 mm/Hg 
History of fasting 
sugar >=7.8 
mmol/L or at 
stroke, or on DM 
drugs 
-- -- TC>=5.7mmol/L 







Carlo AD History of HTN, 
on HTN drugs, or 
>=160/90 mm/Hg 
History of DM, on 
DM drugs, or 
fasting >=7.8 
mmol/L  
History of AF, or 
by ECG at 
admission 
History of MI -- Current or former 
smoking 
Specified as 
average units per 
day 
Grau AJ History of 
>160/90  mm/Hg 
or on HTN drugs 
History of 
elevated blood 
glucose, or on 




-- NR History of TC> 
5.7 mmol/L or on 
lipid-lowering 
drugs 





from GP or 
hospital records  
Self-reported -- -- -- NR -- 
Hajat C 
b 




from GP or 
History of DM 




outpatient clinic or 
at hospital  
History of angina 
or MI 
-- Ever smoked >14 units per 
week in women 
and >21 units per 
week in men 
 




History of HTN, 
on HTN drugs, or 
>160/95 mm/Hg 
History of DM, on 
DM drugs, or 
fasting > 6.7 
mmol/L 
-- -- -- Current smoking -- 
Lindgren A -- -- ECG proof after 
stroke 
-- -- -- -- 
Marti-Vilalta JL History of 
>160/95 mm/Hg,  
or evidence of 
HTN related end 
organ damage 




-- -- -- History of 
smoking within 5 
years  
-- 
Schulz UGR History of HTN, 
on HTN drugs, or 
>160/95 mm/Hg 
before stroke 
History of DM or 
on DM drugs 
-- -- -- Current smoking Daily 
consumption 
Vemmos KN History of 
>160/95 mm/Hg 
History of DM 
drugs use or 
fasting >6.0 
mmol/L before 
By ECG History of MI, 






smoking or within 
previous year 
-- 
Silvestrelli G History of 
>160/95 mm/Hg 
History of DM 
drug use or 
fasting >6.0 
mmol/L before 





smoking or within 
previous year  
NR 
HTN=Hypertension; DM=Diabetes mellitus; AF=Atrial fibrillation; IHD=Ischaemic heart disease; MI=myocardial infarct; CHF=congestive heart failure; 
ECG=electrocardiography; CUS=carotid ultrasound; HC=Hypercholesterolaemia; HTG=Hypertriglyceridaemia; --=no data - the risk factor was not 
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studied or unavailable from the publication; NR=not reported; risk factor was studied but definition not reported; GP=general practice; Hajat C 
a
=TOAST classification; Hajat C 
b
=OCSP classification. 
The order of studies was ranked according to the alphabet initials of first author. 
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Figures 




IS subtypes using the Atherosclerosis Risk in Communities (ARIC) classification (Fang et al. 
2012). 
b 
Excluding patients with cardiogenic emboli (Zhao et al. 2008); excluding patients with other 
major medical illness (e.g., cancer, anaemia, thyroid dysfunction, etc.; Zhang et al. 2009); 
data only in men (Zhang et al. 2004). 
c 
Weather (Chen et al. 1995), circadian variation of stroke onset (Cheung et al. 2001),and 
homocysteine (Ma et al. 2010). 
  
All titles and abstracts screened 
5772 irrelevant studies excluded  
45 full-text articles of relevant studies 
reviewed 
37 articles excluded:  
- study period before 1990 (3) 
- retrospective design (2) 
- no risk factor data in IS subtypes (22) 
- incomplete data of all IS subtypes (2) 
- IS subtypes classification other than    




-  low  CT/MRI rate (1) 
-  selected patients
 b
 (3)  




8 risk factors for IS subtype studies in 
Chinese populations included 
5817 studies retrieved through 
database and forward citation search 
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Figure 6.2 Selection of studies of risk factors for ischaemic stroke subtypes in white populations. 
 
a 
One study excluded IS patients of posterior circulation infarction, or with uncertain subtype, 
or with unusual cause (e.g. arterial dissection; Jackson et al. 2009), one excluded IS patients 
due to cardiogenic emboli (Schmal et al. 1998), and the other included data only in men 
(Leppala JM et al. 1999). 
All titles and abstracts screened 
3570 irrelevant studies excluded  
22 full-text articles of relevant studies 
reviewed 
11 articles excluded:  
-study period before 1990 (1) 
-no risk factor data in IS subtypes (2)  
-incomplete data in all IS subtypes 
(2) 
-IS classification other than TOAST 





-not in predominantly white 
populations (1) 
11 risk factors for IS subtype studies in 
white populations included 
3591 systematic review/meta-
analysis/primary studies retrieved 
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Figure 6.3 Meta-analyses of prevalence of risk factors among ischaemic stroke patients in Chinese and Whites. 
 0.0 0.2 0.4 0.6 0.8 
Alcohol-W (4) (10108) 0.15 (0.07, 0.27)    I
2
=99% 
Alcohol-C (5) (15092) 0.21 (0.10, 0.33)    I2=99% 
Smoking-W (10) (16021) 0.30 (0.24, 0.37)    I2=99% 
Smoking-C (7) (16199) 0.38 (0.31, 0.45)    I2=98% 
HC-W (4) (7991) 0.30 (0.18, 0.43)    I2=99% 
HC-C (2) (1990) 0.09 (0.02, 0.20)    I2=98% 
IHD-W (4) (9236) 0.20 (0.13, 0.28)    I2=99% 
IHD-C (6) (15627) 0.11 (0.06, 0.18)    I2=99% 
AF-W (5) (6142) 0.27 (0.20, 0.34)     I2=97% 
AF-C (7) (16199) 0.11 (0.09, 0.13)    I2=92% 
DM-W (10) (16021) 0.21 (0.18, 0.24)    I2=94% 
DM-C (7) (16199) 0.25 (0.20, 0.31)    I2=97% 
HTN-W (10) (16021) 0.59 (0.55, 0.64)     I
2
=97% 
HTN-C (7) (16199) 0.59 (0.48, 0.69)     I2=99% 
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SN=study number; CI=confidence interval; Het=heterogeneity; I=inconsistency; HTN=Hypertension; DM=Diabetes Mellitus; AF= Atrial fibrillation; 
IHD=Ischaemic heart disease; HC=Hypercholesterolaemia. Horizontal lines represent 95% CIs. Diamonds represent pooled proportion. 
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Figure 6.4 Meta-analysis of hypertension for LAA versus others ischaemic subtypes in Chinese and Whites. 
 
LAA=Large artery atherosclerosis; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs.  
0.2 0.5 1 2 5 
White populations  (2111/3279, 5707/9410) 1.18 (0.89, 1.57)       I2=87% 
France, Bejot Y          (70/119, 136/213) 0.81 (0.50, 1.32) 
UK, Hajat C                (74/109, 655/1060) 1.31 (0.85, 2.05) 
UK, Schulz UGR        (10/17, 47/85) 1.16 (0.36, 3.93) 
Italy, Silvestrelli G       (216/350, 901/1409) 0.91 (0.71, 1.16) 
Germany, Grau AL      (716/1047, 2571/3970) 1.18 (1.02, 1.37) 
Germany, K-R PL        (37/71, 268/460) 0.78 (0.46, 1.33) 
Greece, Vemmos KN   (114/156, 469/729) 1.50 (1.01, 2.27) 
Spain, Marti'-Vilalta JL (874/1410, 660/1484) 2.04 (1.75, 2.37) 
Chinese populations (4290/5653, 5123/7601)  1.23 (0.95, 1.58)        I2=61% 
China, Wang                (4028/5237, 4381/6323) 1.48 (1.36, 1.61) 
China, Liu XF               (52/120, 228/490) 0.88 (0.57, 1.34) 
Taiwan, Lin YT             (132/183, 157/225) 1.12 (0.71, 1.77) 
Taiwan, Yip PK              (78/113, 357/563) 1.29 (0.82, 2.05) 
Study                        (LAA n/N, AO n/N)          OR                                                 (95% CI)      Het  
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Figure 6.5 Meta-analysis of diabetes for LAA versus other ischaemic subtypes in Chinese and Whites. 
 
LAA=Large artery atherosclerosis; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs.  
0.1 0.2 0.5 1 2 5 
White populations  (873/3277, 2115/9410) 1.42 (1.09, 1.83)      I2=78%   
France, Bejot Y         (26/119, 31/213) 1.64 (0.88, 3.04) 
UK, Hajat C               (23/109, 213/1060) 1.06 (0.62, 1.75) 
UK, Schulz UGR        (0/17, 12/85) 0.19 (0.00, 2.05) 
Italy, Silvestrelli G       (86/350, 209/1409) 1.87 (1.39, 2.50) 
Germany, Grau AL     (298/1047, 1114/3970) 1.02 (0.87, 1.19) 
Germany, K-R PL        (23/71, 107/460) 1.58 (0.87, 2.79) 
Greece, Vemmos KN  (50/156, 188/729) 1.36 (0.91, 2.00) 
Spain, Marti'-Vilalta JL (367/1410, 241/1484) 1.81 (1.51, 2.19) 
Chinese populations (1792/5653, 1973/7601)   1.34 (1.24, 1.44)       I2=0%   
China, Wang Y             (1638/5237, 1611/6323) 1.33 (1.23, 1.45) 
China, Liu XF               (38/120, 125/490) 1.35 (0.85, 2.13) 
Taiwan, Lin YT             (74/183, 78/225) 1.28 (0.34, 1.95) 
Taiwan, Yip PK             (42/113, 159/563) 1.50 (0.96, 2.34) 
Study                        (LAA n/N, AO n/N)                OR                                         (95% CI)      Het
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Figure 6.6 Meta-analysis of atrial fibrillation for LAA versus other ischaemic subtypes in Chinese and Whites. 
 
LAA=Large artery atherosclerosis; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.01 0.1 0.2 0.5 1 
White populations   (60/506, 738/2138) 0.19 (0.04, 0.88)      I2=94% 
Italy, Silvestrelli G       (50/350, 414/1409) 0.40 (0.28, 0.55) 
Greece, Vemmos KN   (10/156, 324/729) 0.09 (0.04, 0.17) 
Chinese populations (327/5653, 1165/7601) 0.27 (0.16, 0.47)      I2=66% 
China, Wang Y           (308/5237, 946/6323) 0.36 (0.31, 0.41) 
China, Liu XF              (6/120, 66/490) 0.34 (0.12, 0.80) 
Taiwan, Lin YT            (5/183, 56/225) 0.08 (0.03, 0.22) 
Taiwan, Yip PK            (8/113, 97/563) 0.37 (0.15, 0.78) 
Study                        (LAA n/N, AO n/N)                OR                                       (95% CI)      Het
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Figure 6.7 Meta-analysis of ischaemic heart disease for LAA versus other ischaemic subtypes in Chinese and Whites. 
 
LAA=Large artery atherosclerosis; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.2 0.5 1 2 5 
White populations    (284/1203, 1087/4699) 1.24 (0.69, 2.23)    I2=87% 
Germany, Grau AL      (234/1047, 930/3970) 0.94 (0.80, 1.11) 
Greece, Vemmos KN   (50/156, 157/729) 1.72 (1.15, 2.55) 
Chinese populations (836/5653, 1169/7601) 1.12 (0.76, 1.65)    I2=68% 
China, Wang Y             (769/5237, 965/6323) 0.96 (0.86, 1.06) 
China, Liu XF                (7/120, 51/490) 0.53 (0.20, 1.22) 
Taiwan, Lin YT             (23/183, 17/225) 1.76 (0.87, 3.63) 
Taiwan, Yip PK             (37/113, 136/563) 1.53 (0.96, 2.41) 
Study                        (LAA n/N, AO n/N)                OR                                       (95% CI)      Het
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Figure 6.8 Meta-analysis of smoking for LAA versus other ischaemic subtypes in Chinese and Whites. 
  
LAA=Large artery atherosclerosis; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs.  
0.1 0.2 0.5 1 2 5 
White populations    (1047/3279, 2416/9410) 1.31 (0.93, 1.85)    I2=90% 
France, Bejot Y           (26/119, 53/213) 0.84 (0.47, 1.48) 
UK, Hajat C                 (39/109, 291/1060 1.47 (0.95, 2.26) 
UK, Schulz UGR          (3/17, 16/85) 0.92 (0.15, 3.91) 
Italy, Silvestrelli G         (61/350, 384/1409) 0.56 (0.41, 0.76) 
Germany, Grau AL       (370/1047, 957/3970) 1.72 (1.48, 2.00) 
Germany, K-R PL         (18/71, 53/460) 2.61 (1.33, 4.93) 
Greece, Vemmos KN   (79/156, 216/729) 2.44 (1.69, 3.52) 
Spain, Marti'-Vilalta JL (451/1410, 446/1484) 1.10 (0.83, 1.28) 
Chinese populations (2362/5653, 2930/7601)  1.26 (1.03, 1.54)    I2=46% 
China, Wang Y             (2197/5237, 2500/6323) 1.11 (1.03, 1.19) 
China, Liu XF                (59/120, 195/490) 1.46 (0.96, 2.23) 
Taiwan, Lin YT              (58/183, 63/225) 1.19 (0.76, 1.87) 
Taiwan, Yip PK              (48/113, 172/563) 1.68 (1.08, 2.59) 
Study                        (LAA n/N, AO n/N)                OR                                       (95% CI)      Het
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Figure 6.9 Meta-analysis of alcohol intake for LAA versus other ischaemic subtypes in Chinese and Whites. 
 
LAA=Large artery atherosclerosis; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.2 0.5 1 2 5 
White populations    (159/1397, 486/5379) 0.95 (0.31, 2.91)    I2=95% 
Italy, SIlvestrelli G       (20/350, 147/1409) 0.53 (0.30, 0.85) 
Germany, Grau AL      (139/1047, 339/3970) 1.64 (1.32, 2.03) 
Chinese populations (577/5350, 660/6886) 1.52 (1.05, 2.21)    I2=71% 
China, Wang Y             (549/5327, 565/6323) 1.19 (1.05, 1.35) 
China, Liu XF                (39/120, 91/490) 2.11 (1.31, 3.36) 
Taiwan, Yip PK             (28/113, 89/563) 1.62 (0.96, 2.67) 
Study                        (LAA n/N, AO n/N)                OR                                       (95% CI)      Het  
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Figure 6.10 Summary of risk factor meta-analyses for LAA versus all others (TOAST) in Chinese and Whites. 
  
0.01 0.1 0.2 0.5 1 2 5 
Alcohol-W (2)       (159/1397, 486/5379) 0.95 (0.31, 2.91)    I2=95% 
Alcohol-C (3)       (577/5350, 660/6886) 1.52 (1.05, 2.21)    I2=71% 
Smoking-W (8)    (1047/3279, 2416/9410) 1.31 (0.93, 1.85)    I2=90% 
Smoking-C (4)     (2362/5653, 2930/7601) 1.26 (1.03, 1.54)    I2=46% 
IHD-W (2)             (284/1203, 1087/4699) 1.24 (0.69, 2.23)    I2=87% 
IHD-C (4)             (836/5653, 1169/7601) 1.12 (0.76, 1.65)    I2=68% 
AF-W (2)             (60/506, 738/2138) 0.19 (0.04, 0.88)    I2=94% 
AF-C (4)              (327/5653, 1165/7601) 0.27 (0.16, 0.47)    I2=66% 
DM-W (8)             (873/3277, 2115/9410) 1.42 (1.09, 1.83)    I2=78% 
DM-C (4)              (1792/5653, 1973/7601) 1.34 (1.24, 1.44)    I2=0% 
HTN-W (8)           (2111/3279, 5707/9410) 1.18 (0.89, 1.57)    I2=87% 
HTN-C (4)            (4290/5653, 5123/7601) 1.23 (0.95, 1.58)    I2=61% 







Risk factor commoner in other IS subtypes        Risk factor commoner in LAA 
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SN=study number; LAA=Large artery atherosclerosis; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; 
OR=odds ratio; CI=confidence interval; Het=heterogeneity; I=inconsistency; HTN=Hypertension; DM=Diabetes mellitus; AF=Atrial fibrillation; 
IHD=Ischaemic heart disease; C=Chinese; W=Whites; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
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Figure 6.11 Meta-analysis of hypertension for CE versus other ischaemic subtypes in Chinese and Whites. 
 
CE=cardioembolism; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence 
interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
0.2 0.5 1 2 5 
White populations   (1831/3192, 5986/9497) 0.80 (0.66, 0.96)     I2=73% 
France, Bejot Y          (44/81, 162/251) 0.65 (0.38, 1.12) 
UK, Hajat C                (209/325, 520/844) 1.12 (0.85, 1.48) 
UK, Schulz UGR         (11/19, 46/83) 1.11 (0.36, 3.52) 
Italy, Silvestrelli G       (229/380, 888/1379) 0.84 (0.66, 1.06) 
Germany, Grau AL      (794/1286, 2493/3731) 0.80 (0.70, 0.92) 
Germany, K-R PL        (81/143, 224/388) 0.96 (0.64, 1.44) 
Greece, Vemmos KN   (208/355, 375/550) 0.76 (0.57, 1.03) 
Spain, Marti'-Vilalta JL (255/623, 1278/2271) 0.54 (0.45, 0.65) 
Chinese populations (638/1064, 8775/12190) 0.68 (0.59, 0.77)     I2=0% 
China, Wang Y            (462/714, 7947/10846) 0.67 (0.57, 0.79) 
China, Liu XF              (69/160, 211/450) 0.86 (0.59, 1.25) 
Taiwan, Lin YT             (34/57, 255/351) 0.56 (0.30, 1.05) 
Taiwan, Yip PK              (73/133, 362/543) 0.61 (0.41, 0.91)     
Study                        (CE n/N, AO n/N)                             OR                                            (95% CI)      Het  
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Figure 6.12 Meta-analysis of diabetes for CE versus other ischaemic subtypes in Chinese and Whites. 
 
CE=cardioembolism; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence 
interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs.  
0.01 0.1 0.2 0.5 1 2 5 
White populations      (703/3192, 2284/9497) 0.83 (0.66, 1.06)     I2=75% 
France, Bejot Y          (11/81, 46/251) 0.70 (0.31, 1.47) 
UK, Hajat C                (60/325, 176/844) 0.86 (0.61, 1.20) 
UK, Schulz UGR         (1/19, 11/83) 0.36 (0.01, 2.84) 
Italy, Silvestrelli G        (79/380, 216/1379) 1.41 (1.01, 1.89) 
Germany, Grau AL      (356/1286, 1056/3731) 0.97 (0.84, 1.12) 
Germany, K-R PL        (33/143, 97/388) 0.90 (0.55, 1.44) 
Greece, Vemmos KN   (70/355, 168/550) 0.60 (0.43, 0.84) 
Spain, Marti'-Vilalta JL (93/623, 514/2271) 0.60 (0.47, 0.77) 
Chinese populations (751/2409, 3014/10845) 0.59 (0.44, 0.80)     I2=56% 
China, Wang Y            (143/714, 3106/10846) 0.62 (0.51, 0.75) 
China, Liu XF              (40/160, 123/450) 0.89 (0.57, 1.36) 
Taiwan, Lin YT             (13/57, 139/351) 0.45 (0.21, 0.89) 
Taiwan, Yip PK             (22/133, 179/543) 0.40 (0.23, 0.67) 
Study                        (CE n/N, AO n/N)                             OR                                            (95% CI)      Het  
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Figure 6.13 Meta-analysis of atrial fibrillation for CE versus other ischaemic subtypes in Chinese and Whites.  
 
CE=cardioembolism; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence 
interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
10 100 1000 
White populations     (586/715, 212/1929) 36.81 (28.88, 46.90)      I2=0% 
Italy, Silvestrelli G        (309/380, 155/1379) 34.31 (24.97, 47.29) 
Greece, Vemmos KN    (277/355, 57/550) 41.31 (27.36, 62.49) 
Chinese populations (790/1064, 702/12190) 71.36 (59.16, 86.06)      I2=0% 
China, Wang Y             (586/714, 668/10846) 69.75 (56.52, 86.40) 
China, Liu XF                (66/160, 6/450) 51.96 (21.58, 149.70) 
Taiwan, Lin YT              (46/57, 15/351) 93.67 (37.88, 237.17) 
Taiwan, Yip PK              (92/133, 13/543) 91.48 (45.56, 191.04) 
Study                        (CE n/N, AO n/N)                             OR                                          (95% CI)      Het  
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Figure 6.14 Meta-analysis of ischaemic heart disease for CE versus other ischaemic subtypes in Chinese and Whites. 
 
CE=cardioembolism; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence 
interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.01 0.1 0.2 0.5 1 2 5 10 100 
White populations     (445/1621, 926/4281) 1.31 (1.02, 1.68)      I2=55% 
Germany, Grau AL      (363/1286, 801/3731) 1.44 (1.24, 1.67) 
Greece, Vemmos KN   (82/355, 125/550) 1.10 (0.79, 1.53) 
Chinese populations (342/1064, 1663/12190) 3.62 (1.59, 8.27)     I2=92% 
China, Wang Y             (224/714, 1510/10846) 2.83 (2.38, 3.35) 
China, Liu XF               (48/160, 10/450) 18.86 (9.01, 42.88) 
Taiwan, Lin YT             (3/57, 10/351) 0.47 (0.09, 1.58) 
Taiwan, Yip PK             (67/133, 106/543) 4.19 (2.74, 6.37) 
Study                        (CE n/N, AO n/N)                           OR                                          (95% CI)      Het  
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Figure 6.15 Meta-analysis of smoking for CE versus other ischaemic subtypes in Chinese and Whites. 
 
CE=cardioembolism; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence 
interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs.  
0.01 0.1 0.2 0.5 1 2 5 
White populations   (581/3192, 2882/9497) 0.46 (0.33, 0.65)     I2=88% 
France, Bejot Y           (13/81, 66/251) 0.54 (0.25, 1.06) 
UK, Hajat C                (61/325, 269/844) 0.49 (0.35, 0.68) 
UK, Schulz UGR         (2/19, 17/83) 0.46 (0.05, 2.26) 
Italy, Silvestrelli G        (33/380, 412/1379) 0.22 (0.15, 0.33) 
Germany, Grau AL      (212/1286, 1115/3731) 0.46 (0.39, 0.55) 
Germany, K-R PL        (12/143, 59/388) 0.51 (0.24, 1.00) 
Greece, Vemmos KN   (67/355, 628/550) 0.35 (0.25, 0.49) 
Spain, Marti'-Vilalta JL (181/623, 716/2271) 0.89 (0.73, 1.08) 
Chinese populations (385/1064, 4907/12190) 0.81 (0.62, 1.07)     I2=56% 
China, Wang Y            (273/714, 4424/10846) 0.90 (0.77, 1.05) 
China, Liu XF               (69/160, 185/450) 1.09 (0.74, 1.59) 
Taiwan, Lin YT             (10/57, 111/351) 0.46 (0.20, 0.97) 
Taiwan, Yip PK            (33/133, 187/543) 0.63 (0.39, 0.98) 
Study                       (CE n/N, AO n/N)                                OR                                          (95% CI)     Het  
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Figure 6.16 Meta-analysis of alcohol intake for CE versus other ischaemic subtypes in Chinese and Whites. 
 
CE=cardioembolism; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence 
interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs.  
0.2 0.5 1 2 
White populations (102/1666, 543/5110) 0.55 (0.44, 0.69)      I2=0% 
Italy, Silvestrelli G         (19/380, 148/1379) 0.45 (0.24, 0.72) 
Germany, Grau AL       (83/1286, 395/3731) 0.58 (0.45, 0.75) 
Chinese populations (84/847, 1153/11389) 0.82 (0.62, 1.08)      I2=32% 
China, Wang Y (67/714, 1047/10846) 0.97 (0.74, 1.26) 
China, Liu XF   (28/160, 102/450) 0.72 (0.44, 1.17) 
Taiwan, Yip PK (17/133, 106/543) 0.60 (0.33, 1.06) 
Study                       (CE n/N, AO n/N)                                OR                                          (95% CI)      Het  
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Figure 6.17 Summary of risk factor meta-analyses for CE versus all others (TOAST) in Chinese and Whites. 
  
0.1 0.2 0.5 1 2 5 10 100 
Alcohol-W (2)      (102/1666, 543/5110) 0.55 (0.44, 0.69)          I2=0% 
Alcohol-C (3)       (84/847, 1153/11389) 0.82 (0.62, 1.08)          I2=32% 
Smoking-W (8)    (581/3192, 2882/9497) 0.46 (0.33, 0.65)          I2=88% 
Smoking-C (4)    (385/1064, 4907/12190) 0.81 (0.62, 1.07)          I2=56% 
IHD-W (2)            (445/1621, 926/4281) 1.31 (1.02, 1.68)          I2=55% 
IHD-C (3)             (342/1064, 1663/12190) 3.62 (1.59, 8.27)          I2=92% 
AF-W (2)              (586/715, 212/1929) 36.81 (28.88, 46.90)    I2=0% 
AF-C (4)               (790/1064, 702/12190) 71.36 (59.16, 86.06)    I2=0% 
DM-W (8)             (703/3192, 2284/9497) 
0.83 (0.66, 1.06)          I
2
=75% 
DM-C (4)              (218/1064, 3547/12190) 
0.59 (0.44, 0.80)          I
2
=56% 
HTN-W (8)          (1831/3192, 5986/9497) 0.80 (0.66, 0.96)          I2=73% 
HTN-C (4)            (638/1064, 8775/12190) 









 Risk factor (SN) (CE n/N, AO n/N)                                           OR                                      (95% CI)   Within-group het    Between-group het (p value) 
Risk factor commoner in other IS subtypes          Risk factor commoner in CE 
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SN=study number; CE= cardioembolism; AO=Any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; HTN=Hypertension; DM=Diabetes mellitus; IHD=Ischaemic heart disease; C=Chinese; 
W=Whites; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
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Figure 6.18 Meta-analysis of hypertension for SVD versus other ischaemic subtypes in Chinese and Whites. 
 
SVD=small vessel disease; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.2 0.5 1 2 5 10 
White populations    (2061/2791, 5757/9898) 1.93 (1.47, 2.55)     I2=85% 
France, Bejot Y           (65/89, 141/243) 1.96 (1.12, 3.50) 
UK, Hajat C                 (203/316, 526/853) 1.12 (0.85, 1.48) 
UK, Schulz UGR          (12/20, 45/82) 1.23 (0.41, 3.87) 
Italy, Silvestrelli G         (444/642, 673/1117) 1.47 (1.19, 1.82) 
Germany, Grau AL      (806/1028, 2481/3998) 2.21 (1.87, 2.61) 
Germany, K-R PL        (86/120, 219/411) 2.22 (1.40, 3.56) 
Greece, Vemmos KN   (142/177, 441/708) 2.46 (1.63, 3.78) 
Spain, Marti'-Vilalta JL (303/399, 1231/2495) 3.25 (2.53, 4.18) 
Chinese populations (1822/2409, 7591/10845) 1.78 (1.05, 3.02)     I2=91% 
China, Wang Y             (1477/1938, 6932/9622) 1.24 (1.11, 1.40) 
China, Liu XF                (64/123, 216/487) 1.36 (0.90, 2.06) 
Taiwan, Lin YT             (115/153, 174/255) 1.41 (0.88, 2.28) 
Taiwan, Yip PK             (166/195, 269/481) 4.51 (2.89, 7.22) 
Study                       (SVD n/N, AO n/N)                      OR                                                    (95% CI)     Het  
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Figure 6.19 Meta-analysis of diabetes for SVD versus other ischaemic subtypes in Chinese and Whites. 
 
SVD=small vessel disease; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs.  
0.01 0.1 0.2 0.5 1 2 5 10 
White populations    (838/2791, 2150/9898) 1.50 (1.02, 2.19)      I2=91% 
France, Bejot Y           (17/89, 40/243) 1.20 (0.60, 2.32) 
UK, Hajat C                 (65/316, 171/853) 1.03 (0.74, 1.44) 
UK, Schulz UGR          (2/20, 10/82) 0.80 (0.08, 4.28) 
Italy, Silvestrelli G         (198/642, 97/1117) 4.68 (3.56, 6.18) 
Germany, Grau AL       (359/1028, 1053/3998) 1.50 (1.29, 1.74) 
Germany, K-R PL         (29/120, 101/411) 0.98 (0.59, 1.60) 
Greece, Vemmos KN   (56/177, 182/708) 1.34 (0.92, 1.94) 
Spain, Marti'-Vilalta JL (112/399, 496/2495) 1.57 (1.23, 2.01) 
Chinese populations (751/2409, 3014/10845) 1.17 (1.04, 1.32)      I2=8% 
China, Wang Y            (584/1938, 2665/9622) 1.13 (1.01, 1.25) 
China, Liu XF               (33/123, 130/487) 1.01 (0.62, 1.60) 
Taiwan, Lin YT            (64/153, 88/255) 1.36 (0.88, 2.10) 
Taiwan, Yip PK            (70/195, 131/481) 1.50 (1.03, 2.16) 
Study                       (SVD n/N, AO n/N)                      OR                                                    (95% CI)    Het  
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Figure 6.20 Meta-analysis of atrial fibrillation for SVD versus other ischaemic subtypes in Chinese and Whites. 
 
SVD=small vessel disease; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
 
  
0.01 0.1 0.2 0.5 
White populations     (80/819, 718/1825) 0.14 (0.05, 0.38)      I2=88% 
Italy, Silvestrelli G        (69/642, 395/1117) 0.22 (0.16, 0.29) 
Greece, Vemmos KN   (11/177, 323/708) 0.08 (0.04, 0.15) 
Chinese populations (79/2409, 1413/10845) 0.15 (0.07, 0.31)      I2=64% 
China, Wang Y            (68/1938, 1186/9622) 0.26 (0.20, 0.33) 
China, Liu XF              (0/123, 72/487) 0.02 (0.00, 0.18) 
Taiwan, Lin YT             (7/153, 54/255) 0.18 (0.07, 0.41) 
Taiwan, Yip PK            (4/195, 101/481) 0.08 (0.02, 0.21) 
1.0 
Study                       (SVD n/N, AO n/N)                      OR                                                    (95% CI)    Het  
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Figure 6.21 Meta-analysis of ischaemic heart disease for SVD versus other ischaemic subtypes in Chinese and Whites. 
 
SVD=small vessel disease; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
 
  
0.01 0.1 0.2 0.5 1 2 
White populations    (230/1205, 1141/4697) 0.52 (0.20, 1.37)     I2=92% 
Germany, Grau AL      (212/1028, 952/3989) 0.83 (0.70, 0.98) 
Greece, Vemmos KN   (18/177, 189/708) 0.31 (0.17, 0.53) 
Chinese populations (291/2409, 1714/10845) 0.55 (0.32, 0.94)     I2=79% 
China, Wang Y            (246/1938, 1488/9622) 0.79 (0.68, 0.92) 
China, Liu XF               (3/123, 55/487) 0.20 (0.04, 0.62) 
Taiwan, Lin YT             (14/153, 26/255) 0.89 (0.41, 1.83) 
Taiwan, Yip PK             (28/195, 145/481) 0.39 (0.24, 0.61) 
Study                       (SVD n/N, AO n/N)                      OR                                                    (95% CI)    Het  
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Figure 6.22 Meta-analysis of smoking for SVD versus other ischaemic subtypes in Chinese and Whites. 
 
SVD=small vessel disease; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs.  
0.5 1 2 5 10 100 
White populations    (762/2791, 2701/9898) 1.31 (0.96, 1.78)     I2=87% 
France, Bejot Y           (27/89, 52/243) 1.60 (0.89, 2.85) 
UK, Hajat C                 (116/316, 214/853) 1.73 (1.30, 2.30) 
UK, Schulz UGR          (9/20, 10/82) 5.89 (1.67, 20.20) 
Italy, Silvestrelli G         (133/642, 312/1117) 0.67 (0.53, 0.85) 
Germany, Grau AL       (261/1028, 1066/3998) 0.93 (0.79, 1.09) 
Germany, K-R PL         (22/120, 49/411) 1.66 (0.91, 2.95) 
Greece, Vemmos KN   (78/177, 217/708) 1.78 (1.25, 2.53) 
Spain, Marti'-Vilalta JL (116/399, 781/2495) 0.90 (0.71, 1.14) 
Chinese populations (934/2409, 4358/10845) 0.97 (0.89, 1.06)     I2=0% 
China, Wang Y            (776/1938, 3921/9622) 0.97 (0.88, 1.07) 
China, Liu XF               (52/123, 202/487) 1.03 (0.68, 1.57) 
Taiwan, Lin YT             (50/153, 71/255) 1.26 (0.79, 1.99) 
Taiwan, Yip PK             (56/195, 164/481) 0.78 (0.53, 1.13) 
Study                       (SVD n/N, AO n/N)         OR                                                               (95% CI)    Het  
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Figure 6.23 Meta-analysis of alcohol intake for SVD versus other ischaemic subtypes in Chinese and Whites. 
 
SVD=small vessel disease; AO=any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; 
CI=confidence interval; Het=heterogeneity; I=inconsistency; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.2 0.5 1 2 5 
White populations     (157/1670, 488/5106) 0.88 (0.47, 1.66)     I2=89% 
Italy, Silvestrelli G        (46/642, 121/1117) 0.63 (0.43, 0.91) 
Germany, Grau AL      (111/1028, 367/3989) 1.19 (0.95, 1.50) 
Chinese populations (213/2133, 1024/10103) 0.97 (0.84, 1.13)     I2=0% 
China, Wang Y             (179/1938, 935/9622) 0.95 (0.79, 1.12) 
China, Liu XF               (30/123, 100/487) 1.25 (0.75, 2.03) 
Taiwan, Yip PK            (34/195, 89/481) 0.93 (0.58, 1.46) 
Study                       (SVD n/N, AO n/N)         OR                                                               (95% CI)    Het  
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Figure 6.24 Summary of risk factor meta-analyses for SVD versus all others (TOAST) in Chinese and Whites. 
  
0.01 0.1 0.2 0.5 1 2 5 
Alcohol-W (2)     (157/1670, 488/5106) 0.88 (0.47, 1.66)     I2=89% 
Alcohol-C (3)      (213/2133, 1024/10103) 0.97 (0.84, 1.13)     I2=0% 
Smoking-W (8)   (762/2791, 2701/98989) 1.31 (0.96, 1.78)     I2=87% 
Smoking-C (4)   (934/2409, 4358/10845) 0.97 (0.89, 1.06)     I2=0% 
IHD-W (2)          (230/1205, 1141/4697) 0.52 (0.20, 1.37)     I2=92% 
IHD-C (4)           (291/2409, 1714/10845) 0.55 (0.32, 0.94)     I2=79% 
AF-W (2)            (80/819, 718/1825) 0.14 (0.05, 0.38)     I2=88% 
AF-C (4)             (79/2409, 1413/10845) 0.15 (0.07, 0.31)     I2=64% 
DM-W (8)            (838/2791, 2150/9898) 1.50 (1.02, 2.19)     I2=91% 
DM-C (8)             (751/2409, 3014/10845) 1.17 (1.04, 1.32)     I2=8% 
HTN-W (8)           (2061/2791, 5757/9898) 1.93 (1.47, 2.55)     I2=85% 







 Risk factor (SN) (SVD  n/N, AO n/N)                          OR                            (95% CI)      Within-group het        Between-group het (p value) 
Risk factor commoner in other IS subtypes         Risk factor commoner in SVD 
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SN=study number; SVD= Small vessel disease; AO=Any other subtypes; n=number of patients with risk factor; N=total number of patients; OR=odds 
ratio; CI=confidence interval; Het=heterogeneity; I=inconsistency; HTN=Hypertension; DM=Diabetes mellitus; IHD=Ischaemic heart disease; 
C=Chinese; W=Whites; Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
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Figure 6.25 Meta-analysis of hypertension for lacunar versus non-lacunar infarcts in Chinese and Whites. 
 
n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; I=inconsistency; 
Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
 
  
0.5 1 2 5 
White populations   (514/942, 1170/2392) 1.23 (1.06, 1.43)      I2=0% 
UK, Hajat C                (173/282, 310/580) 1.38 (1.02, 1.87) 
Europe, Carlo AD       (341/660, 860/1812) 1.18 (0.99, 1.42) 
Chinese populations (788/1433, 719/1512) 1.13 (0.73, 1.77)      I2=88% 
China, Yang P             (268/463, 265/469) 1.06 (0.81, 1.38) 
China, Li W                 (258/502, 311/812) 1.70 (1.35, 2.15) 
China, Li H                   (262/468, 143/231) 0.78 (0.56, 1.09) 
Study                      (lacune n/N, non-lacune n/N)         OR                                                             (95% CI)      Het 
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Figure 6.26 Meta-analysis of diabetes for lacunar versus non-lacunar infarcts in Chinese and Whites. 
 
n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; I=inconsistency; 
Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.5 1 2 
White populations   (213/942, 493/2392) 1.14 (0.95, 1.36)      I2=0% 
UK, Hajat C                (54/282, 113/580) 0.98 (0.67, 1.42) 
Europe, Carlo AD       (159/660, 380/1812) 1.20 (0.96, 1.48) 
Chinese populations (946/3559, 2689/11043) 1.14 (0.89, 1.45)      I2=69% 
China, Yang P             (87/463, 204/469) 0.81 (0.58, 1.13) 
China, Jian Q              (675/2126, 2440/9531) 1.35 (1.22, 1.50) 
China, Li W                 (64/502, 96/812) 1.09 (0.76, 1.55) 
1.28 (0.87, 1.91) 
Study                      (lacune n/N, non-lacune n/N)                         OR                                          (95% CI)      Het 
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Figure 6.27 Meta-analysis of atrial fibrillation for lacunar versus non-lacunar infarcts in Chinese and Whites. 
 
n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; I=inconsistency; 
Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.01 0.1 0.2 0.5 1 2 
White populations  (129/991, 581/2509) 0.49 (0.35, 0.68)      I2=50% 
UK, Hajat C               (47/282, 139/580) 0.63 (0.43, 0.93) 
Europe, Carlo AD      (7/660, 45/1812) 0.46 (0.35, 0.60) 
Sweden, Lindgre A      (7/49, 45/117) 0.27 (0.09, 0.67) 
Chinese populations (66/1433, 195/1512) 0.40 (0.22, 0.75)      I2=73% 
China, Yang P            (15/463, 46/469) 0.31 (0.16, 0.57) 
China, Li W                 (27/502, 135/812) 0.29 (0.18, 0.44) 
China, Li H                   (24/468, 14/231) 0.84 (0.41, 1.79) 
Study                      (lacune n/N, non-lacune n/N)                                OR                                       (95% CI)      Het 
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Figure 6.28 Meta-analysis of ischaemic heart disease for lacunar versus non-lacunar infarcts in Chinese and Whites. 
 
n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; I=inconsistency; 
Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.1 0.2 0.5 1 2 5 
White populations  (123/942, 365/2392) 0.79 (0.51, 1.24)      I2=74% 
UK, Hajat C                (69/282, 142/580) 1.00 (0.71, 1.41) 
Europe, Carlo AD        (54/660, 223/1812) 0.64 (0.46, 0.87) 
Chinese populations (56/970, 41/1043) 0.81 (0.24, 2.68)       I2=80% 
China, Li W                   (6/502, 23/812) 0.41 (0.14, 1.06) 
China, Li H                    (50/468, 18/231) 1.42 (0.79, 2.64) 
Study                        (lacune n/N, non-lacune n/N)                       OR                                              (95% CI)      Het 
 
Chapter 6. Risk factor meta-analyses in ischaemic subtypes – TOAST and OCSP  181 
Figure 6.29 Meta-analysis of smoking for lacunar versus non-lacunar infarcts in Chinese and Whites. 
 
n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; I=inconsistency; 
Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.5 1 2 
White populations    (465/942, 1118/2392) 1.06 (0.91, 1.24)      I2=0% 
UK, Hajat C                 (180/282, 357/580) 1.10 (0.81, 1.50) 
Europe, Carlo AD        (285/660, 761/1812) 1.05 (0.87, 1.26) 
Chinese populations (586/1433, 562/1512) 1.00 (0.85, 1.17)      I2=0% 
China, Yang P             (257/463, 272/469) 0.90 (0.69, 1.18) 
China, Li W                  (127/502, 188/812) 1.12 (0.86, 1.47) 
China, Li H                    (202/468, 102/231) 0.96 (0.69, 1.34) 
Study                        (lacune n/N, non-lacune n/N)                       OR                                              (95% CI)      Het 
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Figure 6.30 Meta-analysis of alcohol intake for lacunar versus non-lacunar infarcts in Chinese and Whites. 
 
n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; I=inconsistency; 
Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
  
0.5 1 2 5 
White populations  (277/942, 634/2392) 1.15 (0.83, 1.59)      I2=56% 
UK, Hajat C               (39/282, 86/580) 0.92 (0.60, 1.41) 
Europe, Carlo AD       (238/660, 548/1812) 1.30 (1.07, 1.57) 
Chinese populations (317/965, 285/1281) 1.51 (1.21, 1.87)      I2=15% 
China, Yang P              (1233/463, 178/469) 1.66 (1.27, 2.17) 
China, Li W                    (84/502, 107/812) 1.32 (0.96, 1.83) 
Study                        (lacune n/N, non-lacune n/N)                       OR                                              (95% CI)      Het 
 
Chapter 6. Risk factor meta-analyses in ischaemic subtypes – TOAST and OCSP  183 
Figure 6.31 Summary of risk factor meta-analyses for lacunar versus non-lacunar (OCSP) in Chinese and Whites. 
 
0.1 0.2 0.5 1 2 5 
1.15 (0.83, 1.59)   I2=56% 
Alcohol-C (2)        (317/965, 285/1281) 1.51 (1.21, 1.87)   I
2
=15% 
Smoking-W (2)     (465/942, 1118/2392) 1.06 (0.91, 1.24)   I2=0% 
Smoking-C (3)    (586/1433, 562/1512) 1.00 (0.85, 1.17)   I
2
=0% 
0.79 (0.51, 1.24)   I
2
=74% 
0.81 (0.24, 2.68)   I2=80% 
0.49 (0.35, 0.68)   I2=50% 
0.40 (0.22, 0.75)   I2=73% 
1.14 (0.95, 1.36)   I2=0% 
1.14 (0.89, 1.45)   I
2
=69% 
1.23 (1.06, 1.43)   I2=0% 
1.13 (0.73, 1.77)   I2=88% HTN-C (3)           (788/1433, 719/1512) 
DM-C (4)             (946/3559, 2689/11043) 
DM-W (2)             (213/942, 493/2392) 
 Risk factor (SN)(lacunar n/N, non-lacunar n/N)                             OR                                         (95% CI)     Within-group het       Between-group het 
AF-C (3)               (66/1433, 195/1512) 
AF-W (3)               (129/991, 581/2509) 
IHD-C (2)              (56/970, 41/1043) 
IHD-W (2)             (123/942, 365/2392) 







HTN-W (2)           (514/942, 1170/2392) 
Risk factor commoner in non-lacunar stroke        Risk factor commoner in lacunar stroke 
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SN=study number; n=number of patients with risk factor; N=total number of patients; OR=odds ratio; CI=confidence interval; Het=heterogeneity; 
I=inconsistency; HTN=Hypertension; DM=Diabetes mellitus; IHD=Ischaemic heart disease; C=Chinese; W=Whites; Horizontal lines represent 95% 
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 Risk factor analyses for Chapter 7:
intracerebral haemorrhage versus ischaemic 
stroke in NTUH patients 
7.1 Introduction 
Intracerebral haemorrhage (ICH) is the most devastating pathological type of stroke, 
with a high case-fatality, and poor functional outcome (Balami et al. 2012; Ash et al. 
2010). It accounts for 10-20% of total strokes in western populations, while the 
incidence and proportion of ICH are higher in eastern Asians (Feigin et al. 2009; Ash 
et al. 2010). Although knowledge of stroke, availability of brain imaging, and 
medical care have improved in the past two decades, the incidence and mortality of 
ICH have not decreased (Ash et al. 2010; Qureshi et al. 2009).  
My systematic reviews in Chapter 3  reported that Chinese populations had a twofold 
higher proportion of ICH, and a lower proportion of ischaemic stroke (IS)  among all 
strokes as compared with predominantly white populations (Tsai et al. 2013). My 
subsequent meta-analysis of vascular risk factors for ICH versus IS in Chapter 5 
found hypertension and alcohol intake were significantly more frequent in ICH than 
IS in Chinese, but not in predominantly white populations. Nevertheless, these 
findings could be confounded by some factors such as age (mean age of onset was 
younger in Chinese for ICH versus IS, but similar in Whites), gender, other risk 
factors, and varying risk factor definitions. 
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To explore some of these issues further, I aimed to perform individual patient 
analyses of data from the National Taiwan University Hospital (NTUH) Stroke 
Registry in Chinese populations, comparing risk factor profiles between ICH and IS 
and adjusting for potential confounding factors. While Chinese make up the largest 
number of populations in the world, a better understanding of the reasons for a much 
higher proportion of ICH in Chinese could lead to a better realisation of the causes of 
ICH as well as efficient prevention strategies, and help to reduce the stroke burden in 




The National Taiwan University Hospital (NTUH) Stroke Registry  is a hospital-
based registry in north Taiwan, prospectively recruiting consecutive acute stroke or 
transient ischaemic attack patients (TIA) arriving in the Emergency Department or 
being admitted to wards of Neurology, Neurosurgery, Internal Medicine, and 
Paediatrics. It was initiated in January 1995 and joined the national Taiwan Stroke 
Registry in 2006 to contribute to studies of risk factors, associations, clinical 
outcomes, and complications of stroke as well as its subtypes (Yip et al. 1997; Jeng 
et al. 1998; Hsieh et al. 2010; Lee et al. 2010; Chen et al. 2013; Hung et al. 2013). 
For inclusion, acute stroke or TIA patients were required to have onset within 10 
days, with informed consent signed by the patients or family. In each consecutive 
patient, a neurologist assessed the patient and performed a neurological examination 
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soon after arrival, recorded demographic information and clinical symptoms and 
signs, reviewed medical records including previous medical history and vascular risk 
factors, arranged brain imaging [computed tomography (CT) immediately or further 
magnetic resonance imaging (MRI)] if necessary, and discussed the imaging findings 
with a neuroradiologist if needed. The Institutional Review Board of National 
Taiwan University Hospital approved the stroke registry. Since the causes and risk 
factors are quite different between childhood and adult stroke, in this study, I 
included first-ever or recurrent adult ICH and IS patients (aged 18 years or older) in 
NTUH stroke registry from 1 January 2006 to 31 December 2011.  
 
 Diagnosis of stroke and its types 7.2.2
The diagnosis of stroke was based on the clinical features - acute neurologic 
dysfunction of vascular origin with sudden (within seconds) or rapid (within hours) 
occurrence of symptoms and signs lasting for more than 24 hours, and brain CT or 
MRI findings (a corresponding lesion on brain imaging or no visible lesion) (Aho et 
al. 1980; Hatano et al. 1976). Strokes were classified as ischaemic stroke (IS), 
intracerebral haemorrhage (ICH), or subarachnoid haemorrhage (SAH) according to 
the standard definitions (Sudlow et al. 1997). Patients with old stroke and its 
complications, traumatic intracranial haemorrhage, subdural hematoma, no brain 
imaging or non-cerebrovascular causes for their clinical features were excluded.  
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 Risk factor definitions 7.2.3
Vascular risk factors were collected through the included patients, family and 
medical records.  Hence, hypertension as well diabetes was recorded based on 
history of hypertension or diabetes. Atrial fibrillation (AF) was defined as history of 
atrial fibrillation or evidence from electrocardiography. Ischaemic heart disease (IHD) 
was defined as history of angina or myocardial infarction. Hyperlipidaemia was 
recorded if patients had hypercholesterolaemia (>200 mg) or hypertriglyceridaemia 
(> 200 mg/dl). Smoking included current smoking for more than 10 cigarettes per 
day and previous smoking. Alcohol intake was defined as habitual drinking more 
than once per week. I also recorded previous stroke and history of TIA, defined as 
acute onset of transient focal neurological dysfunction lasting less than 24 hours. 
 
 Statistical analysis 7.2.4
For ICH versus IS, I used Student’s t test to compare the mean age, and Pearson’s 
chi-square test to compare the proportions of male gender, risk factors and 1 month 
case fatality between the groups. Since it was not assumed to contribute a linear 
change in odds of ICH versus IS, I divided age into five equal-sized categories. First, 
I calculated crude odds ratios (ORs) with 95% confidence intervals (CIs) for each 
risk factor. Then I fitted a logistic regression model for the relevant risk factor, 
adjusting for age categories and gender, obtaining adjusted ORs I. I developed a 
second logistic regression model to adjust simultaneously for all risk factors as well 
as age and gender. In the second model, I used stepwise selection and analysis of 
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variance to incorporate the strongly significant 2-way interactions among variables 
(p<0.001), and to choose the best fitting model. From the parameters of this model, I 
obtained adjusted ORs II.   
In addition, I conducted subgroup analyses to examine risk factor associations with 
ICH versus IS in different subgroups if there was a strongly significant interaction 
among variables. All the statistical hypothesis tests were two-sided, and p values less 
than 0.05 were regarded as significant. Statistical analyses were performed with R 
statistical software (http://www.R-project.org/). 
 
7.3 Results 
 Characteristics of ICH and IS patients 7.3.1
From 1 January 2006 to 31 December 2011, NTUH stroke registry consecutively 
recruited 6675 acute stroke and 300 TIA patients aged from 1 to 106 years. There 
were 4107 men and 2868 women. The response rate for the stroke registry in terms 
of the proportions of people providing informed consent was more than 90%. In the 
present study, I included first-ever or recurrent ICH or IS patients aged 18 years or 
older, including 1373 ICH patients and 4953 IS patients. For patients who had 
recurrent strokes during this period of time, I adopted the first stroke episodes. All 
these patients had brain CT imaging and 50% of them had further brain MRI and MR 
angiography.  
 
Chapter 7. Risk factor analyses for ICH versus IS in NTUH patients 191 
Of these included ICH and IS patients in our study, ICH patients were younger than 
the IS group (mean age 61 years versus 68 years, p<0.001), while there was no 
significant difference in gender between the groups (males 62% in ICH and 59% in 
IS, p=0.064). ICH patients had a much higher 1 month case fatality than IS (19.3% 
versus 5.5%, p<0.001). 
 
 Risk factor comparisons for ICH versus IS 7.3.2
The clinical characteristics and risk factor distributions for ICH and IS are shown in 
Table 7.1. Generally, ICH patients had a lower prevalence of diabetes, AF, IHD, 
hyperlipidaemia, smoking, previous stroke and TIA than IS patients. Alcohol intake 
was slightly more common in ICH versus IS (crude OR 1.19, 95% CI 1.00 to 1.40), 
and so was hypertension though it did not differ significantly between two types of 
stroke (crude OR 1.01, 95% CI 0.87 to 1.17) (Figure 7.1). Nevertheless, the 
association with ICH versus IS became significantly higher in hypertension after 
adjusting for age and gender in the first logistic regression model (adjusted OR I 1.25, 
95% CI 1.07 to 1.45), whereas the results of other risk factors remained in the same 
direction except that alcohol and previous stroke became statistically non-significant 
(alcohol adjusted OR I 0.98, 95% CI 0.82 to 1.17; previous stroke adjusted OR I 0.97, 
95% CI 0.83-1.13).  
In multiple logistic regression before incorporating interaction among variables, 
hypertension and alcohol intake were significantly associated with ICH in 
comparison to IS (hypertension adjusted OR II 1.60, 95% CI 1.42 to 1.95; alcohol 
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adjusted OR II 1.45, 95% CI 1.16 to 1.79), and the associations became stronger or 
stayed similar while incorporating strongly significant interactions in the second 
model (hypertension adjusted OR II 2.23, 95% CI 1.74 to 2.87; alcohol adjusted OR 
II 1.44, 95% CI 1.16 to 1.77; Figure 7.1). Fully adjusted analyses yielded similar 
results to unadjusted analyses in diabetes, AF, IHD, hyperlipidaemia, smoking and 
TIA, which were still negatively associated with ICH versus IS. Previous stroke 
remained of similar frequency in ICH and IS (adjusted OR II 1.04, 95% CI 0.89 to 
1.22). 
 
 Subgroup analysis in patients of different ages 7.3.3
In the stepwise selection for the second logistic regression model, I found a strongly 
significant interaction between age and hypertension (p<0.001). There was a 
significant difference in the association across different age groups for hypertension, 
but not in other risk factors. Thus I carried out further subgroup analysis to examine 
the risk factor associations for ICH versus IS among five equal-sized age groups 
respectively (18-55 year, 56-64 year, 65-72 year, 73-80 year, and 81-106 year). 
Overall, the results were mostly qualitatively similar across the groups, but varied in 
size (Figure 7.2). Compared with older stroke patients, hypertension had a stronger 
association with ICH versus IS in younger stroke patients. The fully adjusted results 
showed that hypertension was significantly associated with ICH versus IS in patients 
of age 18-55 years (adjusted OR II 2.33, 95% CI 1.79-3.05), 56-64 years (adjusted 
OR II 2.33, 95% CI 1.58-3.48), and 65-72 years (adjusted OR II 1.84, 95% CI 1.22-
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2.87). For patients aged 73 or beyond, the association with hypertension did not 
differ significantly between ICH and IS (age 73-80 adjusted OR II 0.81, 95% CI 0.56 
to 1.18; age 81-106 adjusted OR II 0.96, 95% CI 0.63 to 1.50).  
In terms of other risk factors, diabetes, AF, and hyperlipidaemia remained negatively 
associated with ICH versus IS in all age groups, whereas previous stroke stayed 
neutral between ICH and IS in every age group. IHD, smoking, alcohol and TIA had 
significant negative associations with ICH versus IS in some age groups but not in all 
(Figure 2). Statistically, there was no significant difference in association across 
different age groups in aforementioned risk factors.  
 
7.4 Discussion 
My results showed that ICH patients were relatively younger than IS patients, but 
there was no significant difference in gender between these two groups. Clinically, 
ICH patients had a higher 1 month case fatality than IS patients. In terms of risk 
factor comparisons between ICH and IS, unadjusted and adjusted analyses yielded 
qualitatively similar results, but varied in size of estimates and significance. 
Hypertension and alcohol intake both had positive associations with ICH than IS, 
whereas diabetes, AF, IHD, hyperlipidaemia, smoking and TIA were negatively 
associated with ICH versus IS.  The positive association between hypertension and 
ICH versus IS became even more marked in younger stroke patients, and differed 
significantly across different age groups, with no clear association in older people 
(aged 73 years or beyond).  
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Although Chinese populations have higher age-adjusted ICH incidence and 
proportion than those in western countries (Chang et al. 1995; Jiang et al. 2006; Tsai 
et al. 2013), the data and analyses on risk factor comparisons to explore the possible 
reasons based on robust methods in relatively large numbers of patients are limited. 
Most information has been derived from studies on mainly white populations of 
European origins. My findings provide important information on the main risk factor 
differences for ICH compared with IS, which are consistent with the results from my 
previous meta-analyses in Chapter 5.  After adjusting for possible confounders, 
hypertension and alcohol intake were independent risk factors for ICH as compared 
with IS in Chinese populations. Furthermore, they could be responsible – at least in 
part – for a higher proportion of ICH in Chinese as compared with predominantly 
white populations.   
Few large scale studies in the literature and previous systematic reviews have 
directly compared risk factors between ICH and IS, in either Chinese or other 
populations in the world. An earlier systematic review from cohort and case-control 
studies in mainly white populations reported that risk factors for ICH were age, male 
sex, hypertension, and alcohol intake. In contrast, hypercholesterolaemia was 
associated with a lower risk or ICH (Ariesen et al. 2003). Recently, the 
INTERSTROKE study, a large international case-control study, conducted risk factor 
analyses for all stroke, IS and ICH among 3000 stroke cases and 3000 controls 
(O’Donnell et al. 2010). It enrolled stroke patients from 22 countries across low, 
middle and high income levels, and 38% from Southeast Asia (including Chinese). 
Of these included 3000 cases, 78% were IS and 22% were ICH. The study results 
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showed hypertension, smoking, waist-to-hip ratio, diet, and alcohol intake were 
significant risk factors for ICH. Hypertension was more strongly associated with ICH 
than IS, whereas the association with smoking appeared stronger with IS than ICH. 
However, risk factor associations for IS and ICH were not provided specifically for 
Chinese populations.  
There is plenty of evidence showing that hypertension is one of the most important 
risk factors for ICH (O’Donnell et al. 2010; Ariesen et al. 2003; Takebayashi et al. 
1983). In addition, existing evidence suggests that of ICH the association with 
hypertension probably differs among ethnic groups. Previous research and meta-
analyses of data from Asia Pacific Cohort Studies among predominantly eastern 
Asians (including Chinese, Japanese, Korean and Thailand populations) and among 
predominantly white populations of European origin suggested a stronger association 
of increased blood pressure with haemorrhagic stroke among eastern Asians than 
white populations (Eastern Stroke and Coronary Heart Disease Collaborative 
Research Group. 1998; Woodward et al. Asia Pacific Cohort Studies Collaboration.  
2005). Another meta-analysis comparing the effect of hypertension on stroke 
between Chinese and Caucasians from both cohort and case-control studies also 
reported a significantly stronger association with hypertension in Chinese than 
Caucasians, particularly on haemorrhagic stroke (Zhang et al. 2006). However, these 
studies were conducted for all haemorrhagic strokes, including both ICH and 
subarachnoid haemorrhage together though most of these events were likely due to 
ICH. No separate analysis for ICH was reported. My systematic reviews in Chapters 
2 and 3 as well as my following meta-analysis in Chapter 5 showed that Chinese had 
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a higher incidence of total stroke, a higher proportion of ICH, and hypertension had a 
stronger association with ICH versus IS as compared with predominantly white 
populations. The individual patient data analysis presented here further confirms 
hypertension is a stronger, independent risk factor for ICH versus IS in Chinese after 
controlling for age, sex and other risk factors. 
The reasons for a higher incidence of total stroke and ICH, and the greater 
association with hypertension for ICH in Chinese populations have not been fully 
understood.  It is probably at least in part related to the preference of dietary intake 
with high salt, inadequate treatment of hypertension, and a higher proportion of deep 
ICH in Chinese populations (predominantly associated with hypertension) (Wang et 
al. 2012; Woo et al. 2002). Chinese people prefer to have high dietary intake of 
sodium. In the INTERMAP study among British, American, Japanese and Chinese 
populations, Chinese were found to have the highest daily sodium intake (as 
measured by 24-hour urinary collection), which was known to related to high blood 
pressure and to increase risk of stroke (Zhou et al. 2003, Zhao et al. 2004; He et al. 
1999). Although the prevalence of hypertension in Chinese is similar to most white 
populations, the proportion of awareness, treatment and control rates are quite low 
(Gu et al. 2002; Su et al. 2008; Falaschetti et al. 2009; Wolf-Maier et al. 2003). From 
a recent study conducted in mainland China, only 45% were aware of high blood 
pressure, 28% took antihypertensive medication, and 8% achieved control target 
(<140/90mm Hg) (Gu et al. 2002). In Taiwan, despite improvements in awareness, 
treatment, and control rate after the implementation of the National Health Insurance 
system, the proportion of treatment and control are still relatively low, particularly in 
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younger stroke patients aged less than 65 years (Su et al. 2008). Thus, reduced 
dietary sodium intake and effective treatment of hypertension are supposed to have 
greater benefit of reducing incidence of ICH in Chinese populations. 
In term of lipids, increased total cholesterol is associated with the risk of IS, but not 
haemorrhagic stroke in both Asian and white populations of European origin (Zhang 
et al. Asia Pacific Cohort Studies Collaboration. 2003). There seems to be a positive 
association of increasing cholesterol with IS and a negative association with 
haemorrhagic stroke. Furthermore, low total cholesterol and high blood pressure 
have been reported to have synergistic interaction on the risks of haemorrhagic 
stroke in Japanese (Suzuki et al. 2011). Apart from cholesterol, recent research has 
shown that low serum triglyceride is associated with increased risk of ICH though 
the exact mechanism to ICH is still unclear (Wieberdink et al. 2011). In my study, 
hyperlipidaemia was indeed significantly less frequent in ICH as compared with IS. 
No significant interaction was found between hyperlipidaemia and hypertension or 
other risk factors. Nevertheless, data on cholesterol and triglyceride were not 
available for me to do analyses of each of these separately. Further study of 
individual lipid components and the associations with ICH and IS may provide 
deeper insights in this field. 
Despite the fact that effects of alcohol may be mediated through blood pressure due 
to its documented blood pressure elevating effect (Yoshita et al. 2005),  in my study, 
alcohol intake was still a significant independent risk factor for ICH as compared 
with IS regardless of age, sex, hypertension, or other risk factors. The risk caused by 
alcohol appears to differ among types of stroke. Previous meta-analyses have shown 
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that alcohol has a dose-dependent relationship with haemorrhagic stroke, whereas it 
has a curvilinear relationship with IS - a protective effect for low to moderate intake 
and increased risk for high consumption (Renolds et al. 2003; Patra et al. 2010). 
Although the definitions of alcohol intake are different across the studies in meta-
analyses and ICH and subarachnoid haemorrhage are not analysed separately in the 
latest review, there is still increasing evidence that risk of ICH increases with 
increasing alcohol intake, while for IS, modest alcohol intake (1-30 drinks per month) 
is protective, but heavier alcohol intake still increases risk (O’Donnell et al. 2010).  
The varying relationships of risk caused by alcohol are probably because of different 
mechanisms of different types of stroke. As alcohol intake becomes more common in 
Chinese populations due to westernisation of lifestyles, it may have further 
increasing impact on stroke since excessive alcohol intake is an established risk 
factor for both haemorrhagic and ischaemic strokes.  
 
 Strength and limitations 7.4.1
The current analyses provide important information on risk factor comparisons for 
ICH versus IS in Chinese populations, in whom there is a relatively higher stroke 
incidence, along with a much higher proportion of ICH and a lower proportion of IS 
among all strokes as compared with predominantly white populations. My study has 
several strengths. First, NTUH Stroke Registry is a well-established stroke registry, 
prospectively and systematically recruiting consecutive acute stroke patients since 
1995 with comprehensive records of essential information including risk factors. My 
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analyses benefited from large numbers of patients and included recent data up to 
2011. Second, the inclusion of acute stroke patients was based on a standard 
definition of stroke, having stroke onset within 10 days with timely brain imaging, 
early specialist assessment, and reliable classification of its pathological types (since 
the brain CT or MRI performance rate was 100% in this registry). Third, I used 
multiple logistic regression model to adjust for possible confounding factors 
including age, sex and other risk factors, and incorporated 2-way interactions among 
these variables. Furthermore, I carried out subgroup analyses to examine 
hypertension association with ICH versus IS in different age groups. 
Nevertheless, I have to acknowledge several limitations. First, the registry is a 
hospital-based stroke registry, whereas an ideal study population is supposed to be 
community-based, including all stroke patients in a geographical area, irrespective of 
hospital admission rate (Sudlow et al. 1996; Feigin et al. 2004). Prevalence of risk 
factors and stroke subtypes may have some differences between hospitalized and 
non-hospitalized patients (Schulz et al. 2003). Second, risk factors in our study were 
collected through the patients, family and medical records prior to stroke occurrence. 
Though most included patients had available medical records before stroke, I could 
not totally exclude the possibility of recall bias from a few patients without records. 
In addition, the risk factor status was dichotomized, not continuously measured, 
making it impossible to assess the severity or the shape of association of risk factors 
with stroke types. Finally, although all included patients had brain CT imaging, only 
around 50% of them had brain MRI. The limited access to MRI precludes assessment 
of brain microbleeds. 
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 Conclusion 7.4.2
In spite of a decreasing trend of ICH incidence in Chinese populations, there is still a 
relatively higher stroke incidence as well as a much higher proportion of ICH in all 
strokes as compared with white populations (Jiang et al. 2006; Tsai et al. 2013 in 
Chapter 3). Similar findings are also noted in other eastern Asians (Asch et al. 2010; 
Burke et al. 2006). ICH is a multifactorial disease caused by several risk factors and 
interactions. Here I report that hypertension and alcohol intake are independent risk 
factors for ICH versus IS regardless of age, sex, or other risk factors in a Chinese 
population in Taiwan,  whereas diabetes, atrial fibrillation, IHD, hyperlipidaemia, 
smoking and TIA are negatively associated with ICH versus IS. Furthermore, the 
positive association with hypertension is stronger in younger stroke patients. The 
findings from my study and other research suggest that better treatment of 
hypertension as well as decreasing alcohol intake should have a great benefit to 
reducing ICH burden in Chinese populations.  
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Table 
Table 7.1 Study characteristics and risk factor distributions in patients with ICH and IS in NTUH Stroke Registry, 2006-2011. 
 
ICH (N=1373) IS (N=4953) 
ICH versus IS 
(P value) 
Mean Age in years (±SD) 61.4 (±15.7) 68.1 (±13.8) P<0.001** 
 N (%) (95% CI) N (%) (95% CI)  
Gender (male) 850 61.9% 59.2-64.5% 2929 59.1% 57.8-60.5% P=0.064* 
Hypertension 1058 77.1% 74.7-79.2% 3809 76.9% 75.7-78.7% P=0.904* 
Diabetes 310 22.6% 20.4-24.9% 1838 37.1% 35.8-38.4% P<0.001* 
Atrial fibrillation 125 9.1% 7.6-10.8% 1180 23.8% 22.6-25.0% P<0.001* 
Ischaemic heart disease 102 7.4% 6.1-8.9% 759 15.3% 14.3-16.4% P<0.001* 
Hyperlipidemia 238 17.3% 15.3-19.4% 1744 35.2% 33.9-36.6% P<0.001* 
Smoking 327 23.8% 21.6-26.1% 1455 29.4% 28.1-30.7% P<0.001* 
Alcohol intake 221 16.1% 14.2-18.1% 689 13.9% 13.0-14.9% P=0.041* 
Previous stroke 282 20.5% 18.4-22.8% 1175 23.7% 22.5-24.9% P=0.013* 
TIA 11 0.8% 0.4-1.4% 193 3.9% 3.4-4.5% P<0.001* 
1 month case fatality 265 19.3% 17.2-21.5% 272 5.5% 4.9-6.2% P<0.001* 
ICH=intracerebral haemorrhage; IS=ischaemic stroke; NTUH=National Taiwan University Hospital; N=number; CI=confidence interval; SD=standard 
deviation; TIA=transient ischaemic attack. 
** based on Student’s t test; * based on Pearson’s chi-square test.
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Figures 
Figure 7.1 Risk factor analyses for ICH versus IS 
 
Risk factor                                                         OR                                         95% CI 
0.1 0.2 0.5 1 2 5 
OR II 0.21 (0.10, 0.37) 
OR I 0.19 (0.10, 0.34) 
TIA CR 0.20 (0.10, 0.37) 
OR II 1.04 (0.89, 1.22) 
OR I 0.97 (0.83, 1.13) 
Previous stroke CR 0.83 (0.72, 0.96) 
OR II 1.44 (1.16, 1.77) 
OR I 0.98 (0.82, 1.17) 
Alcohol CR 1.19 (1.00, 1.41) 
OR II 0.49 (0.41, 0.59) 
OR I 0.56 (0.48, 0.66) 
Smoking CR 0.75 (0.65, 0.86) 
OR II 0.30 (0.26, 0.36) 
OR I 0.35 (0.30, 0.41) 
Hyperlipidaemia CR 0.39 (0.33, 0.45) 
OR II 0.67 (0.52, 0.82) 
OR I 0.53 (0.42, 0.65) 
Ischaemic heart CR 0.44 (0.35, 0.55) 
OR II 0.23 (0.17, 0.30) 
OR I 0.40 (0.33, 0.49) 
Atrial fibrillation CR 0.32 (0.26, 0.39) 
OR II 0.48 (0.41, 0.56) 
OR I 0.53 (0.46, 0.61) 
Diabetes CR 0.49 (0.43, 0.57) 
OR II 2.23 (1.74, 2.87) 
OR I 1.25 (1.07, 1.45) 
Hypertension CR 1.01 (0.87, 1.17) 
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OR=odds ratio; CR=crude odds ratio; OR I=adjusted odds ratio I (adjusting for age and 
gender); OR II=adjusted odds ratio II (adjusting for age, and gender and risk factors and 
incorporating the strong interaction); TIA=transient ischaemic attack; CI=confidence interval. 
Horizontal lines represent 95% CIs. Diamonds represent pooled ORs. 
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Figure 7.2 Subgroup analyses of all risk factors for ICH versus IS in different age groups 
0.01 0.1 0.2 0.5 1 2 5 
OR II 81-106Y 1.02 (0.43, 2.25) 
OR II 73-80Y 1.33 (0.71, 2.44) 
OR II 65-72Y 1.00 (0.61, 1.61) 
OR II 56-64Y 1.58 (1.00, 2.45) 
Alcohol OR II 18-55Y 1.88 (1.32, 2.67) 
OR II 81-106Y 0.67 (0.37, 1.16) 
OR II 73-80Y 0.60 (0.36, 0.95) 
OR II 65-72Y 0.89 (0.59, 1.34) 
OR II 56-64Y 0.36 (0.24, 0.54) 
Smoking OR II 18-55Y 0.35 (0.25, 0.48) 
OR II 81-106Y 0.44 (0.24, 0.75) 
OR II 73-80Y 0.30 (0.18, 0.49) 
OR II 65-72Y 0.29 (0.20, 0.43) 
OR II 56-64Y 0.23 (0.16, 0.33) 
Hyperlipidaemia OR II 18-55Y 0.31 (0.23, 0.41) 
OR II 81-106Y 0.46 (0.26, 0.77) 
OR II 73-80Y 0.71 (0.44, 1.11) 
OR II 65-72Y 0.92 (0.58, 1.44) 
OR II 56-64Y 0.79 (0.42, 1.40) 
Ischaemic heart OR II 18-55Y 0.48 (0.26, 0.83) 
OR II 81-106Y 0.23 (0.13, 0.39) 
OR II 73-80Y 0.44 (0.26, 0.72) 
OR II 65-72Y 0.20 (0.10, 0.36) 
OR II 56-64Y 0.14 (0.06, 0.28) 
Atrial fibrillation OR II 18-55Y 0.15 (0.07, 0.31) 
OR II 81-106Y 0.46 (0.28, 0.73) 
OR II 73-80Y 0.58 (0.38, 0.84) 
OR II 65-72Y 0.57 (0.40, 0.80) 
OR II 56-64Y 0.42 (0.30, 0.58) 
Diabetes OR II 18-55Y 0.38 (0.27, 0.53) 
OR II 81-106Y 0.96 (0.63, 1.50) 
OR II 73-80Y 0.81 (0.56, 1.18) 
OR II 65-72Y 1.84 (1.22, 2.87) 
OR II 56-64Y 2.33 (1.58, 3.48) 
Hypertension OR II 18-55Y 2.33 (1.79, 3.05) 
Risk factor                                                         OR                                         95% CI 
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OR II=adjusted odds ratio II (adjusting for gender and risk factors); Y=years; CI=confidence 
interval. Horizontal lines represent 95% CIs. Diamonds represent pooled ORs.
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 Risk factors analyses for ischaemic Chapter 8:
stroke subtypes in NTUH patients 
8.1 Introduction 
Stroke is a heavy burden on Chinese populations (Liu et al. 2011). In Chapters 2 and 
4, I  reported that Chinese stroke patients have younger age of onset, a higher stroke 
incidence, and may also have different distributions of ischaemic stroke (IS) 
subtypes - a higher proportion of small vessel disease stroke (SVD) and a lower 
proportion of cardioembolism stroke (CE) compared with predominantly white 
populations (Tsai et al. 2013). Yet questions such as what might cause the 
differences remain unanswered. In Chapter 6, my risk factor meta-analyses in IS 
further showed that Chinese IS patients had a similar proportion of hypertension, 
diabetes, smoking and alcohol, and a lower prevalence of atrial fibrillation (AF), 
ischaemic heart disease (IHD) and hypercholesterolaemia compared with Whites. 
Associations of risk factors with individual IS subtypes were qualitatively similar 
(although different in size) in Chinese and predominantly white populations. 
Compared with other IS subtypes: large artery atherosclerosis (LAA) strokes were 
associated with diabetes; CE strokes were associated with AF and IHD; SVD (or 
lacunar) strokes were associated with hypertension and diabetes. However, these 
findings could be possibly confounded by some factors such as age, gender, other 
risk factors, incomplete information and variable definitions of some risk factors. In 
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addition, they may be driven by the risk factor dependent nature of the TOAST 
classification scheme. 
To overcome the potential confounding effects, in the present study, I aimed to 
perform further analyses of individual patient data from the National Taiwan 
University Hospital (NTUH) Stroke Registry in Chinese populations. I evaluated the 
risk factor distributions in overall IS, compared the risk factor associations with each 
main IS subtype versus other subtypes using the Trial of Org 10172 in Acute 
Ischaemic Stroke (TOAST, a classification system incorporating risk factor in its 
definition) or the Oxfordshire Community Stroke Project (OCSP, a risk factor free 
classification system) classification, and adjusted for potential confounders (Adams 




In the present study, I obtained data from the National Taiwan University Hospital 
(NTUH) Stroke Registry, which was established in January 1995 and joined the 
national Taiwan Stroke Registry in 2006 to study the risk factors, associations, 
clinical outcomes, and complications of stroke and its subtypes (Yip et al. 1997; Jeng 
et al. 1998; Hsieh et al. 2010; Lee et al. 2010; Chen et al. 2013; Hung et al. 2013). It 
prospectively recruited consecutive acute stroke or transient ischaemic attack patients 
(TIA) patients arriving in the Emergency Department or being admitted to wards. For 
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inclusion, acute stroke or TIA patients were required to have onset within 10 days.  
Informed consents were signed by the patients or family. For each patient, a 
neurologist assessed the patient and performed neurological examinations upon 
arrival, recorded demographic information and clinical presentations, reviewed 
medical records including previous medical history and vascular risk factors, 
arranged brain imaging study [computed tomography (CT) or magnetic resonance 
imaging (MRI)] immediately, and discussed the imaging findings with a 
neuroradiologist if needed. The stroke registry was approved by the NTUH 
Institutional Review Board. Since the causes and risk factors are quite different 
between childhood and adult IS, in the present study, I included first-ever or 
recurrent adult IS patients aged 18 years or older from 1 January 2006 to 31 
December 2011.  
 
 Diagnosis of ischaemic stroke and its subtypes 8.2.2
The diagnosis of IS was based on the clinical features - acute neurologic dysfunction 
of vascular origin lasting for more than 24 hours, and brain CT or MRI findings (a 
corresponding ischaemic lesion on brain imaging or no visible lesion) (Aho et al. 
1980; Hatano et al. 1976). IS was classified into five aetiological subtypes (LAA, CE, 
SVD, other determined aetiology, and undetermined aetiology) according to the 
TOAST classification, or into the four anatomical subtypes of the OCSP 
classification scheme - lacunar infarct (LACI), total anterior circulation infarct 
(TACI), partial anterior circulation infarct (PACI), and posterior circulation infarct 
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(POCI) (Adams et al. 1993; Bamford et al. 1991). Patients with old stroke and its 
complications, intracranial haemorrhage, subarachnoid haemorrhage, subdural 
hematoma, no brain imaging or non-cerebrovascular causes for their clinical features 
were excluded.  
 
 Risk factor definitions 8.2.3
Vascular risk factors were collected through the included patients, family and 
medical records.  Hence, hypertension as well diabetes was recorded based on 
history of hypertension or diabetes. Atrial fibrillation (AF) was defined as history of 
atrial fibrillation or evidence from an electrocardiography. Ischaemic heart disease 
(IHD) was defined as history of angina or myocardial infarction. Hyperlipidaemia 
was recorded if patients had hypercholesterolaemia (>200 mg) or 
hypertriglyceridaemia (> 200 mg/dl). Smoking included current smoking for more 
than 10 cigarettes per day and previous smoking. Alcohol intake was defined as 
habitual drinking more than once per week. I also recorded previous stroke and 
history of TIA, defined as acute onset of transient focal neurological dysfunction 
lasting less than 24 hours. 
 
 Statistical analysis 8.2.4
For IS subtypes, I used analysis of variance (ANOVA) to compare the mean age, and 
Pearson’s chi-square test to compare the proportions of male gender and risk factors 
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among IS subtypes. Since it was not assumed to contribute a linear change in odds of 
each IS subtype versus other subtypes, I divided age into five equal-sized categories. 
First, I calculated proportions of risk factors in each IS subtype, and computed crude 
odds ratio (OR) with 95% confidence intervals (CIs) for LAA versus other subtypes, 
SVD versus other subtypes, and CE versus other subtypes for each risk factor in the 
TOAST classification. Then I fitted a logistic regression model for the relevant risk 
factor, adjusting for age categories and gender, obtaining adjusted ORs I. I developed 
a second logistic regression model to adjust simultaneously for all risk factors as well 
as age and gender. In the second model, I used stepwise selection and analysis of 
variance to incorporate the strongly significant 2-way interactions among variables 
(p<0.001), and to choose the best fitting model. From the parameters of this model, I 
obtained adjusted ORs II.  IS subtypes using the OCSP classification were 
categorized into lacunar infarct (LACI) and non-lacunar infarct (NLAC) groups. I 
used the same method to obtain crude ORs, adjusted ORs I and II with 95% CIs for 
LACI versus NLAC.  
In the IS subtypes using the TOAST classification, I did not include AF in the second 
logistic regression model since IS patients with the presence of AF were most likely 
assigned to CE subtype, irrespective of other risk factors and investigation results. If 
there was a strongly significant interaction among variables, I conducted further 
subgroup analysis to exam risk factor associations in different groups. All the 
statistical hypothesis tests are two-sided, and p values less than 0.05 were regarded as 
significant. Statistical analyses were performed with R statistical software 
(http://www.R-project.org/). 
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8.3 Results 
 Characteristics of overall IS patients  8.3.1
A total of 6675 acute stroke and 300 TIA patients were consecutively recruited into 
NTUH stroke registry from 1 January 2006 to 31 December 2011. The response rate 
for the stroke registry in terms of the proportions of people providing informed 
consent was more than 90%. Of these acute stroke patients, I included 4953 first-ever 
and recurrent IS patients aged 18 or older into current study. For patients who had 
recurrent strokes during this period of time, I adopted first stroke episodes. All 
registered patients had brain CT imaging and electrocardiography upon arrival. 
Around 80% of them had carotid duplex examination and 60% had further MR 
angiography to assess extracranial and intracranial vascular abnormality. The mean 
age of IS patients was 68.1 years (SD=13.8 years), and 59% of them were men. The 
clinical characteristics and risk factor distributions in overall IS patients are shown in 
Table 8.1. Generally, the prevalence of hypertension, diabetes, AF, and 
hyperlipidaemia in this study based in Taiwan was significantly higher, while the 
prevalence of smoking was significantly was lower than the pooled results in my risk 
factor meta-analysis for IS (Chapter 6) for all Chinese populations (nearly 90% from 
mainland China).  
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 Risk factors for IS subtypes in the TOAST 8.3.2
classifications 
In the TOAST classifications, SVD was the most common IS subtype (27.5%), 
followed by CE (24.3%), undetermined (22.1%), LAA (21.0%), and other 
determined aetiology (5.0%) (Table 8.2). There were significant differences in age 
distributions among IS subtypes (p<0.001). CE subtype was the oldest stroke group 
(mean age 72.5 ± 13.2 years), while the subtype of other determined etiology had the 
youngest stroke patients (mean age 48.4 ± 14.4 years). LAA had the highest 
proportion of men (66.7%), whereas CE possessed the lowest proportion of men 
(51.9%). Distributions for the proportions of male gender and all vascular risk factors 
were significantly different among IS subtypes (Table 8.2). 
Compared with other IS subtypes, LAA was associated with all risk factors studied, 
including hypertension, diabetes, IHD, hyperlipidaemia, smoking, alcohol intake, 
previous stroke and TIA (Figure 8.1). After controlling for age, gender and all risk 
factors, the results remained very similar except that IHD, smoking and alcohol did 
not differ significantly between groups. Among these significant risk factors, 
hypertension, diabetes, and TIA were the three leading risk factors with positive 
associations. The fully adjusted OR for hypertension was 1.94 (95% CI 1.59 to 2.38), 
for diabetes was 1.52 (95% CI 1.32 to 1.75), and for TIA was 1.72 (95% CI 1.24 to 
2.36). There was no strongly significant interaction among variables. 
CE subtype was positively associated with age and IHD in comparison with other IS 
subtypes in fully adjusted analyses (Figure 8.2). There was a strongly significant 
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interaction between IHD and age (p<0.001), and the association seemed to increase 
with younger age for CE versus others (Figure 8.3).  While incorporating this 
interaction, the fully adjusted OR for IHD was 6.74 (95% CI 4.16 to 10.87). In 
contrast, CE was negatively associated with male gender, diabetes, hyperlipidaemia 
and smoking, whereas fully adjusted analyses did not show significant difference in 
alcohol, previous stroke and TIA between CE versus other subtypes.  
In SVD versus other subtypes, unadjusted analyses showed positive associations with 
hypertension, diabetes, and hyperlipidaemia, and borderline associations with male 
gender and smoking (Figure 8.4). Strongly significant interactions were found 
between age and hypertension, and between hypertension and diabetes (p<0.001, 
Figures 8.5 to 8.7). While incorporating these interactions in the second multiple 
logistic regression model, the associations with hypertension and diabetes became 
much stronger. The fully adjusted OR for hypertension was 4.84 (95% CI 3.39 to 
7.03), and for diabetes was 2.65 (95% CI 1.92 to 3.65). In contrast, SVD had a 
negative association with IHD (adjusted OR II 0.32, 95% CI 0.25 to 0.40), and a 
borderline negative association with previous stroke (adjusted OR II 0.83, 95% CI 
0.71 to 0.97). There was no significant difference in smoking, alcohol, and TIA 
between SVD and others subtypes.  
 
 Risk factors for IS subtypes in the OCSP classifications 8.3.3
In IS subtype analyses using the OCSP classification, ANOVA showed significant 
differences of age distributions across subtypes (p<0.001) (Table 8.3). The mean age 
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of stroke onset was oldest in TACI subtype (69.6 ± 15.0 years), and youngest in 
POCI subtype (66.7 ± 13.9 years). POCI had the highest proportion of men (62.9%), 
whereas TACI possessed the lowest proportion of men (50.7%). There were 
significant differences in the distributions of proportions in male gender and all 
vascular risk factors except TIA.  
In comparison to NLAC, LACI was positively associated with hypertension 
(adjusted OR II 4.58, 95% CI 3.16 to 6.75), diabetes (adjusted OR II 2.40, 95% CI 
1.71 to 3.37) and hyperlipidaemia (adjusted OR II 1.55, 95% CI 1.34 to 1.79), while 
negatively associated with AF (adjusted OR II 0.10, 95% CI 0.07 to 0.13) and IHD 
(adjusted OR II 0.42, 95% CI 0.33 to 0.54) in fully adjusted analyses (Figure 8.8). 
Similar to the results for TOAST SVD versus other subtypes, there were significant 
and strong interactions between age and hypertension, and between hypertension and 
diabetes (p<0.001, Figures 8.9 to 8.11).  As for other risk factors such as smoking, 
alcohol, previous stroke and TIA, they stayed neutral between LACI and NLAC. The 
unadjusted and adjusted analyses results for LAC versus NALC were close to those 
in SVD versus other subtypes using the TOAST classifications scheme.  
 
8.4 Discussion 
In this chapter, my results showed that the prevalence of hypertension, diabetes, AF, 
and hyperlipidaemia in overall IS patients based in Taiwan was higher, whereas the 
prevalence of smoking was lower than the results in my risk factor meta-analyses for 
IS (Chapter 6) based on all Chinese populations in different geographical areas 
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(nearly 90% from mainland China). In terms of risk factor associations, the findings 
after controlling for potential confounders were mostly close to my previous meta-
analysis results in the TOAST classification. Compared with other IS subtypes: LAA 
strokes were associated with hypertension, diabetes, hyperlipidaemia and TIA; CE 
strokes were associated with IHD; SVD strokes were associated with hypertension, 
diabetes and hyperlipidaemia. In the OCSP classification for LAC versus NLAC, the 
unadjusted and adjusted analyses yielded similar results to SVD versus other 
subtypes in the TOAST classification scheme. There were positive associations with 
hypertension, diabetes and hyperlipidaemia, and negative associations with AF and 
IHD.   
In my study, I found that the prevalence of several cerebrovascular risk factors of 
metabolic syndrome such as hypertension, diabetes, and hyperlipidaemia in overall 
IS patients based in Taiwan was higher than my previous risk factor meta-analyses 
for IS for all Chinese populations in Chapter 6 (nearly 90% from mainland China), 
and other studies from mainland China (Liu et al. 2006; Wang et al. 2006). Recently, 
the international REACH registry reported that there was a stepwise increase in the 
rates of hypertension, diabetes, hypercholesterolaemia and obesity in Chinese 
patients, from mainland China to Hong Kong/Singapore/Taiwan, and to North 
America/Western Europe (Chiu et al. 2010). These findings suggest that 
westernization of life style and dietary habits have a heavy impact on the prevalence 
of risk factors in these highly developed economic areas including Taiwan.  
China and Taiwan may represent different stages of epidemiological transitions. 
Yusuf et al proposed several stages of epidemiological transitions of cardiovascular 
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diseases (Yusuf et al. 2001). The main circulatory diseases at the earliest stage are 
due to infections and nutritional deficiency such as rheumatic heart disease and 
nutritional cardiomyopathies, which are prevalent in sub-Saharan Africa and rural 
India. As infections reduce and nutrition improves, hypertension related disease such 
as haemorrhagic stroke and hypertensive heart disease become more common in the 
second stage, and China is a representative country of this stage. In the third stage, as 
the life expectancy and economics continue improving, people tend to have more 
high-fat diet, smoking and sedentary life styles. Atherosclerotic cardiovascular 
disease such as ischaemic heart disease, atherosclerotic stroke, and diabetes become 
more common, especially at younger age (e.g. Latin America and urban India).   
Taiwan is probably at this stage because of earlier economic development (Taiwan is 
one of the high-income countries based on the World Bank classification, while 
China is in the group of middle-come countries), democratic policies and more 
influence on diet, lifestyle and culture from the western countries.  The 
epidemiological data in Taiwan could be useful to predict the future disease patterns 
in China. As mainland China is experiencing rapid economic and life style changes 
in recent decades, the prevalence of the aforementioned risk factors is likely to 
increase further in the years ahead. Prevention and better control of hypertension as 
well as diet and lifestyle modification through various education and intervention 
projects (e.g. heathy diet, smoking cessation, exercise program etc.) will improve the 
risk factors and reduce the associated cardiovascular diseases including ischaemic 
stroke in Chinese populations (Feigin et al. 2011; Yang et al. 1999; Kelly et al. 2008).  
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LAA strokes, which are pathophysiologically close to coronary heart disease, have 
been reported to be associated with age, male sex, and factors in metabolic syndrome 
as compared with other IS subtypes (Arboix et al. 2000; Grau et al. 2001; Silvestrelli 
et al. 2006). My findings are in line with previous studies, showing that hypertension, 
diabetes, and hyperlipidaemia are independent risk factors for LAA versus other 
subtypes after controlling for other confounders. Hypertension and diabetes are both 
well-established risk factor for ischaemic stroke, especially for large vessel and small 
vessel diseases (WHO Diabetes Drafting Group 1985). Compared with stroke related 
to extracranial atherosclerosis, diabetes was a more important factor for intracranial 
atherosclerosis related stroke (Rincon et al. 2009). Hyperlipidaemia is another well-
known risk factor. Previous studies have shown that higher total cholesterol levels 
are associated with increased risk of ischaemic stroke, particularly large artery 
atherosclerosis and lacunar strokes (Tirschwell et al. 2004; Laloux et al. 2004). 
In the present study, the proportion of CE subtype as well as the prevalence of AF in 
IS was higher than my systematic review in Chapter 4 and risk factor meta-analysis 
for IS in Chapter 6 for all Chinese populations. This may relate to the high 
performance rate of electrocardiography in NTUH. Every IS patient had 
electrocardiography examination upon arrival, and further continuous bedside 
electrographic monitoring was performed in around 25% IS patients admitted to the 
stroke intensive care unit, which was likely to detect AF. Although I did not include 
AF in the TOAST IS subtypes analyses because IS patients with the presence of AF 
were most likely assigned to CE subtype, irrespective of other risk factors or 
investigation results, my findings were similar to other studies (Arboix et al. 2000; 
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Schulz et al. 2003). Compared with other IS subtypes, CE had a totally different risk 
factor distribution. Apart from AF, CE was positively associated with IHD, while 
negatively associated with male gender, diabetes, hyperlipidaemia, and smoking. In 
literature, the most common causes contributed to cardioembolism are non-valvular 
AF, recent myocardial infarction, mechanical prosthetic valve, dilated 
myocardiopathy and mitral rheumatic stenosis (Arboix et al. 2012, Ferro et al 2003). 
Anticoagulation treatment is recommended for stroke prevention in patients with 
non-rheumatic AF and a history of stroke or TIA (Saxena R et al. 2004).  
SVD was the most common IS subtype in this study, which was consistent with my 
systematic review in Chinese hospital-based studies using the TOAST classification 
(Chapter 4), and a recent community-based study using the Atherosclerosis Risk in 
Communities (ARIC) classification scheme in Chinese population (Tsai et al. 2013; 
Fang et al. 2012). SVD was positively associated with hypertension, diabetes, and 
hyperlipidaemia, while negatively associated with IHD. In fully adjusted analyses, 
the associations with hypertension and diabetes became even stronger for SVD 
versus others, and were significantly higher than those in LAA or CE versus others. 
Analyses for LACI versus NALC using the OCSP classification also showed very 
similar findings qualitatively and quantitatively. These findings suggest that 
hypertension and diabetes are independent and strong risk factors for lacunar strokes 
compared with other subtypes in our patients, regardless of age, gender and other risk 
factors. Recently, the Hisayama cohort study in Japan reported that the magnitude of 
the blood pressure impact on stroke differed among subtypes, being greatest for 
cerebral haemorrhage and lacunar infarction than other subtypes in IS (Arima et al. 
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2009). My findings are similar to this and other studies in eastern Asians (Fang et al. 
2012; Arima et al. 2009; Lai et al. 2008), but slightly different from those in 
predominantly western populations, showing a marginal excess of hypertension and 
no difference of diabetes between lacunar and non-lacunar infarcts using TOAST or 
OCSP classification (Jackson et al. 2005; Schulz et al. 2003; Jackson et al. 2010).   
Differences in age and sex distributions and geographical areas, varying methods of 
case ascertainment, different risk factor definitions, as well as genuine differences in 
risk factor associations with lacunar infarcts among ethnic groups may account for 
these results.  
 
 Strengths and limitations 8.4.1
The current analyses provide important information on risk factor comparisons 
among IS subtypes in Chinese populations, in whom the distribution of IS subtypes 
are different from predominantly white populations, with a higher proportion of 
lacunar strokes and a lower proportion of cardioembolic stroke. My study has several 
strengths. First, NTUH Stroke Registry is a well-established registry, prospectively 
and systematically recruiting consecutive acute stroke patients since 1995 with 
relatively complete records of essential information including risk factors. My 
analyses benefited from inclusion of a large number of patients (nearly five 
thousands), and recent data from 2006 to 2011. Second, the inclusion of acute stroke 
patients was based on a standard definition of stroke, having stroke onset within 10 
days with early specialist assessment, timely brain imaging, and detailed 
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investigations for aetiology. The brain CT or MRI as well as electrocardiography 
performance rate was 100%, around 80% had carotid duplex examination, and 60% 
had MR angiography to assess extracranial and intracranial vascular abnormality. 
Third, I used multiple logistic regression modelling to adjust for possible 
confounding factors including age, sex and other risk factors, and incorporated 
strongly significant interactions among risk factors to acquire the true independent 
risk factors for each IS subtype versus others.  
Nevertheless, there are some limitations. First, the registry is a hospital-based stroke 
registry, whereas an ideal study population is supposed to be community-based, 
including all stroke patients in a geographical area, irrespective of hospital admission 
rate (Sudlow et al. 1996; Feigin et al. 2004). Prevalence of risk factors and stroke 
subtypes may possibly differ between hospitalized and non-hospitalized patients 
(Schulz et al. 2003). Second, risk factors in this study were collected from medical 
records prior to stroke occurrence, and from patients and family after the onset of 
stroke. Whilst most included patients had available medical records before stroke, I 
could not totally exclude the possibility of recall bias in case of a few patients 
without previous records. In addition, the risk factor status was dichotomized, not 
measured continuously. It is difficult to assess the severity or the shape of association 




Chapter 8. Risk factor analyses for IS subtypes in NTUH patients 221 
Accumulating evidence has suggested the distributions of ischaemic subtypes and 
risk factors vary among races and ethnicities, and there are different associations of 
risk factors among subtypes (Schulz et al. 2003; Jackson et al. 2005; Jackson et al. 
2010; Fang et al. 2012; Lai et al. 2008; Ohira et al. 2006; Tsai et al. 2013). Here I 
report the independent risk factors for each IS subtype regardless of age, sex, or other 
risk factors in a Chinese population in Taiwan. While ischaemic stroke is the major 
part of the heavy stroke burden on Chinese, my findings could help shed light on the 
different contributions of risk factors among ischaemic stroke subtypes, providing 
insights into to effective strategies of stroke prevention and treatment. 
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Tables 
Table 8.1 Study characteristics and risk factor distributions in overall IS patients, NTUH Stroke 
Registry 2006-2011, Taiwan. 
 
Overall IS (N=4953) 
Mean Age (Y) 68.1 (±13.8) 
  N (%) (95% CI) 
Gender (male) 2929 59.1% 57.8-60.5% 
Hypertension 3809 76.9% 75.7-78.7% 
Diabetes 1838 37.1% 35.8-38.4% 
Atrial fibrillation 1180 23.8% 22.6-25.0% 
Ischaemic heart disease 759 15.3% 14.3-16.4% 
Hyperlipidaemia 1744 35.2% 33.9-36.6% 
Smoking 1455 29.4% 28.1-30.7% 
Alcohol intake 689 13.9% 13.0-14.9% 
Previous stroke 1175 23.7% 22.5-24.9% 
Transient ischaemic attack 193 3.9% 3.4-4.5% 
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Table 8.2 Study characteristics and risk factor distributions in IS patients using the TOAST classifications, NTUH Stroke Registry 2006-2011, Taiwan. 
 TOAST classifications        











 27.5% 21.0% 24.3% 5.0% 22.1%          P<0.001* 
Mean age (Y) 67.8 (±11.8) 70.1(±11.4) 72.5 (±13.2) 48.4(±14.4) 66.2(±14.6) P<0.001
** 
 N (%) N (%) N (%) N (%) N (%)  
Gender (male) 848 62.2% 694 66.7% 624 51.9% 163 65.7% 600 54.7% P<0.001* 
Hypertension 1124 82.4% 908 87.2% 928 77.1% 115 46.4% 734 66.9% P<0.001* 
Diabetes 556 40.8% 492 47.3% 379 31.5% 35 14.1% 376 34.3% P<0.001* 
Atrial fibrillation 41 3.0% 63 6.1% 1037 86.2% 10 4.0% 29 2.6% P<0.001* 
Ischaemic heart disease 96 7.0% 193 18.5% 337 28.0% 11 4.4% 122 11.1% P<0.001* 
Hyperlipidaemia 634 46.5% 437 42.0% 280 23.3% 68 27.4% 325 29.6% P<0.001* 
Smoking 434 31.8% 350 33.6% 270 22.4% 82 33.1% 319 29.1% P<0.001* 
Alcohol intake 197 14.4% 177 17.0% 134 11.1% 34 13.7% 147 13.4% P=0.002* 
Previous stroke 296 21.7% 301 28.9% 312 25.9% 34 13.7% 232 21.1% P<0.001* 
Transient ischaemic attack 43 3.2% 61 5.9% 53 4.4% 15 6.0% 21 1.9% P<0.001* 
IS=ischaemic stroke; NTUH=National Taiwan University Hospital; SVD=small vessel disease; LAA=large artery atherosclerosis; CE=cardioembolism; 
N=number; CI=confidence interval. 
** based on analysis of variance (ANOVA); * based on Pearson’s chi-square test. 
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Table 8.3 Study characteristics and risk factor distributions in IS patients using the OCSP classifications in NTUH Stroke Registry 2006-2011, Taiwan. 
 OCSP classifications         









        23.5%         20.9%         32.0% 23.7%           P<0.001* 








 N (%) N (%) N (%) N (%)  
Gender (male) 726 62.5% 524 50.7% 942 59.4% 737 62.9% P<0.001* 
Hypertension 945 81.3% 755 73.1% 1173 74.0% 936 79.9% P<0.001* 
Diabetes 453 39.0% 308 29.8% 569 35.9% 508 43.3% P<0.001* 
Atrial fibrillation 38 3.3% 549 53.1% 375 23.6% 218 18.6% P<0.001* 
Ischaemic heart disease 85 7.3% 268 25.9% 251 15.8% 155 13.2% P< 0.001* 
Hyperlipidaemia 535 46.0% 238 23.0% 502 31.7% 469 40.0% P<0.001* 
Smoking 367 31.6% 256 24.8% 480 30.3% 352 30.0% P=0.003* 
Alcohol intake 166 14.3% 127 12.3% 207 13.1% 189 16.1% P=0.043* 
Previous stroke 251 21.6% 234 22.7% 413 26.0% 277 23.6% P= 0.041* 
Transient ischaemic attack 37 3.2% 42 4.1% 69 4.4% 45 3.8% P= 0.469* 
IS=ischaemic stroke; NTUH=National Taiwan University Hospital; LAC=lacunar infarct; TACI=total anterior circulation infarct; PACI=partial  
anterior circulation infarct; POCI=posterior circulation infarct; N=number; CI=confidence interval. 
** based on analysis of variance (ANOVA); * based on Pearson’s chi-square test.  
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Figures 
Figure 8.1 Risk factors for LAA versus other TOAST IS subtypes. 
 
Risk factors                                OR                                                              95% CI 
0.5 1 2 5 
OR II 1.72 (1.24, 2.36) 
OR I 1.75 (1.27, 2.39) 
TIA crude OR 1.78 (1.28, 2.45) 
OR II 1.19 (1.02, 1.40) 
OR I 1.34 (1.14, 1.56) 
Previous stroke crude OR 1.41 (1.21, 1.65) 
OR II 1.16 (0.93, 1.44) 
OR I 1.26 (1.03, 1.54) 
Alcohol crude OR 1.36 (1.12, 1.67) 
OR II 1.05 (0.87, 1.27) 
OR I 1.16 (0.98, 1.37) 
Smoking crude OR 1.29 (1.11, 1.49) 
OR II 1.42 (1.22, 1.64) 
OR I 1.53 (1.32, 1.76) 
Hyperlipidaemia crude OR 1.44 (1.25, 1.66) 
OR II 1.13 (0.94, 1.36) 
OR I 1.26 (1.05, 1.51) 
Ischaemic heart crude OR 1.35 (1.12, 1.62) 
OR II 1.52 (1.32, 1.75) 
OR I 1.69 (1.47, 1.94) 
Diabetes crude OR 1.71 (1.48, 1.97) 
OR II 1.94 (1.59, 2.38) 
OR I 2.24 (1.84, 2.74) 
Hypertension crude OR 2.38 (1.96, 2.92) 
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LAA=large artery atherosclerosis; IS=ischaemic stroke; OR=odds ratio; OR I=adjusted odds 
ratio I (adjusting for age and gender); OR II=adjusted odds ratio II (adjusting for age, gender 
and risk factors); TIA=transient ischaemic attack; CI=confidence interval. Horizontal lines 
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Figure 8.2 Risk factors for CE versus other TOAST IS subtypes. 
 
 
Risk factors                            OR                                                                 95% CI 
0.2 0.5 1 2 5 10 100 
OR II 1.25 (0.88, 1.75) 
OR I 1.30 (0.93, 1.80) 
TIA crude OR 1.19 (0.84, 1.65) 
OR II 1.09 (0.93, 1.28) 
OR I 1.07 (0.92, 1.25) 
Previous stroke crude OR 1.17 (1.00, 1.36) 
OR II 1.14 (0.89, 1.45) 
OR I 1.00 (0.81, 1.24) 
Alcohol crude OR 0.72 (0.59, 0.88) 
OR II 0.78 (0.64, 0.95) 
OR I 0.81 (0.68, 0.96) 
Smoking crude OR 0.63 (0.54, 0.73) 
OR II 0.51 (0.43, 0.59) 
OR I 0.51 (0.44, 0.60) 
Hyperlipidaemia crude OR 0.47 (0.41, 0.55) 
OR II 6.74 (4.16, 10.87) 
OR I 2.78 (2.36, 3.29) 
Ischaemic heart crude OR 3.07 (2.60, 3.62) 
OR II 0.67 (0.57, 0.77) 
OR I 0.70 (0.61, 0.81) 
Diabetes crude OR 0.72 (0.63, 0.83) 
OR II 0.91 (0.76, 1.07) 
OR I 0.85 (0.73, 1.00) 
Hypertension crude OR 1.02 (0.87, 1.19) 
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CE=cardioembolism; IS=ischaemic stroke; OR=odds ratio; OR I=adjusted odds ratio I 
(adjusting for age and gender); OR II=adjusted odds ratio II (adjusting for age, gender and 
risk factors, and incorporating a strongly significant interaction); TIA=transient ischaemic 
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Figure 8.3 Subgroup analyses of ischaemic heart disease for CE versus other TOAST IS 
subtypes in different age groups. 
 
CE=cardioembolism; IS=ischaemic stroke; OR II=adjusted odds ratio II (adjusting for gender 
and other risk factors); CI=confidence interval. Horizontal lines represent 95% CIs. 
Diamonds represent pooled ORs. 
  
1 2 5 10 100 
OR II 81-106Y 2.07 (1.51, 2.84) 
OR II 74-80Y 2.08 (1.47, 2.94) 
OR II 67-73Y 3.61 (2.46, 5.31) 
OR II 58-66Y 4.76 (3.05, 7.46) 
OR II 18-57Y 7.79 (4.65, 13.09) 
Age groups                                OR                                                  95% CI 
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Figure 8.4 Risk factors for SVD versus other TOAST IS subtypes. 
 
 
Risk factors                                         OR                                                    95% CI     
0.2 0.5 1 2 5 10 
OR II 0.71 (0.49, 1.01) 
OR I 0.72 (0.51, 1.01) 
TIA crude OR 0.75 (0.52, 1.06) 
OR II 0.83 (0.71, 0.97) 
OR I 0.86 (0.74, 1.00) 
Previous stroke crude OR 0.85 (0.73, 0.99) 
OR II 0.86 (0.70, 1.07) 
OR I 0.95 (0.79, 1.15) 
Alcohol crude OR 1.06 (0.88, 1.27) 
OR II 1.09 (0.92, 1.30) 
OR I 1.06 (0.93, 1.27) 
Smoking crude OR 1.17 (1.02, 1.35) 
OR II 1.84 (1.60, 2.10) 
OR I 1.90 (1.67, 2.16) 
Hyperlipidaemia crude OR 1.94 (1.70, 2.21) 
OR II 0.32 (0.25, 0.40) 
OR I 0.34 (0.27, 0.42) 
Ischaemic heart crude OR 0.33 (0.26, 0.42) 
OR II 2.65 (1.92, 3.65) 
OR I 1.21 (1.07, 1.38) 
Diabetes crude OR 1.24 (1.09, 1.41) 
OR II 4.84 (3.39, 7.03) 
OR I 1.61 (1.37, 1.89) 
Hypertension crude OR 1.58 (1.34, 1.86) 
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SVD=small vessel disease; IS=ischaemic stroke; OR=odds ratio; OR I=adjusted odds ratio I 
(adjusting for age and gender); OR II=adjusted odds ratio II (adjusting for age, gender, and 
risk factors, and incorporating strongly significant interactions); TIA=transient ischaemic 
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Figure 8.5 Subgroup analyses of hypertension for SVD versus other TOAST IS subtypes in 
different age groups. 
 
SVD=small vessel disease; IS=ischaemic stroke; OR II=adjusted odds ratio II (adjusting for 
gender and other risk factors); CI=confidence interval. Horizontal lines represent 95% CIs. 
Diamonds represent pooled ORs. 
  
0.5 1 2 5 10 
OR II 81-106Y 1.20 (0.74, 2.01) 
OR II 74-80Y 1.69 (1.07, 2.73) 
OR II 67-73Y 1.51 (0.96, 2.43) 
OR II 58-66Y 1.66 (1.25, 2.67) 
OR II 18-57Y 5.09 (3.31, 8.05) 
Age groups                                OR                                                                 95% CI 
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Figure 8.6 Subgroup analyses of hypertension for SVD versus other TOAST IS subtypes in 
patients with or without diabetes. 
 
SVD=small vessel disease; IS=ischaemic stroke; OR II=adjusted odds ratio II (adjusting for 
age, gender and other risk factors); CI=confidence interval. Horizontal lines represent 95% 
CIs. Diamonds represent pooled ORs. 
 
  
0.5 1 2 5 10 
OR II (without diabetes) 5.37 (3.51, 8.46) 
OR II (with diabetes) 
1.44 (0.79, 2.70) 
     Patient groups                           OR                                                               95% CI 
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Figure 8.7 Subgroup analyses of diabetes for SVD versus other TOAST IS subtypes in patients 
with or without hypertension. 
 
SVD=small vessel disease; IS=ischaemic stroke; OR II=adjusted odds ratio II (adjusting for 
age, gender and other risk factors); CI=confidence interval. Horizontal lines represent 95% 
CIs. Diamonds represent pooled ORs. 
 
  
0.5 1 2 5 
OR II (without hypertension) 2.62 (1.88, 3.63) 
OR II (with hypertension) 1.00 (0.86, 1.15) 
     Patient groups                           OR                                                               95% CI 
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Figure 8.8 Risk factors for LACI versus NLAC in the OCSP classification.  
 
Risk factors                                                            OR                                   95% CI 
0.01 0.1 0.2 0.5 1 2 5 10 
OR II 0.76 (0.51, 1.11) 
OR I 0.74 (0.51, 1.06) 
TIA crude OR 0.77 (0.52, 1.11) 
OR II 0.88 (0.74, 1.04) 
OR I 0.86 (0.73, 1.00) 
Previous stroke crude OR 0.85 (0.73, 1.00) 
OR II 0.93 (0.74, 1.16) 
OR I 0.93 (0.76, 1.14) 
Alcohol crude OR 1.04 (0.88, 1.26) 
OR II 1.00 (0.83, 1.21) 
OR I 1.05 (0.89, 1.23) 
Smoking crude OR 1.15 (0.99, 1.33) 
OR II 1.55 (1.34, 1.79) 
OR I 1.79 (1.56, 2.05) 
Hyperlipidaemia crude OR 1.82 (1.59, 2.09) 
OR II 0.42 (0.33, 0.54) 
OR I 0.37 (0.29, 0.47) 
Ischaemic heart crude OR 0.37 (0.28, 0.46) 
OR II 0.10 (0.07, 0.13) 
OR I 0.08 (0.05, 0.11) 
Atrial fibrillation crude OR 0.08 (0.05, 0.11) 
OR II 2.40 (1.71, 3.37) 
OR I 1.09 (0.95, 1.25) 
Diabetes crude OR 1.11 (0.97, 1.27) 
OR II 4.58 (3.16, 6.75) 
OR I 1.44 (1.21, 1.70) 
Hypertension crude OR 1.41 (1.16, 1.67) 
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LACI=lacunar; NLAC=non-lacunar; IS=ischaemic stroke; OR=odds ratio; OR I=adjusted 
odds ratio I (adjusting for age and gender); OR II=adjusted odds ratio II (adjusting for age, 
gender, and risk factors, and incorporating strongly significant interactions); TIA=transient 
ischaemic attack; CI=confidence interval. Horizontal lines represent 95% CIs. Diamonds 
represent pooled ORs. 
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Figure 8.9 Subgroup analyses of hypertension for LACI versus NLAC (OCSP classification) in 
different age groups. 
 
 
LACI=lacunar; NLAC=non-lacunar; IS=ischaemic stroke; OR II=adjusted odds ratio II 
(adjusting for gender and other risk factors); CI=confidence interval. Horizontal lines 
represent 95% CIs. Diamonds represent pooled ORs. 
  
0.5 1 2 5 10 
OR II 81-106Y 1.63 (0.95, 2.88) 
OR II 74-80Y 1.43 (0.87, 2.41) 
OR II 67-73Y 1.36 (0.84, 2.26) 
OR II 58-66Y 1.75 (1.08, 2.90) 
OR II 18-57Y 4.73 (3.02, 7.63) 
Age groups                                OR                                                                 95% CI 
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Figure 8.10 Subgroup analyses of hypertension for LACI versus NLAC (OCSP classification) in 
patients with or without diabetes. 
 
LACI=lacunar; NLAC=non-lacunar; IS=ischaemic stroke; OR II=adjusted odds ratio II 
(adjusting for age, gender and other risk factors); CI=confidence interval. Horizontal lines 
represent 95% CIs. Diamonds represent pooled ORs. 
 
  
0.5 1 2 5 10 
OR II (without diabetes) 5.03 (3.23, 8.08) 
OR II (with diabetes) 1.22 (0.66, 2.64) 
Patients groups                                OR                                                            95% CI 
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Figure 8.11 Subgroup analyses of diabetes for LACI versus NLAC (OCSP classification) in 
patients with or without hypertension. 
 
LACI=lacunar; NLAC=non-lacunar; IS=ischaemic stroke; OR II=adjusted odds ratio II 
(adjusting for age, gender and other risk factors); CI=confidence interval. Horizontal lines 
represent 95% CIs. Diamonds represent pooled ORs. 
 
0.5 1 2 5 
OR II (without hypertension) 2.36 (1.66, 3.34) 
OR II (with hypertension) 0.81 (0.69, 0.95) 
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 Summary and implications for Chapter 9:
further research 
9.1 Summary of stroke epidemiology and its 
subtypes in Chinese populations 
 Stroke incidence  9.1.1
Does stroke incidence in Chinese differ from that in white populations?  
My systematic review in Chapter 2 showed that, compared with predominantly white 
populations, Chinese had a higher age-adjusted incidence of stroke, and a lower 
mean age of stroke onset. Additionally, I found that there was a striking variation 
among Chinese populations in different geographical areas (which varied around 
threefold in the age range 45-74 years). Earlier studies had suggested higher stroke 
incidence in Chinese versus white populations, and variable stroke incidence rates 
within China (with a north-south gradient), but did not include people aged older 
than 64 years and some comparisons included recurrent as well as first-ever strokes 
(Thorvaldsen et al, 1995; Wu et al. 2001). My results showed reliably that such 
differences existed after 1990 and extended previous findings to those aged 65 years 
and beyond, among whom most strokes occur. These differences were based on 
comparisons of methodologically robust community-based studies, including first-
ever strokes in both admitted and not admitted to hospital, with appropriate age-
standardization, and inclusion of an open-ended upper age band. They were therefore 
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unlikely to be an artefact of variable hospital admission rates or of incomplete 
adjustment for age.  
In the literature, many factors have been suggested to explain the Chinese-Whites 
differences of stroke incidence as well as the variations among Chinese populations 
in overall stroke incidence, including differences in vascular risk factors, dietary 
habits (e.g. variable intake of salt), weather, socio-economic status, and genetic 
factors (Asch et al. 2010; Zhou et al. 2003; Wu et al. 2001; Yang et al. 2004; Zhao et 
al. 2004). These vary substantially within Chinese populations as well as between 
Chinese and white populations. 
In terms of the trend of stroke incidence in Chinese populations, the Sino-MONICA-
Beijing community-based stroke incidence study among people aged 25-74 years 
found, between 1984 and 2004 a 4% increase in age-standardized incidence of all 
types of stroke (Zhao et al. 2008). However, there are few comparable, large 
community-based data including older ages yet available after 2000. Since Chinese 
populations are experiencing rapid economic and lifestyle changes, there will be 
probably further changes in stroke incidence in the decades ahead.  
 
 Pathological types of stroke 9.1.2
Is the distribution of pathological types of stroke different between Chinese and 
white populations? 
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In Chapter 3, I showed that, compared with Whites, Chinese populations had an 
around twofold higher proportion of intracerebral haemorrhage (ICH), and a lower 
proportion of ischaemic stroke (IS). The proportion of ICH in Chinese was 
significantly higher either in all studies combined or in only community-based 
studies. In addition, there was a greater proportion of ICH in mainland China than 
Taiwan, and a striking variation of ICH within mainland China, with the highest 
proportion of ICH up to 52% in Changsha.  
The Sino MONICA community-based stroke study (1987-1993) also reported a 
higher proportion of haemorrhagic stroke (ICH and subarachnoid haemorrhage) in 
Chinese among people aged 25-74 years, ranging from 25% to 64% (Wu et al. 2003). 
Subsequently, the Sino-MONICA-Beijing community-based stroke study among 
people aged 25-74 years further showed a 5% increase in IS and 1% decrease in 
haemorrhagic stroke between 1984 and 2004 (Zhao et al. 2008). My study found that 
the higher proportion of haemorrhagic stroke was due to ICH, not subarachnoid 
haemorrhage. Furthermore, despite of a decreasing trend of ICH, the significantly 
higher proportion of ICH had persisted in the most recent studies in Chinese 
populations, even those with highly developed economies, such as Taiwan. These 
changes occurred during a time of rapid economic development and increasing 
adoption of western lifestyles, increased dietary fat and cholesterol intake, increased 
mean cholesterol levels, increased prevalence of obesity and diabetes, and possibly 
better hypertension control.  
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 Ischaemic stroke subtypes  9.1.3
Is the distribution of ischaemic stroke subtypes in Chinese different from those in 
white populations? 
In Chapter 4, my systematic review showed that, compared with predominantly 
white populations, there was a significantly higher proportion of small vessel disease 
(SVD) strokes (lacunar infarction), a lower proportion of cardioembolism (CE) 
strokes and of other specific/undetermined IS subtypes in Chinese.  
However, I could not find any community-based studies of IS subtypes based on the 
TOAST or OCSP classification. Since only hospital-based studies were available in 
Chinese populations, different hospital admission rates could contribute to the 
variations among Chinese studies as well as between the hospital-based Chinese 
studies and the community-based studies in Whites (Schulz et al. 2003). In addition, 
the proportion of strokes in the ‘other or undetermined’ ischaemic subtype using the 
TOAST classification scheme varied widely among the Chinese studies, and was 
generally lower than among studies in Whites. This could be due to differences in the 
investigations, interpretation, and application of aetiological classification systems 
for ischaemic stroke subtypes. The proportion of stroke cases with complete 
investigation would influence the assignment of IS subtypes, since the higher the 
proportion of complete investigations, the lower would be the proportion assigned an 
undetermined subtype (Jackson et al. 2005). The problem of variable investigation 
rates does not influence the anatomical OCSP classification system, which is based 
on clinical symptoms and signs, requiring no investigation results beyond a brain 
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scan to exclude haemorrhage (Bamford et al. 1991). This may explain the more 
consistent findings among the Chinese studies using the OCSP system, as well as 
making comparisons between studies based on this system more reliable. Although 
the OCSP-based Chinese-Whites comparisons still show a higher proportion of 
lacunar ischemic strokes in Chinese populations, community-based studies are 
needed to further support this finding. 
 
 Risk factors for ICH versus IS  9.1.4
Do the associations with risk factors differ between ICH and IS in Chinese as well 
as between Chinese and Whites? 
To further explore the possible reasons for the observed differences in the 
proportions of the main pathological types of stroke - a twofold higher proportion of 
ICH and a lower proportion of IS in Chinese as compared to predominantly white 
populations, in Chapter 5, I performed meta-analyses to systematically assess the 
evidence for differences in the vascular risk factor profiles between ICH and IS in 
Chinese, and compared these results with data from predominantly white populations.  
My results showed that the relative frequencies of risk factors in ICH versus IS were 
generally of similar direction in stroke patients from both Chinese and predominantly 
white populations, but the associations varied in size and significance. Both 
hypertension and alcohol intake were significantly more frequent in ICH versus IS in 
Chinese but not in white stroke patients, while both hypercholesterolaemia and 
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smoking were significantly less frequent in ICH versus IS in Whites but not Chinese 
stroke patients. As for diabetes, atrial fibrillation (AF) and ischaemic heart disease 
(IHD), they were significantly less common in ICH in both ethnic groups. However, 
the risk factor associations with ICH versus IS did not differ significantly between 
Chinese and Whites except for IHD, which had a stronger association with IS versus 
ICH in Chinese than predominantly white populations. 
These meta-analyses results should be interpreted with caution since there was 
substantial statistical heterogeneity among the studies, which could arise from 
differences in age and sex distributions, methodological differences (e.g. case 
ascertainment methods), variable risk factor definitions, differences between 
geographical areas, as well as genuine differences in risk factor associations between 
ethnic groups. Because my meta-analyses were based on published data, I did not 
have individual patient data to allow adjustment for potential confounders such as 
age and gender.  
Fortunately, I acquired an opportunity to have stroke research collaboration with 
National Taiwan University Hospital (NTUH), analysing data of nearly seven 
thousands Chinese acute stroke patients in NTUH stroke registry from 2006 to 2011. 
The NTUH Stroke Registry is a hospital-based registry based in north Taiwan, 
prospectively recruiting consecutive acute stroke or transient ischaemic attack 
patients (TIA) arriving in the Emergency Department or being admitted to wards. In 
Chapter 7, I was able to overcome the limitations of my meta-analyses of published 
studies, adjusting for age, gender and other risk factors. The findings were broadly 
consistent with the results from my meta-analysis, showing that hypertension and 
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alcohol intake were independent risk factors for ICH versus IS in Chinese 
populations regardless of age, sex, or other risk factors, whereas diabetes, atrial 
fibrillation, IHD, hyperlipidaemia, smoking and TIA were negatively associated with 
ICH versus IS. Furthermore, in subgroup analysis, the positive association with 
hypertension was found to be stronger in younger stroke patients.  
 
 Risk factors for IS subtypes 9.1.5
Are the prevalence of risk factors in IS and the associations of risk factors with IS 
subtypes in Chinese different from those in white populations? 
In Chapter 6, I conducted subsequent risk factor meta-analyses for IS and its 
subtypes to explore the possible causes of the different distribution of IS subtypes in 
Chinese (a higher proportion of lacunar strokes and a lower proportion of CE strokes) 
as compared with predominantly white populations. My results showed that Chinese 
IS patients had a similar proportion of hypertension, diabetes, smoking and alcohol, 
and a lower prevalence of AF, IHD and hypercholesterolaemia compared with 
Whites. As for the associations of risk factors with individual IS subtypes, they were 
qualitatively similar (although different in size) in Chinese and predominantly white 
populations. Compared with other IS subtypes: large artery artherosclerosis (LAA) 
strokes were associated with diabetes; CE strokes were associated with AF and IHD; 
SVD (or lacunar) strokes were associated with hypertension and diabetes. However, 
these meta-analysis findings could be possibly confounded by some factors such as 
age, gender, other risk factors, incomplete information, variable investigations and 
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interpretations of IS classification system, and different definitions of some risk 
factors.  
To overcome the potential confounding effects in the meta-analyses, in Chapter 8, I 
performed further analyses of individual patient data including nearly five thousand 
acute IS patients from the NTUH Stroke Registry of a Chinese population in Taiwan. 
Interestingly, I found that the prevalence of several risk factors of the metabolic 
syndrome, especially hypertension, diabetes, and hyperlipidaemia in overall IS 
patients based in Taiwan,  was higher than my previous risk factor meta-analyses for 
IS for all Chinese populations in Chapter 6 and other reports from mainland China 
(Liu et al. 2006; Wang et al. 2006). My findings were consistent with the findings in 
the international REACH registry, which showed a stepwise increase in the rates of 
hypertension, diabetes, hypercholesterolaemia and obesity in Chinese patients, from 
mainland China to highly developed economic areas such as Hong 
Kong/Singapore/Taiwan, and to North America/Western Europe (Chiu et al. 2010). 
These findings suggest that westernization of life style and dietary habits have a 
heavy impact on the prevalence of risk factors in Chinese. Hong Kong and Taiwan 
are economically highly developed areas, and they probably represent the interim 
status of economic and epidemiological transition in Chinese populations.  
In terms of risk factor associations, the findings after controlling for potential 
confounders were mostly close to my previous meta-analysis results except for 
lacunar strokes. Compared with other IS subtypes: LAA strokes were associated with 
hypertension, diabetes, hyperlipidaemia and TIA; CE strokes were associated with 
IHD. As for SVD (or lacunar) strokes, in fully adjusted analyses, hypertension and 
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diabetes were independent and strong risk factors regardless of age, sex and other 
risk factors in both TOAST and OCSP classifications. My findings are similar to 
other studies in eastern Asians (Fang et al. 2012; Arima et al. 2009; Lai et al. 2008), 
but slightly different from those in predominantly western populations, showing a 
marginal excess of hypertension and no difference of diabetes between lacunar and 
non-lacunar infarcts (Jackson et al. 2005; Schulz et al. 2003; Jackson et al. 2010).   
Differences in age and sex distributions and geographical areas, varying methods of 
case ascertainment, different risk factor definitions, as well as genuine differences in 
risk factors associations with lacunar infarcts among ethnic groups may account for 
these results.  
 
9.2 Implications and plans for further research  
 Community-based studies 9.2.1
From my systematic reviews of stroke studies in Chinese populations, despite a 
comprehensive literature search, I found few community-based studies of incidence 
of stroke, pathological types of stroke or ischaemic stroke subtypes, and risk factors 
in Chinese populations without an upper age limit, especially after the year 2000. In 
addition, there were insufficient data for 1 month case fatality analysis. An ideal 
study population should be community-based with multiple overlapping sources, 
including all stroke patients in a geographical area, irrespective of the hospital 
admission rate (Sudlow et al. 1996; Feigin et al. 2004). Nevertheless, there were few 
studies based on ideal study populations in Chinese, and many stroke studies did not 
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include older patients. Stroke is a non-communicable disease mainly occurring in 
older people, and the incidence of stroke increases with each decade of life. Thus, 
studies with an upper age limit or including only hospital patients would exclude a 
considerable number of stroke patients, losing the full picture of stroke. Furthermore, 
distribution of stroke subtypes and prevalence of risk factors may possibly differ 
between hospitalized and non-hospitalized patients (Schulz et al. 2003).  
Although Chinese populations have a relatively higher incidence of total stroke as 
compared with western countries, the data and analyses on stroke incidence, subtypes, 
and risk factors from large numbers of stroke patients in community-based studies 
using robust methods to explore the possible underlying reasons are quite limited. 
Most relevant information has been derived from studies on predominantly white 
populations. Well-designed community-based studies of stroke in Chinese would 
allow us to have accurate data on incidence of stroke and subtypes, to 
comprehensively assess risk factor profiles for stroke, to make reliable comparisons 
among countries or populations, to evaluate trends with time, to help planning more 
efficient strategies of stroke prevention, and ultimately to reduce the heavy stroke 
burden in Chinese populations as well as the total stroke burden around the world 
(Sudlow et al. 1996).  
 
 Intracerebral haemorrhage subtypes 9.2.2
ICH is the most catastrophic type of stroke, leading to high case-fatality, poor 
functional outcome, and heavy disability burden in the world (Feigin et al. 2009; Ash 
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et al. 2010; Qureshi et al. 2009). My systematic review in Chapter 3 showed that 
Chinese populations had around a twofold higher proportion of ICH as compared 
with predominantly white populations (28% versus 12%), and the differences 
became even greater when the comparisons were made solely based on community-
based studies (34% versus 12%).   
Recently, several studies have reported that risk factors for ICH vary according to the 
location of haemorrhage (Woo et al. 2002; Biffi at el. 2010; Martini et al. 2012). ICH 
is most commonly classified into lobar ICH and deep (non-lobar) ICH subtypes, and 
apoliprotein E (APOE) polymorphism is an established risk factor for ICH in white 
populations (Wermer et al. 2002; Woo et al. 2002; Martini et al. 2012). While 
hypertension appears to pose the greatest risk to deep ICH in the basal ganglia, 
thalamus, brainstem, cerebellum, or periventricular white matter, apolipoprotein 
genotypes APOE4 and APOE2 seem to have the highest attributable risk to lobar 
ICH (Woo et al. 2002). Additionally, a study based in Dijon suggested that ICH risk 
factor profiles were changing in recent decades (Bejot et al. 2013). They found an 
80% increase in ICH incidence among people aged 75 years or older, whereas a 50% 
decrease was noted in individuals aged less than 60 years. A suggested explanation 
for the increasing ICH incidence in older people, who are prone to vasculopathies 
such as cerebral amyloid angiopathy, may be including use of antithrombotic drugs. 
In Chinese populations, hypertension is generally thought to account for the higher 
proportion of ICH in Chinese or other Asian populations, especially for deep ICH. 
Nevertheless, there have been few studies designed to assess the risk factors 
including medication use and genetic factors for ICH subtypes in Chinese 
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populations. Given that the ICH incidence and proportion are significantly higher in 
Chinese and other Asian populations, there is a pressing need for more studies to 
clarify the roles of risk factors for ICH and its subtypes in these populations.  
 
 Ischaemic stroke classification  9.2.3
In my study of IS subtypes in Chapter 4, I found the proportion of the “stroke of 
other determined or undetermined aetiology” IS subtype using the TOAST 
classification scheme varied widely among the Chinese studies.  This could partly be 
due to differences in the interpretation, investigations, and application of the 
aetiological classification systems for IS subtypes. Currently, the TOAST 
classification is the most widely used classification scheme for IS subtyping. It is 
mainly based on clinical features of IS and other results from investigations for the 
possible aetiology of stroke such as neuroimaging, electrocardiography, 
echocardiography, neurosonography, cerebral angiography and various blood tests, 
with moderate inter-rater reliability (Gordon et al. 1993; Meschia et al. 2006). 
Although it is simple, logical, informative, and easy to use, the TOAST classification 
has several limitations. First of all, the accuracy and the proportions of IS subtypes 
may depend on the proportion of complete investigations. The higher the proportion 
of complete investigations, the lower the proportion which is assigned to the 
undetermined aetiology IS subtype. In addition, when patients have multiple 
aetiologies, they are assigned to the undetermined aetiology subtype, usually leading 
to a large group of undetermined subtype. Furthermore, TOAST classification is not 
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a risk factor-free classification scheme, and it could possibly lead to classification 
bias (Jackson et al. 2005).  
As modern diagnostic technology and understanding of IS mechanisms have 
improved considerably in recent decades, there are several newly developed 
classification systems such as Causative Classification System (CCS), 
Atherosclerosis, Small-Vessel Disease, Cardiac Source, Other Cause (A-S-C-O) 
classification system, and Chinese Ischaemic Stroke Subclassification (CISS) system 
(Ay et al. 2005; Amarenco et al. 2009; Gao et al. 2011). A good classification system 
has to be valid, reliable, evidence-based and easy to use. Accurate classification is 
important to epidemiology studies including risk factors and prognosis, clinical trials 
of treatment for IS subtypes, and further genetic association research of stroke (Chen 
et al. 2012). More reliability and validity data in different ethnic groups are needed 
for these new classification systems. 
 
 Stroke genetics  9.2.4
At present, there is an increasing interest in the influence of genetic factors on stroke. 
Research in stroke genetics continues to make substantial advances (Meschia et al. 
2013; Sharma et al. 2013). As technology improves, the genomic analysis of stroke 
has changed from candidate gene association studies to genome-wide association 
studies (Lanktree et al. 2010). Apart from monogenic stroke disorders such as 
cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL), recently, large-scale international research 
 
Chapter 9. Summary and implications for further research  254 
collaborations have reported some new genetic risk factors to IS, which seem to be 
specific to IS subtypes. The International Stroke Genetics Consortium and the 
Wellcome Trust Case Control Consortium 2 performed a genome-wide association 
study of IS patients and controls of European origin (International Stroke Genetics 
Consortium; Wellcome Trust Case Control Consortium 2. 2012). They have 
replicated the associations of PITX2 and ZFHX3 with cardiogenic embolic stroke, 
and a locus 9p21 with large vessel stroke. In addition, they have identified a new 
association of HDAC9 with large vessel stroke on chromosome 7p21.1. Subsequent 
meta-analyses of genome-wide association studies in a large number of patients and 
controls of European ancestry by METASTROKE collaboration have confirmed the 
aforementioned findings (Traylor et al. International Stroke Genetics Consortium. 
2012).  These results suggest different genetic mechanisms have associations with 
different IS subtypes.  
In ICH, there is increasing evidence of strong association of apolipoprotein E type 
(APOE4/APOE2) with lobar ICH, which is related to cerebral amyloid angiopathy 
(Woo et al. 2002; Biffi et al. 2010; Martini et al 2012; Rannikmae et al. 2013). 
Around one third of all lobar ICH patients are reported to be attributable to APOE2 
or APOE4, whereas half of non-lobar ICH cases are attributable to hypertension 
(Woo et al. 2002). However, most of these studies have been conducted in white 
stroke patients of European descent, with few comparable data from other 
populations. Recently, the Perindopril Protection Against Recurrent Stroke Study 
(PROGRESS) study, which included 3457 Europeans and 2148 Asians (38%), found 
that patients carrying APOE 2 or APOE4 had an increased risk of both incident and 
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recurrent ICH, and both lobar and deep ICH. Moreover, most risk estimates in their 
study were higher in Asians than in Europeans (Tzourio et al. 2008). In Chinese 
populations, several genetic studies regarding APOE genotype as well as other 
genetic markers such as TNF-α gene and 1425G/A SNP in PRKCH have been 
reported recently to be associated with cerebral haemorrhage (Zhang et al. 2012; 
Chen et al. 2010; Wu et al. 2009). Clearly, further large-scale studies are necessary to 
replicate and confirm these findings, and to find the new genetic risk factors. 
 
9.3 Conclusion 
My systematic review in Chapters 2 to 4 has shown a younger onset of stroke, a 
relatively higher stroke incidence of total stroke, an around twofold higher 
proportion of ICH, a lower proportion of IS, and different distributions of ischaemic 
stroke subtypes, with a higher proportion of lacunar strokes and a lower proportion 
of cardioembolic strokes in Chinese compared with predominantly white populations 
since 1990, with substantial regional variations among Chinese populations. Also, 
from my risk factor meta-analyses for ICH versus IS in Chapter 5, I have showed 
differences between Chinese and predominantly white populations in the strength 
and significance of associations of several risk factors with ICH versus IS. 
Hypertension and alcohol intake are independent, modifiable risk factors for ICH 
versus IS in Chinese populations, regardless of age, sex, or other risk factors 
(Chapter 7). In terms of risk factor for IS (Chapters 6 and 8), Chinese IS patients 
have a similar prevalence of hypertension, diabetes, smoking and alcohol, and a 
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lower prevalence of AF, IHD and hypercholesterolaemia compared with Whites. The 
associations of risk factors with individual IS subtypes are mostly qualitatively 
similar (although differed in size) in Chinese and predominantly white populations. 
Compared with other IS subtypes: LAA strokes are associated with hypertension and 
diabetes; CE strokes are associated with AF and IHD; lacunar strokes are associated 
with hypertension and diabetes. The associations with hypertension and diabetes 
became stronger for lacunar strokes versus others after adjusting for potential 
confounders in Chinese populations.  
Although non-modifiable risk factors such as age, gender, and genetics play certain 
roles in stroke, it is of vital importance to target modifiable risk factors since they are 
manageable through intervention of lifestyle and medication, and they may vary 
among populations. The findings in my studies have important clinical and public 
health implications, especially for Chinese populations. A better understanding of the 
underlying reasons for the higher incidence of total stroke and ICH as well as 
different distributions of IS subtypes could help shed light on different stroke 
mechanisms, guide further well-designed research in this area, better predict the 
potential impacts ahead due to the rapid growth in the economy and changing 
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Appendix 1. Search strategy for community-based 
stroke incidence studies  
MEDLINE 
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp 
brain ischemia/ or exp carotid artery diseases/ or exp intracranial arterial diseases/ or 
exp "intracranial embolism and thrombosis"/ or intracranial hemorrhages/ or stroke/ 
or exp brain infarction/ or exp vertebral artery dissection/ 
2. Incidence/ or Cohort Studies/ 
3. 1 and 2 
4. ((incident or incidence or new cases or trend$) and (stroke or cerebrovasc$ or 
brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or isch?emi$ attack$ or tia$ or 
SAH)).tw. 
5. (((incident or incidence or new cases or trend$) and (brain$ or cerebr$ or cerebell$ 
or cortical or vertebrobasilar or hemispher$ or intracran$ or intracerebral or 
infratentorial or supratentorial or MCA or anterior circulation or posterior circulation 
or basal ganglia)) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$)).tw. 
6. (((incident or incidence or new cases or trend$) and (brain$ or cerebr$ or cerebell$ 
or intracerebral or intracran$ or parenchymal or intraventricular or infratentorial or 
supratentorial or basal gangli$ or subarachnoid or putaminal or putamen or posterior 
fossa)) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or 
bleed$)).tw. 
7. ((new or first$) adj5 stroke$).tw. 
8. 3 or 4 or 5 or 6 or 7 
9. china/ or hong kong/ or taiwan/ 
10. Asian Continental Ancestry Group/ 
11. (china or chinese or taiwan$ or hong kong).tw. 
12. (china$ or hong kong or taiwan).cp. 
13. chinese.lg. 





15. 8 and 14 
EMBASE 
1. cerebrovascular disease/ or basal ganglion hemorrhage/ or exp brain hematoma/ or 
exp brain hemorrhage/ or exp brain infarction/ or exp brain ischemia/ or exp carotid 
artery disease/ or cerebral artery disease/ or cerebrovascular accident/ or occlusive 
cerebrovascular disease/ or stroke/ 
2. stroke unit/ or stroke patient/ 
3. 1 or 2 
4. incidence/ or cohort analysis/ 
5. 3 and 4 
6. ((incident or incidence or new cases or trend$) and (stroke or cerebrovasc$ or 
brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or isch?emi$ attack$ or tia$ or 
SAH)).tw. 
7. (((incident or incidence or new cases or trend$) and (brain$ or cerebr$ or cerebell$ 
or cortical or vertebrobasilar or hemispher$ or intracran$ or intracerebral or 
infratentorial or supratentorial or MCA or anterior circulation or posterior circulation 
or basal ganglia)) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$)).tw. 
8. (((incident or incidence or new cases or trend$) and (brain$ or cerebr$ or cerebell$ 
or intracerebral or intracran$ or parenchymal or intraventricular or infratentorial or 
supratentorial or basal gangli$ or subarachnoid or putaminal or putamen or posterior 
fossa)) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or 
bleed$)).tw. 
9. ((new or first$) adj5 stroke$).tw. 
10. 5 or 6 or 7 or 8 or 9 
11. china/ or hong kong/ or taiwan/ 
12. chinese/ 
13. (china or chinese or taiwan$ or hong kong).tw. 







17. 11 or 12 or 13 or 14 or 15 or 16 







Appendix 2. Search strategy for and stroke 
types/ischaemic subtypes and risk factors in Chinese  
MEDLINE 
 1. china/ or hong kong/ or taiwan/ 
2. Asian Continental Ancestry Group/ 
3. (china or chinese or taiwan$ or hong kong).tw. 
4. (china$ or hong kong or taiwan).cp. 
5. chinese.lg. 
6. 1 or 2 or 3 or 4 or 5 
7. cerebrovascular disorders/cl or exp basal ganglia cerebrovascular disease/cl or exp 
brain ischemia/cl or exp carotid artery diseases/cl or exp intracranial arterial 
diseases/cl or exp "intracranial embolism and thrombosis"/cl or intracranial 
haemorrhages/cl or stroke/cl or exp brain infarction/cl or exp vertebral artery 
dissection/cl 
8. 6 and 7 
9. *cerebrovascular disorders/ep or exp *basal ganglia cerebrovascular disease/ep or 
exp *brain ischemia/ep or exp *carotid artery diseases/ep or exp *intracranial arterial 
diseases/ep or exp *"intracranial embolism and thrombosis"/ep or *intracranial 
haemorrhages/ep or *stroke/ep or exp *brain infarction/ep or exp *vertebral artery 
dissection/ep 
10. 6 and 9 
11. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp 
brain ischemia/ or exp carotid artery diseases/ or exp intracranial arterial diseases/ or 
exp "intracranial embolism and thrombosis"/ or intracranial haemorrhages/ or stroke/ 
or exp brain infarction/ or exp vertebral artery dissection/ 
12. (stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or 
isch?emi$ attack$ or tia$ or SAH).tw. 
13. ((brain$ or cerebr$ or cerebell$ or cortical or vertebrobasilar or hemispher$ or 
intracran$ or intracerebral or infratentorial or supratentorial or MCA or anterior 
circulation or posterior circulation or basal ganglia) adj5 (isch?emi$ or infarct$ or 





14. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or 
intraventricular or infratentorial or supratentorial or basal gangli$ or subarachnoid or 
putaminal or putamen or posterior fossa) adj5 (haemorrhage$ or hemorrhage$ or 
haematoma$ or hematoma$ or bleed$)).tw. 
15. 11 or 12 or 13 or 14 
16. (type$ of stroke or stroke type$ or subtype$ or classification or TOAST or 
BAMFORD).tw. 
17. (stroke adj5 categor$).tw. 
18. risk factors/ or risk factor$.tw.  
19. *cerebrovascular disorders/et or exp *basal ganglia cerebrovascular disease/et or 
exp *brain ischemia/et or exp *carotid artery diseases/et or exp *intracranial arterial 
diseases/et or exp *"intracranial embolism and thrombosis"/et or *intracranial 
haemorrhages/et or *stroke/et or exp *brain infarction/et or exp *vertebral artery 
dissection/et 
20. 16 or 17 or 18 or 19 
21. 6 and 15 and 20 
22. 8 or 10 or 21 
EMBASE 
1. china/ or hong kong/ or taiwan/ 
2. chinese/ 
3. (china or chinese or taiwan$ or hong kong).tw. 
4. (china or hong kong or "taiwan republic of china").cp. 
5. chinese.sl. 
6. chinese.lg. 
7. 1 or 2 or 3 or 4 or 5 or 6 
8. cerebrovascular disease/ or basal ganglion hemorrhage/ or exp brain hematoma/ or 
exp brain hemorrhage/ or exp brain infarction/ or exp brain ischemia/ or exp carotid 
artery disease/ or cerebral artery disease/ or cerebrovascular accident/ or occlusive 





9. stroke patient/ or stroke unit/ 
10. (stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or 
isch?emi$ attack$ or tia$ or SAH).tw. 
11. ((brain$ or cerebr$ or cerebell$ or cortical or vertebrobasilar or hemispher$ or 
intracran$ or intracerebral or infratentorial or supratentorial or MCA or anterior 
circulation or posterior circulation or basal ganglia) adj5 (isch?emi$ or infarct$ or 
thrombo$ or emboli$)).tw. 
12. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or 
intraventricular or infratentorial or supratentorial or basal gangli$ or subarachnoid or 
putaminal or putamen or posterior fossa) adj5 (haemorrhage$ or hemorrhage$ or 
haematoma$ or hematoma$ or bleed$)).tw. 
13. 8 or 9 or 10 or 11 or 12 
14. classification/ or exp clinical classification/ or exp disease classification/ 
15. (type$ of stroke or stroke type$ or subtype$ or classification or TOAST or 
BAMFORD).tw. 
16. (stroke adj5 categor$).tw. 
17. cardiovascular risk/ or risk factor/ 
18. risk factor$.tw. 
19. 14 or 15 or 16 or 17 or 18 
20. 7 and 13 and 19 
21. *cerebrovascular disease/ep, et or *basal ganglion hemorrhage/ep, et or exp 
*brain hematoma/ep, et or exp *brain hemorrhage/ep, et or exp *brain infarction/ep, 
et or exp *brain ischemia/ep, et or exp *carotid artery disease/ep, et or *cerebral 
artery disease/ep, et or *cerebrovascular accident/ep, et or *occlusive 
cerebrovascular disease/ep, et or *stroke/ep, et 
22. 7 and 21 
23. 20 or 22 
24. limit 23 to human 
25. (199$ or 20$).em. 





Appendix 3. Search strategy for systematic review 
and meta-analysis of risk factors in stroke 
types/subtypes in white populations 
MEDLINE 
1. cerebrovascular disorders/cl or exp basal ganglia cerebrovascular disease/cl or exp 
brain ischemia/cl or exp carotid artery diseases/cl or exp intracranial arterial 
diseases/cl or exp "intracranial embolism and thrombosis"/cl or intracranial 
haemorrhages/cl or stroke/cl or exp brain infarction/cl or exp vertebral artery 
dissection/cl 
2. *cerebrovascular disorders/ep or exp *basal ganglia cerebrovascular disease/ep or 
exp *brain ischemia/ep or exp *carotid artery diseases/ep or exp *intracranial arterial 
diseases/ep or exp *"intracranial embolism and thrombosis"/ep or *intracranial 
haemorrhages/ep or *stroke/ep or exp *brain infarction/ep or exp *vertebral artery 
dissection/ep 
3. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp 
brain ischemia/ or exp carotid artery diseases/ or exp intracranial arterial diseases/ or 
exp "intracranial embolism and thrombosis"/ or intracranial haemorrhages/ or stroke/ 
or exp brain infarction/ or exp vertebral artery dissection/ 
4. (stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or 
isch?emi$ attack$ or tia$ or SAH).tw. 
5. ((brain$ or cerebr$ or cerebell$ or cortical or vertebrobasilar or hemispher$ or 
intracran$ or intracerebral or infratentorial or supratentorial or MCA or anterior 
circulation or posterior circulation or basal ganglia) adj5 (isch?emi$ or infarct$ or 
thrombo$ or emboli$)).tw. 
6. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or 
intraventricular or infratentorial or supratentorial or basal gangli$ or subarachnoid or 
putaminal or putamen or posterior fossa) adj5 (haemorrhage$ or hemorrhage$ or 
haematoma$ or hematoma$ or bleed$)).tw. 
7. 3 or 4 or 5 or 6 
8. (type$ of stroke or stroke type$ or subtype$ or classification or TOAST or 
BAMFORD).tw. 
9. (stroke adj5 categor$).tw. 





11. *cerebrovascular disorders/et or exp *basal ganglia cerebrovascular disease/et or 
exp *brain ischemia/et or exp *carotid artery diseases/et or exp *intracranial arterial 
diseases/et or exp *"intracranial embolism and thrombosis"/et or *intracranial 
haemorrhages/et or *stroke/et or exp *brain infarction/et or exp *vertebral artery 
dissection/et 
12. 8 or 9 or 10 or 11 
13. 7 and 12 
14. 1 or 2 or 13 
15. meta-analysis/ 
16. meta-analysis as topic/ 
17. (meta anal$ or meta-anal$ or metaanal$).tw. 
18. "Review Literature as Topic"/ 
19. (systematic$ adj4 (review$ or overview$)).tw. 
20. (selection criteria or (extract$ adj3 data)).ab. 
21. review.pt. and (systematic.ab. or overview.ti.) 
22. (handsearch$ or hand-search$ or manual search$).ab. 
23. (search$ adj3 (MEDLINE or PUBMED or EMBASE or relevant journals or 
Science Citation Index or reference list$ or bibliograph$ or database$)).ab. 
24. or/15-23 
25. 14 and 24 
26. (199$ or 20$).ed. 
27. 25 and 26 
EMBASE 
1. cerebrovascular disease/ or basal ganglion hemorrhage/ or exp brain hematoma/ or 
exp brain hemorrhage/ or exp brain infarction/ or exp brain ischemia/ or exp carotid 
artery disease/ or cerebral artery disease/ or cerebrovascular accident/ or occlusive 
cerebrovascular disease/ or stroke/ 





3. (stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or 
isch?emi$ attack$ or tia$ or SAH).tw. 
4. ((brain$ or cerebr$ or cerebell$ or cortical or vertebrobasilar or hemispher$ or 
intracran$ or intracerebral or infratentorial or supratentorial or MCA or anterior 
circulation or posterior circulation or basal ganglia) adj5 (isch?emi$ or infarct$ or 
thrombo$ or emboli$)).tw. 
5. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or 
intraventricular or infratentorial or supratentorial or basal gangli$ or subarachnoid or 
putaminal or putamen or posterior fossa) adj5 (haemorrhage$ or hemorrhage$ or 
haematoma$ or hematoma$ or bleed$)).tw. 
6. 1 or 2 or 3 or 4 or 5 
7. classification/ or exp clinical classification/ or exp disease classification/ 
8. (type$ of stroke or stroke type$ or subtype$ or classification or TOAST or 
BAMFORD).tw. 
9. (stroke adj5 categor$).tw. 
10. cardiovascular risk/ or risk factor/ 
11. risk factor$.tw. 
12. 7 or 8 or 9 or 10 or 11 
13. 6 and 12 
14. "systematic review"/ or "systematic review (topic)"/ 
15. meta analysis/ or "meta analysis (topic)"/ 
16. (systematic$ adj4 (review$ or overview$)).tw. 
17. (meta anal$ or meta-anal$ or metaanal$).tw. 
18. (selection criteria or (extract$ adj3 data)).ab. 
19. overview.ti. 
20. (search$ and (MEDLINE or PUBMED or EMBASE)).ab. 
21. 14 or 15 or 16 or 17 or 18 or 19 or 20 





23. limit 22 to human 
24. (199$ or 20$).em. 






Appendix 4. A cover letter for research collaboration 











DIVISION of CLINICAL NEUROSCIENCES 
 
The University of Edinburgh 
Bramwell Dott Building 
Western General Hospital 
Crewe Road 
Edinburgh EH4 2XU 
 
Telephone 0131 537 2082 




Dr.Jiann-Shing, MD, PhD  
Associate Professor  
Stroke Center and Department of Neurology  
National Taiwan University Hospital  
 
4 July 2011 
 
Dear Dr Jiann-Shing, 
 
Potential research collaboration 
 
I am pleased to introduce myself as Chung-Fen Tsai’s supervisor for her PhD 
on epidemiology and genetics of stroke and its subtypes in Taiwan, China 
and Hong Kong. You will see from her summary report that she has made an 
excellent start on a systematic review of the relevant literature on studies of 
incidence of stroke, its pathological types and subtypes and risk factors.  
 
She is keen to continue her research in this area with some analyses of 
relevant data. We wondered about the possibility of collaborating with you on 
analyses of the Taiwan Stroke Registry data, perhaps in particular from the 





some proposals with you. In particular, we considered that it might be of 
interest to assess: 
 
(1) The distribution of pathological types and main aetiological subtypes in 
comparison with European origin populations 
 
(2) The relative frequencies of vascular risk factors among different 
ischaemic stroke subtypes in comparison with European origin populations 
 
(3) Family history of stroke and other vascular diseases among those with 
different stroke types and subtypes in comparison with European origin 
populations 
 
(4) Genetic differences between aetiological subtypes of ischaemic stroke in 
comparison with European origin populations. 
 
Chung-Fen will be in Taiwan from 6/7 July until early August and hopes to 
meet with you to discuss these ideas. If you are interested, I would be happy 
to discuss any of these further with you by email or telephone. 
 
I look forward to hearing your thoughts in due course, and in the meantime, 
best wishes, 
 
Yours sincerely,  
Dr Cathie Sudlow 








Appendix 5. National Taiwan Stroke Registry – Patient 
information form 
Stroke and Cerebral Atherosclerosis Study at NTUH (SCAN) 
CI Ath Lacune CEI Specific Unclassified ICH SAH TIA 
         
 
A. Basic Information: 
  Case No:          , Chart No :             , ID No. :                
  Name:            , Tel :                 Ward :             
  Birth date:             , Age :         , Sex : male , female 
  Date of admission:            , Date of transferring to other ward :             
  Date of discharge:             , Duration of hospitalization :        days 
  BW:        kg, BL:        cm 
 
B. Past History: 
   1. Hypertension: Yes, No            
   2. Diabetes mellitus: Yes, No 
   3. Ischemic heart disease: Yes, No     
   4. Atrial fibrillation: Yes, No 
   5. Rheumatic heart disease: Yes, No﹔operation                   
   6. Other heart disease:                  
   7. Stroke: Yes, No﹔type: CI, ICH, SAH 
   8. TIA: Yes, No 
   9. Smoking: Yes（current, ex-smoking, pack-year      ）No 
  10. Drinking: Yes, No 
  11. Malignancy:  
12. Other disease: 
 
C. Family History: 
   1. HT: grandparents, parents, brothers/sisters, siblings 
   2. DM: grandparents, parents, brothers/sisters, siblings 
   3. Stroke: grandparents, parents, brothers/sisters, siblings 
   4. IHD: grandparents, parents, brothers/sisters, siblings 
 
D. Preset Illness: 
   1. Stroke/TIA onset date/time:                         
   2. Symptoms/signs: headache, dizziness/vertigo, vomiting, fever, neck 
stiffness, conscious disturbance (drowsiness, stupor, coma), 





UL, LL), diplopia, ataxia, aphasia, dysarthria, dysphagia, 
sphincter incontinence, mental confusion,  visual field defect, seizure, 
Others:                             
   3. Duration of onset to door: <3h, 3-6h, 6-12h, 12-24h, 2-3D, 4-7D, 
>7D  
   4. Date/time of ER arrival:                
   5. Onset-to-peak: sudden, <1h, 1-3h, 3-6h, 6-12h, 12-24h, 2-3D, 
>3D 
   6. Initial GCS:              Initial NIHSS:          
   7. Initial blood pressure:       /      mmHg 
 
E. Complications: death (Time      ), due to                             
chest infection, UTI, UGI bleeding, LGI bleeding, 
GU bleeding, acute coronary syndrome, AMI, pressure 
sore, falls, fracture, depression, DVT, pulmonary 
embolism, painful shoulders, respiratory failure, epileptic 
seizure (the      day), others : 
 
 
F. Images of Brain: CI, ICH, SAH      By CT (Time    ), MRI (Time     ) 
    CI site: cortical, small subcortical (lacune), large subcortical, small 
brainstem, large brainstem/cerebellum,  negative  
CH site: lobe/cortical, putamen, thalamus, putamen-thalamus, 
cerebellum, pons, caudate, IVH, multiple, Others :         Sites: 
    MRA: 
CTA: 
    Angiography: 
 
G. Biochemistry: 
  1. CBC: Hb       , Hct       , WBC       , PLT       
  2. Glucose AC        , HbA1C         UA         
    CHOL        , TG        , HDL        , LDL            
  3. PT:         /          INR          PTT :         /         
  4. BUN/CR:         /           
  5. AST/ALT:         /           
 
H. EEG, ECG and CXR: 
1. EEG: normal, focal SW, diffuse SW(with, without focal 
predominance),  
focal spikes    





3. CXR : Cardiomegaly, Aortic wall calcification 
 
I. Ultrasonography: 
  1. Duplex of neck vessels (No.            ) : 
    ECCA atherosclerosis: present, absent CCA IMT: R     mm, L     mm 
    ECCA stenosis > 50%: present, absent 
    Plaque scoring: 
 CCA1 CCA2 Bulb ICA ECA 
Right      
Left      
     Total score:           
2. TCDI (No.         )                    
3. TTE: 
4. TEE:    
 
 
 
